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ABSTRACT
Cells are constantly subjected to DNA damage from endogenous and exogenous sources.
Spontaneous DNA damage alone accounts for -30,000 DNA lesions per day in a mammalian
cell. Cells are also exposed to an enormous variety of environmental agents that can cause a
wide range of modified bases and aberrant DNA structures. To respond to the large diversity of
DNA lesions that can be produced, cells possess a host of DNA repair and damage tolerance
systems. The majority of these processes operate with exquisite accuracy to restore the correct
DNA sequence and structure to maintain genomic stability. However, in some cases, DNA
damage induces a mutagenic response and these mechanisms are responsible for the active
introduction of mutations into the genomes of all organisms.
Since the discovery in 1999 of a novel superfamily of error-prone translesion DNA
polymerases, we have gained substantial insight into the biochemical mechanisms of DNA
damage tolerance and mutagenesis. Translesion polymerases are specialized to insert a
nucleotide opposite to DNA lesions and often produce mutations during the replication of
undamaged DNA. It is now appreciated that the regulation of DNA damage tolerance systems at
multiple levels is critical to the appropriate deployment of these potentially mutagenic
translesion polymerases to prevent rampant mutagenesis.
In particular, this thesis has focused on determining the regulation of the translesion
polymerase Revl in the model organism Saccharomyces cerevisiae. The REV] gene is
responsible for the vast majority of spontaneous and damage-induced mutagenesis in all
eukaryotes, from unicellular yeast to multicellular humans. Thus, an understanding the
regulation and molecular mechanisms of REV1 activity will provide critical insight into the
processes of mutagenesis underlying disease and evolution.
The studies described here provide evidence supporting a new model of translesion
synthesis, based on the observation of the cell-cycle regulation of the Rev1 protein.
Additionally, mutations in conserved motifs in Revl have allowed characterization of the
protein-protein interactions critical for REV1 activity in survival and mutagenesis. Taken
together, the data presented here argue for a cellular response mediated through Rev regulation
which temporally and spatially restricts potentially mutagenic translesion synthesis such that it is
employed only when necessary.
Thesis Advisor: Graham C. Walker
Title: Professor of Biology
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Chapter One
Introduction
Chapter One--Introduction
Overview
The faithful replication of DNA and proper transmission of chromosomes is essential to
inherit an accurate and complete genome, which encodes the information necessary for life.
Ironically, the process of living itself generates reactive metabolites that can cause DNA damage.
Cells are also exposed to a vast array of exogenous stresses that can directly or indirectly lead to
DNA damage. Although cells contain multiple, highly complex systems to faithfully restore
DNA to its original sequence and structure, at times distinct mechanisms are required to
temporarily tolerate DNA damage without mediating repair of a lesion. These DNA damage
tolerance processes contribute to survival after DNA damage and, in some situations, also
actively promote the generation of mutations. The factors responsible for spontaneous and
damage-induced mutagenesis are now known to include specialized DNA polymerases, termed
translesion polymerases. Understanding of these potentially dangerous, yet highly conserved,
polymerases is critical to a complete knowledge of cell stress responses, mechanisms of genomic
integrity, cell death after DNA damage, induction of mutations, disease development, and the
processes of adaption and evolution. My thesis work has focused on the regulation of one of
these translesion DNA polymerases, S. cerevisiae Revl, and the molecular mechanisms of its
function.
Here I will provide an introduction to the many strategies a cell may employ to allow
survival in the face of DNA damage. I focus on the contribution of damage tolerance
mechanisms, in particular translesion synthesis, and review our current understanding of the
regulation of translesion synthesis, including a discussion of the prevailing model and the
emergence of new paradigms. I describe the DNA polymerases that mediate translesion
synthesis and highlight the unique properties of the Rev1 family. To further understand the
contribution of RE V to translesion synthesis and mutagenesis, I have characterized its
regulation, discussed in Chapter Two. Additionally, I have undertaken structure-function
studies, described in Chapter Three, to elucidate the role of the several domains of Rev1 in its
function in vivo.
1.1 Types of DNA damage
DNA damage represents a major obstacle to proper cellular functions. It has been
estimated that there are approximately -30,000 lesions generated spontaneously in a mammalian
cell per day (114). DNA damage can occur both spontaneously and from environmental sources.
Spontaneous sources of DNA damage include reactive oxygen species generated primarily
during aerobic metabolism; base deamination, especially of cytosine to uracil; and the inherent
lability of DNA to depurinations and depyrimidinations (47, 114). Additionally, many
environmental factors can cause DNA damage, such as ionizing or ultraviolet (UV) radiation and
chemical agents -including methyl methanesulfonate (MMS), cisplatin, and benzo[a]pyrene (47).
Reflecting the diversity of DNA damaging agents, there are a wide variety of DNA lesions which
can adversely affect the cell. These fall broadly into two classes of DNA damage: modifications
to the nitrogenous base or alterations in the sugar-phosphate backbone. Many types of base
modifications canl take place, including: base loss by cleavage of the N-glycosidic bond;
adduction by aldehydes, alkylation, or other electrophilic additions to any of various reactive
positions on the base; oxidative damage, mostly by addition of hydroxyl to double bonds;
covalent linkages between adjacent bases, such as cis-syn and 6-4 TT dimers, to form intrastrand
crosslinks; and interstrand crosslinks caused by bifunctional alkylating agents (47). Alterations
in the sugar-phosphate backbone can take the form of single or double strand breaks generated
by cleavage at abasic sites, by free radical abstraction of a hydrogen from the ribose moiety, or
by inhibition of a DNA nicking activity such as topoisomerase I (47).
1.2 DNA repair
11.2.1 Repair of base modifications
The diversity of DNA lesions produced necessitates a panoply of cellular responses to
DNA damage. Accordingly, cells have developed multiple DNA repair pathways. The repair of
base modifications constitutes one class of DNA repair pathways. A modified base may be
repaired by direct reversal, such as the enzymatic cleavage of UV photoproducts by photolyase
(47, 175). Alternatively, a lesion or improper base pair may be excised and the DNA
resynthesized by several excision repair pathways: nucleotide excision repair (NER) which
mainly acts on large, bulky lesions that distort the DNA helix (39, 47, 174), base excision repair
(BER) which predominantly repairs alkylation damage and depurinations (9, 47, 174), or
mismatch repair (MMR) which recognizes DNA mismatches produced during DNA replication
or by deamination events (47, 97, 176). All of these pathways function by a conceptually similar
strategy. First, a DNA damage recognition factor binds to a DNA lesion and recruits
endonucleases which nick the DNA flanking the lesion. In the case of BER, this recognition
factor is a glycosylase that removes the damaged base while leaving the DNA backbone intact
(9, 47, 174). For NER and MMR, the recognition factor does not cleave the DNA itself but
instead recruits other endonucleases (39, 47, 97, 174, 176). A helicase or other enzyme will
remove the intervening damage, creating a gap which is then filled in by a DNA polymerase
using the undamaged strand as a template. The remaining nick is sealed by a DNA ligase.
Long-patch and short-patch, and in some cases very-short-patch, variations of these pathways
exist and there is considerable overlap and cross-talk among the excision repair pathways (47).
Moreover, these pathways are to some extent redundant with each other, reflecting the cell's
dedication to ensuring genomic integrity, as well as the severity of potentially lethal effects of
unrepaired DNA damage.
1.2.2 Repair of strand breaks
1.2.2.1 Double strand break repair
DNA strand breaks constitute a distinct form of DNA damage handled by another set of
DNA repair pathways. Double-strand breaks (DSBs) are repaired by three separate pathways:
non-homologous end-joining (NHEJ), homologous recombination (HR), and single strand
annealing (SSA). In highly repetitive vertebrate genomes or when a homologous sequence is not
available such as in G 1 haploid yeast, repair of DSBs occurs by the end joining of non-
homologous chromosomes (47, 68). Briefly, Ku proteins bind to the ends of DSBs and recruit
end-bridging factors-DNA-PK and Artemis in vertebrates, the Mrel l/Rad50/Xrs2 complex in
yeast-which process the ends of the breaks (47, 68). This is necessary since DSBs rarely have
clean ends, but usually have broken ribose-phosphate moieties which impede ligation. DNA
ligase IV and X-family DNA polymerases then fill in any gaps and seal the DNA backbone to
restore an intact chromosome (47, 68). Prokaryotes also have a recently discovered NHEJ
pathway which recapitulates the enzymatic steps outlined above in eukaryotes, but using
multifunctional proteins which contain DNA polymerase, nuclease, and ligase activities in a
single polypeptide (20, 68).
When a homologous sequence is available, such as during S-phase and G2 while the
]preferred substrate of a sister chromatid is present, the cell will repair a DSB through
homologous recombination (Fig. 1) (47). The first step of HR is exonucleolytic 5' to 3' resection
of the ends to generate ssDNA with free 3' ends which invade the homologous region of the
double strand substrate (47, 163, 206). This substrate can be a sister chromatid, a homologous
chromosome, a different chromosome, or even a repeated region on the same chromosome (47,
163). Strand invasion displaces the original complementary strand of the substrate, forming a D-
loop structure containing a primed template for DNA polymerase to extend (47, 163, 206). At
this point, HR can proceed through any of three subpathways (47, 163, 186). In the classical
double-strand break repair (DSBR) pathway, the 5' end of the DNA can pair with the substrate in
the D-loop bubble, generating a double Holliday junction (Fig. lA). Holliday junctions can
translocate over many kilobases by branch migration. Once a DNA polymerase has filled in the
gap, Holliday junction resolution separates the two chromosomes, in either a crossover or non-
crossover manner (47, 163, 206). The DSBR pathway has been well-established for meiotic
recombination in eukaryotes. However, mitotic recombination may occur predominantly
through alternative subpathways of HR. In the synthesis-dependent strand annealing (SDSA)
pathway, following the initiation of DNA synthesis after strand invasion, the invading strands
separate from the, substrate and re-anneal to each other to complete DNA synthesis (Fig. 1 B) (47,
163). A form of SDSA is also thought to occur during template switching mode of DNA damage
tolerance (see section 1.3.1). Additionally, HR may occur through break-induced replication
(BIR), in which one half of the broken chromosome is lost and the replication fork reconstituted
by strand invasion recapitulates the entire rest of the chromosome (Fig. 1 C) (47, 163).
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Fig. 1 Pathways of repair of DSB by homologous recombination. [Adapted from (186).] Black
lines and grey lines indicate two different chromosomes. Arrows indicate the 3' end of the DNA
strand and triangles indicate cleavage events. A DSB can be repaired through three
subpathways. First., the 5' ends are resected, allowing the free 3' strands to invade a region of
homology. The displaced strand forms a D-loop structure. (A) In the classic DSBR pathway,
annealing of the other half of the broken chromosome generates a double Holliday junction
which can translocate to increase the region of DNA transferred from one chromosome to
another (not shown). Cleavage can occur in one of two ways (at arrows 1, 3 and 2, 4 or 1, 4 and
:2, 3) to resolve the Holliday junctions in a crossover or non-crossover manner respectively. (B)
Alternatively, annealing of the other half of the broken chromosome can be disrupted after DNA
synthesis has generated complementary ends, such that the two nascent strands can now pair
with each other to finish filling in the remaining gaps. (C) If the other half of the broken
chromosome is lost, establishment of two replication forks can resynthesize the lost DNA using
the other chromosome as a template.
Finally, a DSB can be repaired by single-strand annealing (SSA). This pathway relies on
annealing of direct repeats, usually on the same DNA molecule (47, 163). In this situation,
exonucleolytic processing of the DSB to produce 3' ssDNA uncovers regions of homology that
can then pair. Cleavage of the 3' heterologous tails allows ligation after a DNA polymerase has
filled in the gaps. SSA results in deletion of any intervening sequence and is therefore highly
mutagenic, however SSA appears to be an important DSB repair pathway in higher eukaryotes
(163).
How a cell chooses between the NHEJ and HR modes of repair is not clear and is
currently a focus of ongoing research. In vertebrates, NHEJ predominates over HR while in
yeast, HR is more frequent than NHEJ (47, 68). If multiple breaks are present, NHEJ can result
in chromosomal translocations and even when presented with only one DSB, NHEJ can cause
loss of information at the break site due to end processing which may remove damaged
nucleotides. Despite this mutagenic potential, vertebrates may preferentially use NHEJ since
their genomes contain many repeated regions such that HR could attempt to synapse repeats on
two different chromosomes, causing a genomic rearrangement (47). Additionally, end joining
factors are thought to be recruited very rapidly to hold closely opposed ends of the DSB together
to avoid translocations. In contrast, HR uses a sister chromatid or homologous chromosome as a
template to repair the DSB, resulting in less potential for genomic rearrangements and
information loss. However, the break-induced replication (BIR) mode of HR has been
associated with an increase in point mutations generated by mutagenic translesion polymerase
mediated DNA synthesis (74, 166). Cell-cycle stage contributes to DSB repair choice, as does
the nature of the DSB, but overall the mechanisms controlling this decision are not currently well
understood (47, 206).
1.2.2.2 Single strand break repair
Single-strand break repair (SSBR) requires additional DNA repair components (24, 47).
Although a simple nick can easily be ligated, a strand break often has complex ends composed of
broken ribose or phosphate moieties and may also contain a region of ssDNA. In mammalian
cells, nick recognition is accomplished primarily by poly(ADP-ribose) polymerase (PARP). The
single strand ends can be processed to remove blocked 5' and 3' termini either by the AP-lyase
activity of DNA polymerase P or by polynucleotide kinase. Gap filling is usually accomplished
by an X-family polymnerase such as polymerase P, but the replicative DNA polymerases may
substitute if needed. The scaffolding protein XRCC1 coordinates SSBR by stimulating
polynucleotide kinase, as well as interacting with DNA polymerase 1 and DNA ligase III.
Finally DNA ligase III or DNA ligase I seals the nick (24, 47). Many of the components of
SSBR are unique to mammals and at this time, it is not clear how or if SSBR occurs in lower
eukaryotes.
1.3 DNA damage tolerance
In addition to DNA repair processes, cells have mechanisms to temporarily tolerate DNA
damage encountered during transactions with DNA. Although not generally considered the first
line of defense after DNA damage, tolerance mechanisms are crucial for cellular survival under
conditions when a DNA lesion is encountered during DNA metabolism (47). Inhibition of DNA
metabolism by a lesion may arise due to mutational inactivation of one of the previously
described DNA repair pathways, exposure to high levels of DNA damage, a DNA lesion which
Jis particularly recalcitrant to DNA repair or one which is present in an inaccessible region of the
chromosome, or simply by chance. Damage tolerance is particularly important during DNA
replication, although it may also play a role during transcription (S. Cohen, unpublished data)
and, theoretically, in other situations where DNA and possibly RNA is processed in a sequence-
specific manner. When the replication machinery encounters a modified base that cannot be
used as a template by the highly stringent replicative DNA polymerase, DNA synthesis can
temporarily halt (47, 100). Such replication fork stalling can generate ssDNA stretches due to
the uncoupling of leading and lagging strand synthesis (118, 153, 195). DNA damage tolerance
mechanisms facilitate the restoration of DNA replication at stalled replication forks and also
promote resolution iof aberrant DNA structures left behind when replication forks reprime
downstream of a DNA lesion (47, 107). Conceptually, DNA damage tolerance is very different
from DNA repair' in that, rather than restoring the DNA to its proper sequence and structure,
tolerance pathways help the replication machinery bypass a DNA lesion, leaving the lesion still
present in the DNA after replication (47). This is accomplished by two main modes of DNA
damage tolerance: recombinational bypass and translesion synthesis (TLS), which is the focus of
this thesis, in particular the TLS polymerase Rev 1.
1.3.1 Recombinational bypass
Recombinational bypass of a DNA lesion uses information from another, undamaged
strand as a template to synthesize DNA past a region containing the lesion. This occurs by
dissociation of the nascent DNA strand from its template to allow pairing with an undamaged
template (Fig. 2). The presence at the replication fork of two double-stranded helices comprising
four strands of homologous DNA can lead to a variety of complex DNA structures during bypass
of a lesion. For simplicity, linear pathways are described, but it is important to note that in the
cell, combinations of different topological conformations can occur sequentially. Several non-
exclusive models have been proposed for recombinational bypass (47). The major distinctions in
the pathways rely on the identity of the undamaged template and the timing of the bypass
synthesis relative to encountering the lesion, i.e. whether the DNA opposite the lesion is
synthesized at the replication fork through fork regression or after the fork has passed leaving a
gap that can be filled in later by daughter strand gap repair.
To bypass a DNA lesion at a fork, the stalled replication fork may roll backwards to
reanneal the two parental strands, allowing pairing of the two daughter strands and DNA
synthesis past the site of the lesion using one newly synthesized daughter strand as a template for
the other (Fig. 2A) (37, 47). Multiple resolutions of this "chicken foot" Holliday junction
structure are possible, including reverse branch migration to restore semiconservative replication
(Fig. 2A) or cleavage of the regressed fork to yield a broken chromosome which can then invade
to form a D-loop and restart replication (Fig. 2B) (37, 47). This model is most frequently termed
replication fork regression or template switching.
Alternatively, instead of fork regression, DNA synthesis may reprime downstream of a
lesion, leaving behind a lesion-containing ssDNA gap that can be processed by the
recombination machinery (Fig. 2C) (47, 69). In this case, the template can be an already
replicated homologous sequence from a sister chromatid, a homolog, another chromosome, or a
repeated region on the same chromosome. Pairing, strand exchange, branch migration, and
Holliday junction resolution are envisioned to occur similarly to normal homologous
recombination (see Section 1.2.2.1) (47, 182). This mode of recombinational bypass is known as
daughter strand gap repair, which, despite its name, is a form of damage tolerance since the
lesion remains in the replicated double helix. The term "repair" refers to the gap, which is
removed during the bypass. Though long considered unlikely, it is now appreciated that
daughter strand gap repair could operate well after replication has been completed (107).
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Fig. 2 Pathways of recombinational bypass. Arrows indicate the 3' end of the DNA strand,
triangles indicate the cleavage events, and dashed lines indicate DNA synthesis. Black lines
show the parental DNA strand; grey lines indicate the daughter strand. A DNA lesion which
blocks the leading strand replication fork can be bypassed in several ways. (A) Regression of
the replication fork results in pairing of the two nascent daughter strands by a template switch.
DNA synthesis using the undamaged daughter strand can then proceed past the site of the lesion.
Reverse branch migration of the Holliday junction reanneals the daughter strands to their original
template strands to allow semiconservative replication to resume. (B) Alternatively, once the
fork has regressed to form a Holliday junction, cleavage could occur to generate two linear
molecules which would be substrates for homologous recombination, as described in section
1.2.2.1. (C) Repriming of the DNA polymerase downstream of the site of the lesion creates a
gap in the daughter strand. The recombination machinery can then pair this ssDNA with an
undamaged template and the gap can be filled in using the sister chromatid, or another DNA
molecule with homology.
1.3.2 Translesion synthesis
Translesion synthesis (TLS) is the process by which a DNA lesion is bypassed by
inserting a nucleotide opposite to the lesion (47). Many DNA lesions cannot be used as a
template for the highly stringent replicative DNA polymerases, which are optimized to replicate
the entire genome with high accuracy and efficiency (7, 47). A specialized class of DNA
polymerases, known as TLS polymerases, can use various damaged bases as templates and insert
nucleotides opposite to lesions despite the conformational constraints many modified bases may
impose (47, 56, 164). Most TLS polymerases are members of the Y family of DNA polymerases
(148), with the notable exception of DNA polymerase ý, a member of the B family of replicative
DNA polymerases in eukaryotes (132). In addition to polymerase ý, TLS polymerases include
five major types of Y family polymerases (148). Briefly, they include: 1) the prokaryotic
polymerase V, composed of UmuC and a dimer of the accessory factor UmuD', which bypasses
a variety of DNA lesions in a mutagenic manner; 2) polymerase IV, also known as DinB, Dpo4,
and polymerase K in prokaryotes, archaea, and eukaryotes respectively, which functions in a
relatively error-free manner in cells to bypass adducted G residues; 3) polymerase ir, found only
in eukaryotes, which is specialized to bypass cis-syn TT dimers produced by UV irradiation and
4) its paralog polymerase i whose biological function is unknown; and finally 5) Revl, found
only in eukaryotes, which has limited polymerase activity, restricted to inserting primarily C
residues across from G's and certain lesions (47). (Refer to section 1.3.6 for more details.) In
this thesis, I have focused on understanding the regulation and function of Revl.
1.3.2.1 Physical features of TLS polymerases
Several crystal structures have provided insight into the architectural features that confer
unique properties to the Y family members (115, 116, 137, 138, 180, 189, 190, 216) and recently
many new structures have been elucidated which refine our understanding. Despite a complete
lack of primary sequence homology with all other known DNA polymerases, Y family members
share the classic "right-hand" DNA polymerase fold (7, 164, 212). Like replicative polymerases,
the catalytic aspartate and glutamate residues, which coordinate the divalent magnesium ions that
stabilize the triphosphate group of the incoming dNTP, are located in the central palm region (7,
164, 211). Though the secondary structure of the domains is different in Y-family polymerases,
thumb and fingers domains analogous to those in replicative polymerases grip the DNA and
make specific contacts to the primer and template strands respectively (Fig. 3) (7, 164, 211).
Although they share a common overall architecture, Y family polymerases differ from
replicative polymerases in certain key ways to allow them to perform translesion synthesis. At a
whole-structure level, this can be seen by the presence and absence of entire domains relative to
replicative polymerases. Importantly, Y family polymerases lack the 3' to 5' exonuclease
domain of replicative DNA polymerases which functions to proofread the newly replicated
strand (56, 212). This domain contributes a 102 fold increase in fidelity to replicative DNA
polymerases (96). It should be noted that there is precedent for extrinsic proofreading of
mismatches inserted by non-replicative polymerases by the exonuclease subunits of replicative
polymerases (127). A novel little fingers domain (also called the polymerase associated domain
(PAD) or the wrist) in Y family polymerases extends from the classical fingers domain and
makes extra contacts with the DNA (211, 212). This additional DNA binding region provides
important stability for the ternary complex, since Y family members have short, stubby thumb
and fingers domains which make few contacts with the DNA backbone (164, 211). Y family
polymerases generally have an open grip on the DNA (Fig. 3) and a greatly reduced processivity
relative to replicative DNA polymerases (48, 164); truncations of the little fingers domain
reduces DNA binding and processivity even further (164). The little finger domain appears to
contact the region of the template containing the lesion (Fig. 3) and has been implicated in lesion
specificity (19).
Closer inspection of the active site of Y family and replicative polymerases also reveals
significant differences. Particularly for the archaeal and prokaryotic Y family polymerases, the
active site is larger and more open (Fig. 3) (164, 211, 212). This more spacious active site
allows accommodation of large bulky adducts (117), and even two covalently linked bases in a
thymine-thymine dimer (115). Also, Y family polymerases make fewer contacts to the forming
base pair (211, 212) and, in particular, lack the O-helix of replicative DNA polymerases which,
upon binding of a dNTP, rotates -40' to sterically check the forming base pair (Fig. 3) (155).
Based on crystallographic analysis, the Y family polymerases may not exhibit an induced fit
upon binding of the incoming dNTP, which contributes to the replicative fidelity of replicative
polymerases (212), however this seems not be true of DNA polymerase ri (198).
Replicative polymerase
thumb
Igers
3B TLS polymerase
little fingers
Fig. 3 Comparison of the structures of replicative and TLS polymerases. The template DNA
strand is shown in red, the primer strand in green, and the forming base pair in blue. (A) The
crystal structure of a replicative DNA polymerase lacking its exonuclease domain (83) reveals
extensive contacts with the DNA, both at the whole structure level and in a close-up of the active
site. In particular, the O-helix (shown in orange on the right) is intimately involved in
interactions with the forming base pair. The right hand fold may not be apparent due to the
orientation required to indicate the incipient base pair. (B) In contrast, TLS polymerases, as
shown by archaeal Dpo4 (116), have a substantially more open structure with fewer contacts to
the DNA, especially in the active site. Note the lack of interactions with the template strand (in
red) which allows accomodation of aberrant base modifications into the active site.
At the current time, only three Y family polymerases have been co-crystallized with
DNA: archaeal Dpo4 with a variety of damaged and undamaged templates, human polymerase
t (138), and yeast Rev1 (137). Intriguingly, Rev1 displays a unique catalytic activity restricted to
inserting only dCMP nucleotides (140). This specialized activity is explained by a novel
mechanism of base pairing using a conserved arginine residue that forms a hydrogen bond with
the incoming nucleotide. The template G is flipped out of the active site by contacts with other
conserved residues, allowing bypass of bulky G adducts (137). Since Rev has an unusual
bypass mechanism and polymerase t may use an unusual Hoogsteen base pairing mechanism
(138), more classical translesion synthesis has only been directly observed with Dpo4. Thus, it is
unclear how particular features of different polymerases may contribute to lesion specificity. It
will be of great interest to determine how the molecular architecture of TLS polymerase active
sites is coordinated with specificity of lesion bypass.
1.3.2.2 Fidelity of TLSpolymerases
TLS polymerases exhibit a markedly low accuracy of base pair insertion on undamaged
DNA templates. Compared to replicative DNA polymerases, which incorporate the wrong
nucleotide only once for every -107 bases replicated, TLS polymerases display error rates of
approximately one incorrect nucleotide for every 10 to 10,000 bases (56, 96, 164). The novel
features of Y family DNA polymerases that allow them to use an increased variety of base
structures as templates also confer a decreased replication fidelity. Therefore, TLS polymerases
have potentially mutagenic activity inside the cell (46). The lack of a 3' to 5' proofreading
domain partially explains the reduced fidelity of TLS polymerases (56, 212). However, the loss
of up to four additional orders of magnitude is likely due to the lack of induced fit and fewer
contacts that TLS polymerases make with the template base and incoming nucleotide (211, 212).
Additionally, some TLS polymerases, like DNA polymerase t, may operate through a Hoogsteen
base pairing mechanism rather than the canonical Watson-Crick pairing ( 164).
However, despite their low fidelity on undamaged DNA, a recent paradigm shift has
reclassified TLS polymerases from simply being considered as "error-prone" polymerases (56)
to a more nuanced understanding of their role as lesion-specific bypass polymerases (46).
Originally called "sloppier copiers" and lauded for their "benefits of infidelity", it is now
appreciated that certain TLS polymerases have a high degree of fidelity opposite their cognate
lesions (80, 81, 196). Cognate lesions have been defined for several TLS polymerases both by
their ability to bypass the lesion accurately in vitro and in vivo as well as by their ability to insert
nucleotides with equal or higher efficiency opposite the lesion than on undamaged DNA (80, 81,
.124, 196). This is most notably seen in the case of DNA polymerase rl, which is specialized to
bypass cis-syn TT dimers caused by UV irradiation (81). In humans, mutations of DNA
polymerase rl result in the disease Xeroderma Pigmentosum Variant which is characterized by a
high frequency of sunlight-induced skin cancers (106, 120). Thus, although DNA polymerase i1
exhibits among the lowest fidelities of any TLS polymerase on undamaged DNA (-~10') (121),
opposite its cognate lesion it is highly accurate and when inactivated, the polymerases that
substitute for it in vivo are much less accurate (106).
1.3.2.3 Disadvantages and benefits conferred by TLSpolymerases
Although they may have high accuracy opposite certain lesions, the fact that TLS
polymerases have poor fidelity on undamaged DNA suggests that they are tightly regulated in
vivo to avoid rampant mutagenesis. When overexpressed or misregulated due to mutations
compromising key regulatory motifs, certain TLS polymerases confer a hypermutator phenotype
(10, 13, 92, 144). Additionally, even when not accompanied by an increased level of
mutagenesis, mild overexpression of TLS polymerases could result in alterations in replication
fork speed due to the slow polymerization rate of TLS polymerases (7, 49, 78, 110). However,
the risk to the cell of potential mutations and replication perturbation is presumably outweighed
by the fact that TLS polymerases confer a measure of resistance to DNA damaging agents. In
the absence of TLS polymerases, cells are moderately sensitized to various DNA damaging
agents (46, 47) and, importantly, often contain higher levels of genomic rearrangements (10, 32,
35, 58, 79, 149, 204). Especially in the genomes of higher eukaryotes, which contain a large
amount of noncoding DNA and many repetitive elements, TLS-induced base pair substitutions
would seem to be preferable to aberrant or collapsed replication fork structures or gapped DNA
which occur in the absence of TLS. These structures can elicit recombinational repair, triggering
translocations and other gross chromosomal rearrangements. Even frameshift mutations, which
have a much higher potential to inactivate protein function than a missense mutation, would be
less catastrophic for a cell than chromosomal rearrangements. This may explain why, despite the
carcinogenic potential of mutator polymerases, their overexpression has not, to date, been clearly
correlated with oncogenesis. This is in contrast to the X family DNA polymerase 3,
overexpression of which is strongly linked to cancer (28).
In addition to promoting survival after DNA damage, TLS polymerases can provide other
benefits to cells. In unicellular organisms, TLS polymerases have been implicated in adaptive
mutagenesis-the ability to induce mutations upon cellular stress (43, 46). In higher eukaryotes,
TLS polymerases play a critical role in the generation of mutations in the variable regions of
antibodies produced by B cell lymphocytes in a process known as somatic hypermutation (SHM)
(26). Thus, despite potentially deleterious mutagenic effects, TLS polymerases presumably
provide more benefits than disadvantages to cells, consistent with the observation that TLS
polymerases have been found in all organisms sequenced to date.
1.3.3 Regulation of TLS
In order to limit potentially mutagenic translesion synthesis such that it is employed only
when needed, a set of regulatory mechanisms ensure that TLS polymerases function only at sites
of DNA damage, presumably preferentially at their cognate lesions, or in situations when
mutations would be advantageous, such as during cell stress or antibody generation. TLS
polymerases are regulated at multiple levels-in fact, almost every mechanism the cell has at its
disposal to control the activity of protein is used. In this thesis, I have focused on the regulation
of Rev , discussed further in Chapter Two.
1.3.3.1 Transcriptional, translational, and degradational regulation
In bacteria, the TLS polymerases are under the well-studied transcriptional control of the
SOS response (47). In eukaryotes, some TLS polymerases are induced at the mRNA level after
DNA damage (126, 146, 170). Additionally, all TLS polymerases are upregulated at the mRNA
levels in meiosis in yeast and mouse models (23, 34, 99, 181). In E. coli, UmuC protein levels
are kept at a very low level relative to its transcriptionally coregulated partner UmuD by
translational control (158). The human REV1 and both yeast and human REV3 transcripts
contain small upsteam open reading frames which presumably reduce translational efficiency of
the major open reading frame encoding the Rev1 and Rev3 proteins (53, 54, 102, 111). In
eukaryotes, small upstream open reading frames greatly decrease the frequency with which the
ribosome reaches the main open reading frame and act as a mechanism to reduce basal
expression of a protein (52). Additionally, alternative splicing of the human REV3 gene
produces an in-frame stop codon in -50% of REV3 transcripts, further reducing the levels of
Rev3 protein (102). Timed degradation of TLS polymerase subunits upon completion of the
SOS response also contributes to control of their activity (44). Additionally, in recent work from
our lab, 26S proteasomal degradation of Revl and Rev3 proteins may be involved in keeping the
levels of these mutagenic polymerases low inside the cell (M.E. Wiltrout, L. Waters, unpublished
.data; see Appendix B).
1.3.3.2 Post-translational regulation
A variety of post-translational modifications control TLS polymerases. In many bacteria,
UmuD, the UmuC accessory protein, undergoes auto-proteolytic cleavage liberating the N-
terminal 24 amino acids. This cleavage produces the shorter protein UmuD', which is required
to stimulate the TLS polymerase activity of UmuC (22, 142, 178). In eukaryotes, PCNA, the
eukaryotic sliding processivity clamp, becomes ubiquitinated upon DNA damage (71). PCNA
ubiquitination is thought to recruit TLS polymerases (17, 161) and stimulate catalytic activity of
DNA polymerase 11 (50), as well as possibly DNA polymerase ý and Rev1 (50, 67).
Additionally, many of the TLS polymerases become ubiquitinated themselves, which is thought
to promote recruitment to sites of DNA damage (17). It is unknown at this time if
phosphorylation plays a role in TLS polymerase regulation, however there is some evidence to
support the idea that the various DNA damage checkpoints may, directly or indirectly, affect
translesion synthesis (4, 15, 70, 84). Additionally, genetic interactions between CDC7 kinase
and TLS polymerases may indicate a role for cell-cycle-dependent phosphorylation events
regulating TLS [(159); L. Waters, unpublished data; see Appendix B]. Finally, in principle,
post-translational modification of histones or the action of other chromatin remodeling factors
may be involved in regulating access of the TLS polymerases to sites of DNA damage.
1.3.3.3 Regulation through subcellular localization
Subcellular localization is a major means of regulating translesion synthesis in
eukaryotes. In normally growing cells, GFP fusions to TLS polymerases show diffuse nuclear
localization patterns. In a small percentage of cells, TLS polymerases form punctate foci which
are thought to colocalize with replication forks. Upon DNA damage, the number of cells
exhibiting foci increases dramatically (1, 13, 86, 87, 133, 134, 143, 188). Mutations that abolish
foci formation also impair the ability of TLS polymerases to function in vivo (17, 58, 89). The
recruitment of TLS polymerases into foci after DNA damage has been a major direction of
:research in the field and has provided insight into the mechanisms of regulation of translesion
:synthesis. Besides monitoring survival and mutagenesis after DNA damage, which only
indirectly assesses function at a physiological level, the in vivo assays for TLS polymerase
activity are limited, mainly employing transformation of lesion-bearing plasmids. Therefore,
much of our knowledge regarding the biological relevance of various mutations in TLS
polymerase function has been garnered from localization studies. However, when considering
these studies, it is important to keep in mind several caveats.
First, TLS polymerases in general are present at quite low levels in the cell (see section
1.3.3.1) and increasing their levels can cause spontaneous mutagenesis (13). Therefore, ectopic
overexpression of TLS polymerases from GFP fusions on plasmids may represent artifacts of
escape from normal cellular regulation that restrict TLS polymerases from over-access to the
DNA. Indeed, in one study where Rev was expressed ectopically but at low levels, no foci
could be observed even after DNA damage (169).
Second, focus formation has been assumed to represent recruitment to replication forks
based on colocalization with PCNA. However, as PCNA interacts with over 35 proteins from
many DNA replication, repair, and cell cycle pathways (119), multiple DNA metabolism events
could recruit PCNA. Thus, PCNA foci may not always represent sites of active replication (134)
and distinct pools of PCNA may be recruited into separate "repair foci" (42). In support of this
idea, recent work indicates that monoubiquitinated PCNA has a longer residence time in foci and
may persist at sites of DNA damage until after replication [(42); A. Lehmann, personal
communication].
Third, GFP fluorescence can only detect complexes containing at least -40 molecules.
Sites where TLS polymerases function in only one molecule or in a small complex would not be
visible by this method. In principle, association into foci may represent an inactive mode of
sequestration rather than an active "replication factory".
Lastly, and perhaps most importantly, colocalization by immunofluorescence does not
necessarily indicate either an actual physical interaction or a functional interaction. Although
monitoring by immunofluorescence for the phosphorylation of the histone variant yH2AX has
long been used as a marker for DSBs in vivo, it has been shown by the higher resolution
approach of chromatin immunoprecipitation (ChIP) that yH2AX is actually found several
kilobases away from a DSB and that colocalization of yH2AX with various DSB repair proteins
does not represent an actual physical or direct functional interaction (179). Colocalization is
correlative, but requires further studies to define causality. Nevertheless, recruitment of DNA
damage tolerance proteins to sites of DNA damage, monitored by subcellular localization, has
emerged as a major paradigm for regulation of their activity. Similar studies in prokaryotes are
underway and will provide important information regarding the regulation of translesion
synthesis across all organisms.
-1.3.3.4 Protein-protein interactions
Translesion polymerase activity is also regulated by protein-protein interactions. All Y
family polymerases interact with the sliding processivity clamp, 1 in prokaryotes and PCNA in
eukaryotes, either through specific sequences known as P-binding motifs or PIP-boxes (11, 38,
61-63, 66, 194) or, in the case of Revl, through a PIP-box-independent mechanism (58).
Although it has not been demonstrated to directly interact with PCNA, the translesion synthesis
activity of polymerase 4 is stimulated by PCNA (51). Disruption of the interaction with P or
PCNA generally reduces or abolishes TLS polymerase lesion bypass in vitro (66, 110, 164, 193,
1.94) and function in vivo (11, 14, 58, 63, 110, 193). Notably, the PCNA-interaction region of
Revl was recently mapped to its BRCT domain (58). In contrast to other TLS polymerases,
mutating the PCNA-binding region of Revl does not affect its catalytic activity in vitro (139),
although interestingly it does abolish Rev1 function in vivo (54, 109). In eukaryotes, all Y
family polymerases contain novel ubiquitin interaction motifs known as UBMs or UBZs which
promote interaction with PCNA upon its monoubiquitination after DNA damage (17). Besides
PCNA, eukaryotes also have another sliding clamp known as 9-1-1 that binds ssDNA generated
after replication fork stalling and recruits checkpoint factors, DNA repair, and damage tolerance
factors (85, 154). The one non-Y family TLS polymerase, DNA polymerase C, does not contain
a UBM or UBZ motif, but rather interacts with the alternative 9-1-1 clamp through its Rev7
subunit (172). The 9-1-1 complex has also been shown to interact with DNA polymerase K in S.
pombe (84). Interestingly, strains bearing deletions of the alternative clamp or the large subunit
of the alternative clamp loader display reduced levels of mutagenesis (156). Thus, interactions
with sliding clamps contribute to localization TLS polymerases to sites of DNA damage,
particularly at stalled replication forks, as well as stimulating their catalytic activities.
Additionally, in eukaryotes the TLS polymerases interact with each other. DNA
polymerase ir interacts directly with polymerase t to bring it to sites of DNA damage (87). Revl
interacts with all of the TLS polymerases and may serve as an organization center for lesion
bypass (57, 135, 147, 187, 188). As certain polymerases are specialized for particular lesions,
whereas others seem to extend mismatches preferentially, interactions between TLS polymerases
may allow coordination of bypass in a two-step manner (165). Finally, each TLS polymerase
has a set of unique interaction partners that may serve to provide specificity to their functions.
For example, in prokaryotes, UmuD' interacts with UmuC to stimulate its function (167) whereas
UmuD' interaction with DinB appears to inhibit its activity (V. Godoy, D. Jarosz, S. Simon,
unpublished data). In eukaryotes, DNA polymerase ri interacts with the Rad51 recombinase to
perform its unique role in D-loop extension during homologous recombination (91, 128).
1.3.3.5 Kinetic regulation
Finally, biochemical characterization of the kinetic parameters of TLS polymerases has
revealed yet another level of regulation of their activity. For both polymerase rl and the archaeal,
prokaryotic, and eukaryotic homologs of DinB, incorporation of a nucleotide opposite a cognate
DNA lesion occurs more efficiently and accurately than opposite undamaged DNA (80, 81).
Thus, certain TLS polymerases exhibit higher activity opposite DNA lesions that they are
specialized to bypass, providing an elegant explanation for how a particular TLS polymerase
may be selected to bypass a given lesion. These observations were extended in another set of
experiments designed to address the molecular mechanism conferring increased efficiency of
bypass opposite a cognate lesion. For DNA polymerase ri , the efficiency and fidelity of lesion
bypass depends on its enhanced processivity on DNA containing its cognate lesion, a cis-syn TT
dimer, relative to an undamaged DNA template (124). Moreover, polymerase 11 displays
enhanced binding to a lesion-bearing template relative to a replicative polymerase, and this
stabilization is dependent on the correct nucleotide, an A, being incorporated opposite to a cis-
syn TT dimer (98). A few nucleotides past the lesion, polymerase r1 no longer exhibits enhanced
binding to the primer/template and dissociates, allowing replicative polymerases to regain access
to undamaged DNA (98, 122). Similar data was also obtained with prokaryotic DinB (78). As
the exonuclease activity of replicative polymerases is able to remove mismatched bases, the
ability of TLS polymerases to extend synthesis a sufficient distance past the lesion is critical
(49). Taken together, these data strongly argue for a paradigm of a passive switch between TLS
and replicative polymerases based on enzymatic efficiency.
1.3.4 Polymerase switching
The various post-translational regulatory strategies detailed above have been integrated
into a model for regulation of translesion synthesis activity known as the polymerase-switching
model (45, 123, 162). Briefly, it is thought that when a replicative DNA polymerase stalls at a
DNA lesion, a region of ssDNA is generated by the uncoupling of the leading and lagging strand
polymerases. Aberrant DNA structures and/or the architecture of the stalled polymerase
holoenzyme recruit various factors, including DNA damage checkpoint proteins, replication
restart proteins, DNA repair proteins, and DNA damage tolerance proteins. These factors
promote multiple strategies of resuming replication. For clarity, only those pathways relevant to
translesion synthesis will be discussed. The prevailing model states that access of TLS
polymerases to the DNA is governed by protein-protein interactions which mediate a polymerase
handoff of the primer-template terminus from the replicative polymerase to one or more
translesion DNA polymerases. TLS polymerases are able to bypass the lesion and extend past
the distorting mismatch. A further switch restores the replicative DNA polymerase to the primer
terminus and accurate DNA synthesis resumes. Further details about the polymerase switching
model are described below.
1.3.4.1 Recruitment of TLS polymerases to stalled replication forks
In prokaryotes, little is known about the mechanism of TLS polymerase recruitment. It is
thought, based on visualization of certain components of the replication machinery, that the cell
assembles all of the necessary factors to carry out DNA synthesis into replication factories
visualizable as discrete foci (108). At the replication fork, the homodimeric P clamp appears to
play a pivotal role as a "toolbelt" to bind to multiple polymerases simultaneously in order to
switch the appropriate polymerase onto the primer terminus when needed (11, 78). In support of
this hypothesis, it has been shown that the T7 replicative polymerase exhibits a dynamic
processivity on the sub-second timescale, allowing multiple molecules of the replicative DNA
polymerase to exchange with the sliding clamp without affecting processivity (210). The
"toolbelt" model is attractive and is supported by the importance of the P-binding motif for TLS
polymerase function, but is limited by the fact that only two polymerases could bind the P clamp
at a time, while there are five DNA polymerase families in E. coli. Moreover, the presence of
replication factories has been shown only in certain bacteria and localization studies with TLS
polymerases have not been reported in any bacterial system to date. Thus, how bacterial TLS
polymerases arrive at a stalled replication fork is currently not well understood.
In eukaryotes, the Rad6/Radl 8 heterodimer plays a crucial role in recruiting TLS
polymerases. Rad 18 can bind to the ssDNA generated at a blocked replication fork bringing the
E2 ubiquitin ligase Rad6 to sites of DNA damage where it can ubiquitinate targets to promote
DNA damage tolerance (5, 6). Once at a stalled replication fork, Rad6/Radl 8 monoubiquitinates
PCNA (71), which is thought to have a negative effect on the replicative DNA polymerase in
vivo, possibly by disengaging it from the DNA template (185). Additionally, this modification
plays a role in recruiting TLS polymerases through an interaction between the monoubiquitin
moiety and the recently characterized ubiquitin-binding motifs found in all Y-family
polymerases (17). Eukaryotes also contain at least one other sliding processivity clamp, the
alternative clamp known as 9-1-1 since it is composed of the Rad9, Rad 1, and Hus 1 genes in S.
pombe (Rad 17, Mec3, Ddcl in S. cerevisiae). The alternative clamp is loaded onto regions of
ssDNA by an alternative clamp loader, composed of Rad24 and Rfc2-5 in S. cerevisiae, and
participates in a DNA damage checkpoint by facilitating ATR phosphorylation of Chkl (85,
154). Additionally, the alternative clamp interacts with several DNA repair and tolerance
proteins, including the Rev7 subunit of DNA polymerase 4 (172) to localize them to sites of
DNA damage. Thus, sliding clamps play a key role in recruiting TLS DNA polymerases to
stalled forks and/or DNA lesions in both prokaryotes and eukaryotes.
1.3.4.2 Replicative to TLSpolymerase handoff and lesion bypass
Once present at the stalled replication fork, TLS polymerases require access to the primer
terminus. Regulation of DNA binding is a crucial factor in controlling TLS activity and involves
both extrinsic protein-protein interactions and intrinsic enzymatic properties. Beyond the
protein-protein interactions described above in section 1.3.4.1, it is currently unclear what factors
may actively contribute to a polymerase handoff between the replicative and TLS polymerases.
One suggestion envisions that, in eukaryotes, Revi modulates the handoff through its ability to
bind multiple TLS polymerases (57, 65, 188). However, data supporting the mechanism by
which Revl may promote the polymerase handoffs is currently lacking. The involvement of
Rev 1 in the polymerase handoff is discussed further in Chapter Three. At the present time, it is
believed that the major determinants of the handoff are passive contributions mediated by the
relative enzymatic efficiencies of each polymerase opposite various DNA substrates (see section
1.3.3.5). Briefly, this passive component may be promoted by the dissociation of the replicative
polymerase from the lesion-bearing DNA after abortive polymerization attempts. Following
replicative polymerase dissociation, transient association of multiple polymerases may occur
sequentially until the best suited polymerase is able to perform lesion bypass. Ultimately, the
differential primer/template affinity, processivity, and bypass activities of translesion
polymerases may be the primary mechanism by which a particular DNA polymerase gains
access to the DNA (49, 78, 98, 122, 124).
A further question that remains unanswered at present is how the "correct" TLS
polymerase is selected to bypass a particular DNA lesion. Although an active process may be
involved, currently no evidence supporting such a mechanism exists. Specificity may be
imparted by a passive trial and error approach based on the inherent efficiency of TLS
polymerases opposite their cognate lesion, as detailed above in section 1.3.3.5. Such
discrimination may be partially imposed by the little fingers domain of TLS polymerases (19,
122). Based on crystal structures of the archaeal TLS polymerase Dpo4, the little finger domain
appears to interact with the lesion at the point when the polymerase has synthesized - 2
nucleotides past the lesion (122). This corresponds to the position relative to the lesion at which
the enhanced processivity of DNA polymerase il is lost and replicative polymerases regain
access to the primer terminus (98, 122, 124). Further supporting the role of the little finger
domain in lesion specificity, chimeric constructs interchanging the little fingers domain between
two archaeal TLS polymerases conferred the opposite lesion bypass characteristics onto the
polymerase active site (19).
After insertion of a nucleotide opposite to a lesion, another TLS polymerase may be
needed to extend from the mismatch or distorted base pair (164, 165). Thus, a second
polymerase handoff may be required to complete bypass of the lesion. In eukaryotes, extension
from a lesion is thought to be primarily mediated by polymerase ý, and also to some extent by
DNA polymerase K (164, 165). A further consideration for completion of lesion bypass is that
the length of the patch synthesized by TLS polymerases needs to be sufficient that the replicative
polymerase will not be affected by the distortion produced by the lesion. In prokaryotes, this
appears to be mediated by the stimulation of processivity observed when TLS polymerases
interact with the P sliding clamp (49).
1.3.4.3 TLS to replicative polymerase handoff
Finally, the replicative DNA polymerase must be recruited back onto the DNA to allow
completion of replication in an accurate and efficient manner. Little is known about how the
handoff back to the replicative polymerase is mediated. In eukaryotes, deubiquitinating enzymes
are likely involved in turning off the global cellular recruitment of TLS polymerases to stalled
forks by reducing the amount of monoubiquitinated PCNA (77). Locally at a particular site of
DNA damage, however, it is not known how the replicative polymerase regains access to the
primer terminus, beyond the passive contributions of enzymatic efficiency (described in section
1.3.3.5.).
1.3.4.4 Limitations ofpolymerase switching model and emergence of new paradigms
The polymerase switching paradigm, by definition, implies an S-phase dependence (45,
106, 107). In this model, TLS polymerases gain a temporary access to the DNA during
replication to restart stalled replication forks, such that replicative polymerases function both
before and after the TLS polymerase bypass of a lesion. Although the replication-dependent
function of TLS polymerases is implicit in the polymerase switching model, it has not been
tested until recently. Instead, the S-phase function of TLS polymerases has mainly been
established through multiple studies of DNA polymerase 1, which, due to its role in human
disease, is the most well studied TLS polymerase. Human cells lacking polymerase r1 proceed
more slowly through S-phase than wild-type cells after DNA damage (1, 184). Additionally,
extensive colocalization studies provide support to the idea that polymerase ir functions mainly
.during S-phase (1, 86, 87, 188). However, it is important to note that each TLS polymerase has
.distinct properties, including both in vitro lesion bypass capabilities and in vivo phenotypic
responses, suggesting that, although certain regulatory mechanisms are likely shared by all, each
TLS polymerase is regulated and used inside the cell quite differently. Therefore, although
polymerase r1 may function primarily according to the polymerase switching model, further
investigation of the other TLS polymerases will provide new models for regulation of translesion
synthesis outside of the polymerase switching paradigm. Already, reports have indicated that
polymerase K plays a central role in nucleotide excision repair (NER) (145), that polymerase rq
can extend D-loops during HR (91, 128), and that polymerase ý is involved in break-induced
replication (BIR) pathway of the HR mediated repair of DSBs (74, 166). Given the plethora of
unexpected results surrounding the translesion synthesis field, further surprises are sure to come.
Despite the dominance of the polymerase switching paradigm, historical experiments
have provided evidence that is inconsistent with certain assumptions of the model (107, 195). In
particular, studies showing that replication is inhibited, but not completely halted, after DNA
damage indicate that the cell has the ability to continue DNA synthesis at a low level despite the
presence of replication-blocking DNA lesions (36, 105, 171). Recent experiments have
confirmed these findings and extended other paradigms of damage tolerance. Replication in the
face of DNA damage is likely to occur through repriming of the DNA polymerase downstream
of a lesion, as has recently been demonstrated (69), and would leave behind ssDNA gaps
opposite lesions, which have recently been observed in yeast (118). In E. coli cells, the time
required for translesion synthesis to bypass a lesion was observed to be on the order of -50
minutes (153). The length of time necessary to bypass a lesion relative to the generation time of
E. coli indicates that translesion synthesis must occur to a significant extent in parallel, rather
than exclusively in series (R. Fuchs, personal communication). This suggests that, instead of
TLS-mediated restart of each stalled replication fork in turn, replication can continue
downstream of a lesion such that bypass of all lesions occurs simultaneously and concurrent
with, or even after, replication. Additionally, the unexpected discovery of a cell-cycle dependent
upregulation of Revl outside of S-phase supports a post-replicative function of translesion
synthesis (200). The work presented in Chapter Two discusses a new model of TLS in which
Revl is proposed to play a crucial recruitment role to facilitate gap filling during G2/M at sites
of persistent DNA lesions.
In summary, the work presented in this thesis contributes to the emerging paradigm of
two phases of DNA damage tolerance: one which occurs during replication to promote
continuous replication past DNA lesions (Fig. 4A) and one which takes place post-replicatively
to mediate filling of gaps left behind during replication (Fig. 4B).
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Fig. 4 Two phases of DNA damage tolerance. Arrows indicate the 3' end of the DNA strand,
dashed lines indicate DNA synthesis, and wavy lines indicate regions replicated by TLS
polymerases. Black lines indicate the parental DNA strand; grey lines indicate the daughter
strand. (A) During replication, template switching or translesion synthesis can serve to resolve
stalled replication forks and restart continuous DNA synthesis. For simplicity, alternate fork
regression pathways are not shown. Bypass of the lesion by template switching would be
accurate while bypass by translesion synthesis may result in mutations. (B) Repriming of the
DNA polymerase downstream of DNA damage can generate regions of ssDNA opposite to
lesions which may persist even after replication has been completed. These gaps can be filled by
recombination-mediated daughter strand gap repair mechanisms in an accurate manner or by
translesion synthesis which is associated with mutagenesis.
1.3.5 The eukaryotic RAD6 post-replication repair pathway
In eukaryotes, most DNA damage tolerance is mediated by the RAD6 epistasis group
(191). This set of genes was initially termed the post-replication repair (PRR) pathway, but this
is a misnomer as they function to tolerate rather than repair damage and may do so during
replication as well as afterwards (101). Originally, the RAD6 pathway was defined genetically in
yeast by epistasis analysis. Subsequently, additional genes have been added to the pathway
based on phenotype, often without full characterization relative to other members of the epistasis
group (8, 60, 76, 101, 129, 156, 159). Thus, the relationships between genes in the RAD6 PRR
pathway is poorly understood and multiple genetic interaction maps have been proposed (27,
.207). To further complicate matters, the genetic interactions between components of the RAD6
pathway can vary when different DNA damaging agents are used (159), and when characterizing
spontaneous and induced responses to DNA damage (130). With these caveats, a brief
explanation of each gene of the RAD6 pathway is presented below.
1.3.5.1 RAD6, RAD18, and POL30
Together with the ssDNA-binding protein Radl 18, Rad6 stands at the top of the epistasis
group comprising several DNA damage tolerance mechanisms (47). Rad6 is a ubiquitin E2
ligase which is involved in several cellular stress response pathways, including N-end rule
degradation, retrotransposition, sporulation, silencing, and DNA damage tolerance (47, 101).
Not unexpectedly for a gene that participates in so many diverse regulatory circuits, rad6
mutants exhibit a severe growth defect and are profoundly sensitive to a variety of DNA
damaging agents (47). Rad6 requires several different effector proteins to target its
ubiquitination activity towards a particular pathway (47). In order to mediate its role in DNA
damage tolerance, Rad6 interacts with the DNA damage specific effector Radl 8 (5). Radl8
binds to single-stranded DNA which is generated upon replication fork stalling or from
replication fork repriming after DNA damage. This allows localization of the Rad6 E2 ubiquitin
ligase activity to sites of DNA damage (5, 6). Radl 8 also interacts with and recruits polymerase
ir to stalled replication forks in mammalian cells, independent of its role in the
monoubiquitination of PCNA (199). Radl 8 itself exhibits Rad6-dependent mono- and
polyubiquitination (131). The variously modified forms of Radl 8 show differential subcellular
localization, allowing regulation of the DNA damage tolerance pathways by a feedback loop
controlling Rad6 and Radl8 association (131).
Although it seems likely that this elegant mechanism of coupling an ssDNA-binding
protein with a post-translational regulatory protein may have many targets, currently only one
downstream protein is known to be ubiquitinated in response to DNA damage by the
Rad6/Radl8 heterodimer: the sliding clamp, PCNA, encoded by the POL30 gene (71). PCNA is
post-translationally modified on lysine 164 in order to mediate the majority of PCNA's
regulatory effect towards DNA damage tolerance (64, 71, 185). Monoubiquitinated PCNA
activates all of the downstream damage tolerance pathways and is thought to comprise the main
function of the Rad6/Radl 18 heterodimer (191). Given that the Y-family polymerases were
recently shown to be monoubiquitinated (17, 59), it is an attractive hypothesis that Rad6/Radl8
activity has other targets as well.
As the ubiquitination of PCNA is a major mechanism (191), though not the sole means
(29), for the regulation of the several PRR subpathways, it follows that the deubiquitination of
PCNA would be of primary importance to maintain low background levels and to terminate the
activity of DNA damage tolerance responses. Currently, little is known about how PCNA is
deubiquitinated, but evidence is emerging that specific factors, themselves subject to extensive
regulation, remove ubiquitin from PCNA (77) or promote the accumulation of unmodified
PCNA (183). Ongoing research is dedicated towards resolving the crucial question of how the
DNA damage tolerance response is reset after completion of lesion bypass.
1.3.5.2 Template switching: MMS2, UBC13, RAD5, and SRS2
One subpathway of the RAD6 epistasis group is the template switching branch, mediated
by Rad5 and the Mms2/Ubcl3 heterodimer (47, 191, 192). This set of genes promotes error-free
damage tolerance by replication fork regression (discussed above in section 1.3.1) (47, 191).
Rad5 is a member of the Swi2/Snf2 helicase family, but lacks detectable helicase activity (82),
likely because a RING finger domain is inserted into the helicase domain. In an independent
function from its role as an E3 ubiquitin ligase in template switching, Rad5 also has ssDNA-
dependent ATPase activity which is required for DSB repair (31). Mms2 is an E2 ubiquitin
conjugating enzyme of the UEV subtype that lack the catalytic cysteine needed to transfer
ubiquitin (73). Mms2 requires the E2 ubiquitin ligase Ubc 13 for activity (73). The
Mms2/Ubc 13 heterodimer specifically produces ubiquitin chains linked through the non-
canonical lysine 63 residue which does not cause degradation of the target protein by the 26S
proteasome (72, 73).
The major target of Mms2/Ubcl3 is thought to be the sliding clamp PCNA (71). The
Rad6/Rad 18 modification of PCNA is confined to monoubiquitination, however association of
Rad 18 with Rad5 brings the Rad6/Rad 18 heterodimer in contact with the Mms2/Ubc 13
heterodimer which can then polyubiquitinate PCNA via the lysine 63 linkage (71, 192). It seems
likely that the presence of K63 polyubiquitinated PCNA at the replication fork is refractory to
further polymerization reactions, not only displacing the replicative polymerase but preventing
TLS polymerases from accessing the replication fork as well. However, the molecular
mechanisms by which K63 polyubiquitinated PCNA promotes replication fork regression and
:the details by which the physical DNA transactions of the exchange occur are unknown at this
time.
Additionally, PCNA can be modified by the small ubiquitin-like modifier SUMO at
lysine 127 or lysine 164 (71). SUMO modification of PCNA, while using the same lysine 164
residue as ubiquitination, appears to cooperate with rather than antagonize the roles of
ubiquitination in DNA damage tolerance (191, 201). SUMOylated PCNA recruits the Srs2
helicase which promotes the Rad5/Mms2/Ubcl3 template switching pathway by disrupting
Rad51 filament formation on DNA; in the absence of SRS2, defects in the RAD6 pathway are
suppressed by channeling substrates into the RAD52 HR pathway (191, 201).
1.3.5.3 Translesion synthesis
The other genes which fall into the RAD6 epistasis group are not involved with the K63-
linked polyubiquitination mediated template switching. Rather, they seem to either directly
mediate translesion synthesis (RAD30, REV1, REV3, REV7, POL32) or to indirectly affect TLS
(CDC7, CDC8, UMP1, RAD24, RAD1 7, MEC3, DDC1), presumably by regulating the TLS
polymerases. The TLS branch of the RAD6 epistasis group is well understood biochemically,
but poorly understood genetically. Few of the genes that indirectly regulate TLS have been
placed into pathways or thoroughly phenotypically characterized and there are likely several
more genes controlling TLS polymerase activity that have yet to be identified. For example,
several genes were identified in screens for alterations in DNA damage tolerance that have never
been physically mapped to a particular locus or open reading frame (MM1S3, NGM2, UMR1,
UMR2, and UMR3) (101). In yeast, the TLS polymerases themselves appear to form two distinct
branches: one containing RAD30 and the other consisting of REV], REV3, REV7, and likely
POL32 (75, 126). However, the majority of the genetic analyses of the interactions among TLS
polymerases have been performed in S. cerevisiae which lacks DNA polymerase K and
polymerase t, two of the five major Y family polymerase families (148). Polymerase K was lost
in a group of ascomycete yeast and is also missing in some eukaryotic lineages, but is otherwise
:found in organisms from archaea to humans (L. Waters, unpublished observation). Many
eukaryotes also contain polymerase t, a paralog of polymerase rj, not found in S. cerevisiae.
Additionally, in yeast, RAD30, which encodes polymerase rl, appears to function independently
from REV], REV3, and REV7 (126, 207), whereas in vertebrates, DNA polymerase 11 physically
interacts with Revl (57, 188). Thus, the genetic interactions between TLS polymerases are not
yet clear, although the prospects of clean genetic analyses in higher eukaryotes are promising in
chicken DT40 cells using gene deletions to avoid potential artifacts caused by RNAi knock-
downs (208).
The process of translesion synthesis seems to exclusively use the monoubiquitinated form
of PCNA (64, 185). Monoubiquitination of PCNA may activate the catalytic activity of certain
TLS polymerases, such as polymerase r1 and Rev1 to increase bypass of lesions (50), however
other evidence contradicts this point (67). Additionally, the eukaryotic Y-family polymerases
each have a higher affinity for the monoubiquitinated form of PCNA than the unmodified form
(15, 17, 58, 89, 199). Thus, it is thought that, in addition to potential catalytic stimulation,
monoubiquitinated PCNA activates TLS polymerases by recruiting them to stalled replication
fbrks where they are needed (45, 89, 199). Indeed, the monoubiquitination of PCNA is currently
thought to be the central switch mediating the polymerase handoff between replicative and TLS
polymerases at stalled replication forks (45, 89, 199). The evidence for the importance of PCNA
modification is strong, but it should be kept in mind that there are likely a number of other
factors controlling not only the polymerase handoff but also TLS polymerase activity.
Furthermore, the functions of DNA polymerase 4 and Revl have been found to be partially
independent of monoubiquitinated or SUMOylated PCNA after ionizing radiation (29). Thus,
TLS may well not require modified PCNA under other circumstances as well.
1.3.6 Translesion polymerases
Translesion DNA polymerases are structurally optimized to bypass DNA lesions and bear
a significant similarity to each other, yet are also specialized for particular classes of DNA
lesions and exhibit a range of phenotypes in vivo. Thus, it is not surprising that most TLS
polymerases are members of a superfamily of DNA polymerases known as the Y family, falling
broadly into four different clusters with specific features within the Y family (148). For
example, although all TLS polymerases have a low replication fidelity on undamaged DNA, only
some are responsible for the majority of spontaneous and induced mutagenesis in vivo. Loss of
function or overexpression phenotypes for DNA polymerases rl, t, and K display modest or very
specific alterations of cellular mutagenesis (10, 33, 92, 93, 95, 126, 157, 205, 209); in contrast,
when mutated, UmuC, Rev 1, and DNA polymerase C show profound defects in mutagenesis for
a wide variety of DNA damaging agents and on a range of assay systems (47, 90, 102). Other
major properties of each class of TLS polymerase are summarized below.
1.3.6.1 UmuC
UmuC is found ubiquitously throughout all prokaryotes and encodes a broad-specificity-
range polymerase that preferentially bypasses UV photoproducts, abasic sites, and certain bulky
adducts (47, 56). In vivo, it is responsible for much of spontaneous and damage-induced
mutagenesis, as seen by the fact that loss of function alleles exhibit an unmutable phenotype (47,
90). In E. coli, UmuC is found in an operon with its accessory factor UmuD (47). The umuDC
operon is under the control of the SOS response and is transcriptionally upregulated after DNA
damage (47). Additionally, post-translational regulation plays a major role in UmuC function.
Upon binding to the RecA-ssDNA nucleoprotein filament generated after DNA damage, the
UmuD protein undergoes an autocleavage event which removes the N-terminal 24 amino acids
to produce a shorter UmuD' protein. These two products of the umuD gene perform different
functions in the DNA damage response. The shorter UmuD' stimulates translesion synthesis by
UmuC (167), whereas the full-length UmuD protein effects a primitive DNA damage checkpoint
by inhibiting the resumption of DNA synthesis after DNA damage by the replicative polymerase
III (151). Temporal regulation of the appearance of the post-translationally processed UmuD'
protein may provide a cellular mechanism to delay mutagenic translesion synthesis until more
high-fidelity repair systems have had a chance to repair DNA lesions (151). UmuC was the fifth
DNA polymerase identified in E. coli. Since UmuC exhibits virtually no activity in the absence
of the UmuD' dimer, the term polymerase V typically refers to the UmuI)' 2C complex (47).
1.3.6.2 DinB (polymerase cK)
DinB is the most highly represented TLS polymerase, being found throughout
eukaryotes, prokaryotes, and archaea (148). In eukaryotes, DinB is known as polymerase K.
Polymerase K was lost from the ascomycete lineage that gave rise to S. cerevisiae, so a detailed
genetic understanding of its activity is missing in eukaryotes. Additionally, polymerase K
appears to be missing from Drosophila and other insects, as well as protists (A. Hardin, L.
Waters, unpublished observation). In contrast to UmuC, loss of E. coli DinB does not seem to
affect mutagenesis profoundly, indicating that in vivo under normal regulation, DinB does not
contribute to mutagenesis (95, 205). However, when misregulated by overexpression, DinB does
promote -1 frameshift mutations, but this effect is sequence-specific and only modestly affects
base substitutions (92). In mammalian cells, loss of polymerase K increases mutagenesis induced
by benzo[a]pyrene, indicating the polymerase K bypasses benzo[a]pyrene N2-dG adducts
relatively accurately in vivo (3). Similarly to DNA polymerase 1r, DNA polymerase K and its
archaeal and prokaryotic homologs have been proposed to operate with high accuracy and
efficiency opposite its cognate lesion of N2-adducted dG residues (80). Additionally, polymerase
xK appears to be specialized to extend mismatched primer termini and likely functions as a second
"extender" polymerase when two TLS polymerases are required in concert to bypass a lesion
(164). Cell biological studies have revealed that polymerase K relocalizes from a diffuse nuclear
pattern into foci upon DNA damage (13, 16, 143). Focus formation of polymerase K requires
both its PCNA-interaction motif and its ubiquitin-binding motifs (143). Interestingly,
polymerase K relocalizes in response to DNA damage differently from the other Y family
members, forming fewer spontaneous and damage-induced foci (16, 143). The reports disagree,
however, on whether DNA polymerase K forms foci during S-phase (16, 143). Also distinct
from the other TLS polymerases, DNA polymerase K also appears to contribute substantially to
NER (145).
1.3.6.3 Rad30A (polymerase r7) and Rad30B (polymerase t)
The Rad30 subfamily is found only in eukaryotes and contains two paralogs: Rad30A,
which encodes DNA polymerase r1, and Rad30B, which encodes the highly related polymerase t.
Polymerase i is perhaps the most thoroughly characterized TLS polymerase since, in humans,
loss of polymerase r1 activity results in a cancer-prone syndrome known as Xeroderma
-Pigmentosum Variant (XPV) (106, 120). In vitro, polymerase ir has been shown to bypass cis-
syn cyclobutane pyrimidine dimers (CPD) with high accuracy and efficiency (81) and in vivo, it
is thought to be responsible for restarting stalled replication forks and allowing continuous DNA
synthesis past sites of UV damage (106). In the absence of polymerase 1r, other DNA
polymerases may substitute to bypass cis-syn TT dimers in a more error-prone manner, resulting
in an increased frequency of cancer in XPV patients (106, 120). Interestingly, though
polymerase ir plays a major role in accurately bypassing one particular type of DNA lesion, on
undamaged DNA it exhibits among the lowest fidelity of any DNA polymerase (121, 164). Yet,
polymerase rl mutants display no major reduction in spontaneous or induced mutagenesis with
agents other than UV (126, 170). Intriguingly, overexpression also does not produce a profound
alteration of levels of mutagenesis (93, 157), indicating that polymerase 11 is restricted from
accessing undamaged DNA even when overexpressed. Certain polymerase rl mutants which
confer XPV are capable of translesion synthesis activity in vitro, implying that key regulatory
motifs allowing polymerase ir to be recruited to sites of DNA damage are compromised in these
patients (21). These findings emphasize the importance of regulation of polymerase 1 to its
function. The subcellular localization of polymerase rI has been investigated in multiple reports.
Polymerase ir forms foci spontaneously in a small percentage of cells and focus formation is
increased dramatically after exposure to many DNA damaging agents (1, 16, 86, 87). These foci
are thought to form at sites of DNA damage since they colocalize with PCNA (1, 86, 87).
Additionally, polymerase rl foci formation is stimulated by interaction with monoubiquitinated
PCNA (15, 17, 89, 161, 199). Together with the fact that polymerase r1 mutants progress more
slowly through S-phase after DNA damage (1, 16, 184), these findings linking polymerase rI and
PCNA have led to a model in which polymerase ir rescues replication forks that have stalled at
sites of DNA damage by bypassing the blocking lesion allowing the resumption of continuous
DNA synthesis.
In contrast to the wealth of information about polymerase rl, the role of its paralog,
polymerase t, is poorly understood. Although stated to be found only in higher eukaryotes,
polymerase i has been identified in scattered organisms throughout Eukaryota, including some
yeasts (L. Waters, unpublished observation). However, since polymerase 1 is lacking in S.
cerevisiae, little is known about its genetic relationships to other DNA damage tolerance
pathways. Biochemically, polymerase t is one of the least accurate DNA polymerases,
especially opposite pyrimidines (164). However, physiologically, loss of polymerase i seems to
have little consequence, as the 129/J strain of mice bears a nonsense mutation in the polymerase
L gene that prevents its expression, yet these mice have no observable phenotype (125).
Additionally, alteration in the levels of polymerase t does not lead to profound changes in the
frequency of mutagenesis (33, 209). Polymerase t interacts physically with polymerase rl and
this interaction is required for its localization into DNA damage induced foci (87). Additionally,
the PCNA-interaction motif and ubiquitin binding motifs of polymerase i are also required for
localization into foci after DNA damage, indicating that recruitment to stalled replication forks
by monoubiquitinated PCNA mediates the function of polymerase 1 (17, 193). However, it
should be noted that the biological relevance of the interaction with monoubiquitinated PCNA
has not yet been tested for polymerase t. Future work revealing the cognate lesion for
polymerase t in vivo will provide insight into the role of this less characterized TLS polymerase.
1.3.6.4 Rev]
Uniquely among Y family polymerases in eukaryotes, Rev actively promotes the
generation of mutations from unicellular yeast to multicellular humans (54, 109). Like
prokaryotic UmuC, revl mutants display a drastic reduction in spontaneous and induced
mutagenesis by a wide variety of DNA damaging agents (47, 102). In fact, Rev1 was isolated
from the first screen in any organism to identify genes specifically responsible for mutagenesis
(109). Rev 1 was named for its reversionless phenotype, reflecting the inability of the rev]
mutant strain to revert an auxotropic marker to the wild-type allele after UV irradiation (109). In
almost every genetic background tested, mutants of REV1 abolish mutagenesis, indicating its
fundamental importance to mutagenesis induced by all types of DNA lesions and genetic
alterations (102). Indeed, Revl is responsible for -95% of all mutagenesis (103). Although only
marginally correlated with the onset of cancer (173), REV1 in higher eukaryotes may contribute
to cancer progression. Recently, REV] was shown to modulate the frequencies with which
cisplatin resistant cells were generated from an ovarian carcinoma cell line: reduced REV]
expression decreased the frequency of cisplatin resistance and correspondingly, increased REV1
levels led to a higher frequency of cisplatin resistant cells (112, 150). Thus, understanding the
regulation of Revl activity is crucial to a complete knowledge of mutagenesis in eukaryotes.
:Studies addressing the regulation of Revl are discussed further in Chapter Two.
Rev 1 exhibits distinctive properties from the other Y family members. In contrast to
other translesion polymerases, Rev 1 has only a limited polymerase activity restricted to inserting
primarily dCMP residues opposite template G's and certain DNA lesions (102, 140).
]3iochemically, Revi appears particularly suited to bypass abasic sites and adducted G residues
(102, 197). To accomplish this specificity, Revl uses a novel catalytic mechanism that selects
dCTP as the incoming nucleotide not through base pairing with the template, but rather through
hydrogen bonds with a conserved arginine (137). Contacts are made with the template base to
ensure its identity as a G, but the template base is flipped out of the active site, thus explaining
Revl's ability to bypass large bulky adducts on G residues (137). Revl was the first member of
the Y superfamily to be shown to have polymerase activity (140), however since the activity was
limited, the significance of this finding was not appreciated for several years until the discovery
that other Y family members also were capable of polymerase activity. Intriguingly, a
catalytically inactive mutant of Rev displays no reduction in levels of mutagenesis (65, 169),
although a change in the mutation spectrum is observed (152, 168). Therefore, although Revl's
unique and highly specialized dCMP transferase catalytic activity is conserved from yeast to
humans (111, 140), its activity does not seem to be required for REV1 function from yeast to
higher eukaryotes. Consistent with the importance of REV1 to lesion bypass independent of its
catalytic activity, the presence of REV] is required for bypass of a 6-4 TT dimer in vivo even
though in vitro Revl is unable to insert a nucleotide opposite to UV photoproducts (139, 152,
215).
Additionally, Rev contains an N-terminal BRCT domain not found in any other Y
family polymerase. First characterized in the BRCA1 breast cancer susceptibility protein, BRCT
(BRCA1 C-terminus) domains are found predominantly in DNA metabolism genes where they
mediate protein-protein or protein-DNA interactions (25, 55, 94, 202). Tandem BRCT domains
have been shown to interact preferentially with phosphorylated targets, which are often
components of the DNA damage checkpoint response (55). Revl only has a single BRCT, but
nonetheless has also been implicated in phosphopeptide binding, however the biological
significance of this is currently unknown (214). Unlike the other Y family polymerases, Rev1
does not have a PCNA-interacting motif. However, the BRCT domain interacts directly with
PCNA (58), as well as with the Rev7 subunit of DNA polymerase ý (40) and possibly also with
DNA (94). As BRCT domains tend to interact with DNA at single-stranded regions or double
strand breaks (94, 202), the BRCT of Rev1 may also be involved in localizing Revl to aberrant
DNA structures. Interestingly, in contrast to the catalytic dead mutation, mutations affecting the
BRCT domain inactivate Revl in vivo. In yeast, BRCT mutants exhibit a severe defect in
survival and mutagenesis after DNA damage (109). In higher eukaryotes, mutations in the
B3RCT domain reduce REV] function, however the extent of the defect varies between studies
(58, 79, 169). Thus, although the mechanism is not yet clear, the BRCT domain evidently
contributes to REVI function in vivo by mediating interactions with PCNA, Rev7, and likely
DNA and other proteins.
In addition to the BRCT domain, Revl also contains other protein-protein interaction
modules which are critical for REVI-mediated mutagenesis and resistance to DNA damaging
agents. The extreme C-terminal -100 amino acids of mammalian Revl interact with all of the
other TLS polymerases and also DNA polymerase X (57, 135, 147, 188). Additionally, the C-
terminus of Drosophila Rev1 was used in an affinity column as a purification for DNA
polymerase ý (187). Initially, the C-terminus of Revl did not seem to be conserved between
higher eukaryotes and yeast (88, 135, 188), however extensive sequence alignment and
functional studies have revealed that yeast Rev1 does likely interact with other TLS polymerases
through its C-terminus (40, 169). For further discussion of the role of the C-terminus in yeast,
see Chapter Three.
Finally, Rev1 displays ubiquitin binding mediated by a non-canonical ubiquitin-binding
motif (UBM) and this interaction with ubiquitin is necessary for its localization into DNA
damage induced foci (59). Mutants in the UBM display increased chromosomal aberrations,
decreased viability, and decreased mutagenesis after exposure to DNA damaging agents [(59); L.
Waters, unpublished data, see Chapter Three].
As described above, multiple protein-protein interaction domains are critical to REV]
function whereas the catalytic activity of Revl is dispensable for REV] function under most
circumstances (65, 169). Taken together, these findings have led to a model in which Revl
functions primarily as a scaffold for various post-replication repair proteins to localize mutagenic
translesion complexes to sites of DNA damage and/or to modulate polymerase switching at the
site of a DNA lesion (45, 106). Thus, Revl is thought to play a central role in translesion
synthesis by regulating access of TLS polymerases to the primer terminus (45, 106).
Localization studies have reported that, like the other Y family polymerases, Rev forms
foci after DNA damage (58, 133, 134, 188). However, in one report Revl foci were not
observed either spontaneously or after DNA damage (169). The authors used a more
physiological expression level and propose that lack of foci formation reflects the need of the
cell for only one or a small number of molecules of Revl at sites of stalled replication (169).
Colocalization of Revl foci with PCNA and polymerase j1 have indicated that Revl associates
with replication forks to enable continuous DNA synthesis on templates containing DNA lesions
(58, 133, 188). In conjunction with the implicit assumptions in the polymerase switching model,
the localization studies have led to a model in which Revl is thought to act mainly during
replication (45, 106). However, other studies have proposed that Revl functions predominantly
outside of S-phase (134, 200). For further discussion of the timing of Rev1 function, see Chapter
Two.
1.3.6.5 Rev3/Rev7 (polymerase Q
One non-Y family DNA polymerase is also considered a TLS polymerase: DNA
polymerase ý, which is a heterodimer of the Rev3 catalytic subunit and the Rev7 accessory
subunit (141). Interestingly, Rev3 is a member of the B family of normally highly accurate
replicative DNA polymerases, including DNA polymerases 8, 6, and ca (102, 132). In contrast to
the other B family replicative polymerases, DNA polymerase 4 lacks 3' to 5' exonuclease activity
(102). Although it can bypass certain lesions like a cis-syn TT dimer, polymerase ý appears to
be specialized to extend distorted base pairs, such as mismatches that might result from
inaccurate base insertion by a TLS polymerase or an accurate base pair involving a bulky DNA
lesion (102, 164). Despite no conserved PCNA interaction motifs, polymerase ý exhibits
increased lesion bypass activity in the presence of PCNA, however this stimulation is not
observed with either monoubiquitinated PCNA or the alternative 9-1-1 processivity clamp (50,
51).
Not unexpectedly given its proficiency for extending mismatches, polymerase r
contributes significantly to mutagenesis (102). In fact, REV3 was isolated together with REVi
from a screen for reversionless mutants of yeast (109) and REV7 by a similar screen a few years
later (104). Like revl, rev3 and rev7 mutants are severely defective for spontaneous
mutagenesis, as well as mutagenesis induced by a wide variety of DNA damaging agents and
mutations in DNA repair and tolerance pathways (102). REV1, REV3, and REV7 are considered
to be in the same branch of the RAD6 epistasis group based on phenotypic similarity and limited
epistasis analysis (70, 102). Like REV], DNA polymerase 4 also actively promotes mutagenesis
from yeast to humans (32, 53, 109) and promotes cisplatin resistance in human cancer cells
(113). Together, Rev1 and DNA polymerase ý are thought to mediate the vast majority of the
mutagenic DNA damage tolerance in vivo and, as such, are central to understanding diseases
such as cancer.
Although a very large protein, Rev3 does not seem to contain any known protein-protein
interaction modules or other regulatory motifs. Instead, its accessory factor may control its
regulation since Rev7 contains a HORMA domain known to interact with chromatin (2). In
yeast, Rev7 binds to the 9-1-1 alternative DNA processivity clamp and may recruit DNA
polymerase ý to sites of DNA damage (172). Additionally, Rev7 interacts with Revl (57, 135,
147, 187, 188), which may also allow localization of DNA polymerase ý to DNA lesions.
Moreover, in higher eukaryotes Rev7 has been shown to interact with the specificity factors
Cdhl and/or Cdc20 of the anaphase promoting complex/cyclosome (APC/C) as well as the
spindle checkpoint protein Mad2 (30, 136, 160). Interaction with Rev7 inhibits the ubiquitin
ligase activity of the APC and prevents the onset of mitotic anaphase (30, 160).
Multiple mechanisms collaborate to keep polymerase 4 levels low (102), indicating that
overexpression may be detrimental to cells. Yet loss of polymerase 4 causes embryonic lethality
in mice (12, 41, 203), indicating that during rapid proliferation, mammalian cells require a
function of polymerase ý. The inability to study rev3 mutant cell lines in mammalian systems
has hampered understanding of polymerase 4 function. However, recent studies in the chicken
DT40 line have provided insight into the role of polymerase 4 in vivo, in particular, the
contribution of REV1, REV3, and REV7 to chromosomal rearrangements during recombination
and interstrand crosslink repair (149, 177). Additionally in yeast, REV3 contributes to
mutagenesis in the break-induced replication (BIR) subpathway of homologous recombination
(74, 166). Interestingly, REV1 appears to function independently of REV3/7 in the generation of
sister chromatid exchanges during the recombinational bypass mode of damage tolerance (149).
1.3.6. 6 All polymerases capable of translesion synthesis
It is worth noting that there are other non-replicative DNA polymerases which have
varying abilities to bypass DNA lesions and which synthesize DNA with a range of fidelities
(47). The members of the X family of DNA polymerases in particular can insert nucleotides
opposite to certain lesions, mainly abasic sites or bulged templates (18), and, after the Y family,
display the next lowest replication fidelity of the six major DNA polymerase families (96). The
X family polymerases are occasionally referred to as translesion polymerases and, indeed, can
lay a claim to the name. Even the highly stringent replicative DNA polymerases have very weak
abilities to replicate over certain lesions. However, in general these other polymerases have
other primary physiological functions, such as participation in BER and NHEJ by the X family
polymerases. Accordingly, the term TLS polymerases generally refers to the Y superfamily and
DNA polymerase 4, which have clearly specialized roles limited almost exclusively to lesion
bypass (47, 102).
1.3.7 Evolutionary significance of mutagenic polymerases
Why do cells contain potentially mutagenic translesion polymerases? All organisms-
prokaryotes, archaea, and eukaryotes-contain translesion polymerases that have been shown to
promote both spontaneous and damage-induced mutagenesis. Though potentially dangerous due
to their low fidelity of replication on undamaged DNA, TLS polymerases must serve a valuable
purpose or they would not have been maintained throughout evolution. Translesion polymerases
presumably confer advantages that outweigh the risk of potentially lethal mutations.
Firstly, TLS polymerases provide a measure of resistance to DNA damaging agents; cells
lacking one or more TLS polymerases exhibit a slight to moderate increase in the frequency of
cell death after DNA damage (47). This increase in survival after DNA damage has classically
been thought to reflect the ability to continue replication and cell division in the face of
replication blocking lesions. However, recent evidence showing that the frequency of
chromosomal aberrations is significantly increased in cells lacking TLS polymerases, combined
with evidence for polymerase repriming events downstream of lesions, indicates that restoration
of replication per se may not be the primary advantage conferred by TLS polymerases. Rather,
TLS polymerases may allow the completion of replication, which minimizes recombination due
to ssDNA and restores an intact and stable double helix. Thus, the increase in base substitutions,
or even frameshift mutations, generated by TLS polymerase activity may ultimately prove less of
a negative consequence for cells than genomic instability. This may be especially true in higher
organisms with large, repetitive genomes containing fewer coding regions for point mutations to
manifest as nonfimctional proteins and more sites of limited homology where illegitimate
recombination may act to produce translocations. Indeed, in mammals, it is estimated that -50%
of DNA damage tolerance events occur through translesion synthesis rather than the more error-
free recombinational bypass pathways (3). Additionally, breakage of the linear chromosomes
found in eukaryotes can produce aneuploidy or trisomy.
Secondly, the mutations generated by TLS polymerases produce variation for natural
selection to act upon. In particular, the upregulation of mutagenesis during cell stress could
provide a mechanism for adaptive evolution (43, 46). This hypothesis would predict that
mutants defective in TLS function would be at a competitive disadvantage in times of limited
resources. Indeed, E. coli lacking DinB or UmuC exhibit a reduced fitness when grown in
competition with the wild-type strain (213). The generation of mutations can more easily be
seen to be beneficial towards rapid adaption for unicellular organisms than in multicellular
organisms, where mutations accumulated in somatic tissues provide no reproductive advantage.
For multicellular organisms, which must balance the value of the mutagenic machinery against
the risk of malignancy, it is less clear how the power of adaptive mutations could be harnessed.
lnterestingly, higher eukaryotes contain five TLS polymerases, relative to prokaryotes which
have only two. Given that TLS polymerases appear to be specialized to bypass a particular
cognate lesion in a relatively error-free way, the increase in the number of TLS polymerases in
eukaryotes may increase the number of substrate lesions able to be bypassed accurately and
actually decrease the mutagenic potential of DNA damage (46).
Finally, it may occasionally be advantageous for cells to make use of "programmed
mutagenesis" in situations where an increase in mutation frequency would provide beneficial
variation. In unicellular organisms, this has been seen in adaptive mutagenesis (43, 46) and in
higher eukaryotes in the process of somatic hypermutation (26).
The elaborate regulation of translesion synthesis may provide the final clue into why cells
contain potentially mutagenic translesion polymerases. As described above in Section 1.3.3,
extensive regulatory mechanisms control the production and activation of translesion
polymerases. Much progress has been made into discovering how TLS polymerases function
and how their activity is controlled. However, many pressing questions still remain. The
coming years will provide many new exciting insights and it is with regret that the author takes
leave of the fascinating field of translesion synthesis and mutagenesis.
11.4 Thesis Summary
I have focused my thesis research on understanding the regulation and mechanism of
action of the translesion DNA polymerase Revl in S. cerevisiae. As REVI promotes
mutagenesis from yeast to humans, this knowledge will provide insight into a fundamental
cellular process important for adaption, evolution, and disease. In Chapter Two, I present
experiments revealing a novel cell-cycle regulation of Rev1 that led to an expanded model for
how translesion synthesis functions. In Chapter Three, I describe experiments designed to
address the contributions of the various domains of Rev 1 to its function in promoting survival
and mutagenesis after DNA damage. The data presented is not complete and further experiments
outlined in the discussion will be undertaken in the following months with the intent of
publication. In the Appendices, I present unpublished data showing preliminary work
characterizing the timing of UV sensitivity of a revlA strain during the cell cycle, preliminary
work towards understanding the molecular mechanism of the cell cycle regulation of Rev 1,
attempted purifications of Rev1 and its interacting partners, and a fine timecourse of the cell-
cycle expression of Rev 1. It is my hope that these lines of research will be carried to completion
in the coming years by other lab members.
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Chapter Two
The Critical Mutagenic Translesion DNA Polymerase Revl Is
Highly Expressed During G2/M Rather Than S-Phase
This chapter was previously published as: Waters, L. S., and G. C. Walker. 2006. The critical
mutagenic translesion DNA polymerase Revl is highly expressed during G2/M phase rather than
S phase. Proc Natl Acad Sci U S A 103:8971-6.
Abstract
The Revl protein lies at the root of mutagenesis in eukaryotes. Together with DNA polymerase i
(Rev3/7), Revi function is required for the active introduction of the majority of mutations into
the genomes of eukaryotes from yeast to humans. Rev and polymerase " are error-prone
translesion DNA polymerases, but Rev l's DNA polymerase catalytic activity is not essential for
mutagenesis. Rather, Rev is thought to contribute to mutagenesis principally by engaging in
crucial protein-protein interactions that regulate the access of translesion DNA polymerases to
the primer terminus. This inference is based on the requirement of the N-terminal BRCT domain
of Saccharomyces cerevisiae Revl for mutagenesis and the interaction o f the C-terminal region
of mammalian Rev I with several other translesion DNA polymerases. Here we report that S.
cerevisiae Rev is subject to pronounced cell-cycle control in which the levels of Rev protein
are approximately 50-fold higher in G2 and throughout mitosis than during GI and much of S-
phase. Differential survival of a rev1A strain after UV irradiation at various points in the cell
cycle indicates that this unanticipated regulation is physiologically relevant. This unexpected
finding has important implications for the regulation of mutagenesis and challenges current
models of error-prone lesion bypass as a process involving polymerase-switching that operates
mainly during S-phase to rescue stalled replication forks.
Introduction
The REVI and REV3 genes ofS. cerevisiae were among the first genes known to be
required for mutagenesis. Identified in 1971 in a screen for reversionless yeast strains (35), these
genes play a central role in promoting mutagenesis from yeast to humans (14, 15). REV1 and
REV3, together with REV7 (33), function in the "error-prone" branch of the RAD6 post-
replication repair pathway (28). In contrast, RAD30, which shares homology with REV], appears
Ito function in parallel with REV1/3/7 in a separate "error-free" branch of the RAD6 epistasis
group (28). After decades of genetic characterization, REVi, REV3/7, and RAD30 were shown to
encode translesion DNA polymerases (17, 24, 43, 44).
Revl possesses a unique enzymatic activity in vitro, displaying a marked preference for
inserting only dCMP opposite a template G and several DNA lesions (32, 41, 43). The Rev3/7
heterodimer forms DNA polymerase ý, which, although it is proposed to function mainly as an
extender of mismatched primer termini (32), can also efficiently insert nucleotides across from
lesions when stimulated by PCNA (12). Rad30 encodes DNA polymerase ri which bypasses UV-
induced lesions efficiently and accurately and, when mutated in humans, causes the cancer-prone
syndrome Xeroderma Pigmentosum Variant (34). Intriguingly, although Revl's highly
specialized catalytic activity has an effect on the spectrum of mutations generated (48, 54), its
dCMP transferase activity is not required for its functions in induced mutagenesis or resistance to
DNA damage [(20, 55); L. Waters and G. C. Walker, unpublished data].
In contrast, Revl's BRCT domain is required for mutagenesis and resistance to DNA
damaging agents in yeast (35), although it may be less important in higher eukaryotes (23, 55).
First characterized as the BRCA1 C-terminus, BRCT domains mediate protein-protein
interactions in many cell-cycle and DNA repair proteins (16). Interestingly, the original loss-of-
function rev]-1 mutant (35) carries a point mutation affecting the BRCT domain (15, 30). Since
the purified Rev -1 protein retains translesion synthesis (TLS) activity in vitro (42) while the
revl-1 mutant is non-mutable in vivo, the alteration of the BRCT domain is thought to disrupt
key interactions.
In addition to the N-terminal BRCT domain and a central TLS polymerase domain, the
Rev 1 protein also contains a C-terminal region which, in mammalian cells, has been shown to
interact with multiple other TLS polymerases (19, 40, 45, 63, 64). Revl's C-terminal interaction
region is required for resistance to DNA damaging agents in vertebrates (55) and in yeast [(30);
L. Waters, S D'Souza, G. C. Walker, unpublished data]. Additionally, the C-terminus, as well as
BRCT and little finger domains, of yeast Revl were recently reported to interact with Rev7 (1,
8). Since Rev 1's protein-protein interaction motifs are required for its function in vivo while its
enzymatic activity is not, this enigmatic translesion polymerase is thought to play a
predominantly structural role in assembling a TLS complex (19, 20, 64).
Polymerase switching during DNA replication has been proposed to be a fundamental
mechanism by which cells control the action of TLS polymerases (10, 51, 52), all of which have
low fidelity on undamaged DNA relative to replicative DNA polymerases (17, 27). Polymerase
switching models suggest that when a replicative DNA polymerase stalls at a blocking lesion, a
handoff allows one or more TLS polymerases access to the primer terminus, enabling lesion
bypass and extension past the distortion. A further reciprocal switch would restore the highly
processive and accurate replicative DNA polymerase to the primer terminus. Current models (10,
134) postulate that Revl plays a central role in the polymerase-switching mechanism during S-
phase to facilitate error-prone bypass of DNA lesions either itself, using its limited polymerase
activity, or by recruiting other TLS polymerases to bypass the lesion.
A recent report from Lopes et al. (37) shows that when yeast replication forks encounter
a lesion, leading and lagging strand synthesis uncouple. Repriming events downstream of a DNA
lesion then lead to persistent ssDNA gaps on both strands of the replication fork, which may
remain throughout S-phase into G2. Interestingly, deletion of all of the TLS polymerases did not
further affect uncoupling or replication fork speed over damaged DNA, but rather led to an
increase in single-stranded DNA (ssDNA) gaps along replicated regions. These data strongly
suggest that some component of TLS may occur behind replication forks and possibly
postreplicatively outside of S-phase.
We report here that Rev is expressed in a cell-cycle dependent manner and is highly
upregulated specifically during G2/M phases rather than during DNA replication in S-phase.
Revi's G2/M expression pattern does not significantly change after DNA damage. Moreover,
REV1 function is required for resistance to DNA damage differentially during the cell cycle. This
finding suggests that Rev I-dependent TLS, and therefore much of mutagenesis, occurs to a
significant extent, if not mostly, outside of S-phase during G2/M.
Results
Revl Protein and mRNA Are Cell-Cycle Regulated and Reach Maximal Levels After Most
Replication Is Completed.
To facilitate analysis of S. cerevisiae Rev1 regulation, a chromosomally located C-
terminally tagged Rev construct was expressed from the native REV] promoter. The tagged
strain was indistinguishable from wild-type in its ability to survive DNA damage and to undergo
mutagenesis (Fig. 1).
Our ability to visualize endogenous levels of Rev1 protein led to the unanticipated
discovery that Rev is subject to pronounced cell cycle control (Fig. 2A). S. cerevisiae cells were
arrested in GI with a-factor, released, and allowed to proceed synchronously through the cell
cycle. In c-factor arrested cells, Revl levels are almost undetectable. Surprisingly, Revl levels
are very low in early S-phase and rise only modestly as cells transit through S-phase (also see Fig.
6). Substantial Rev] accumulation occurs as most cells attain a G2 content of DNA (Fig. 2B)
indicating that Revl levels do not peak as DNA is being synthesized, but rather after most
replication is completed. Using anti-tubulin immunofluorescence to monitor spindle length
reveals that Revl is present at high levels as the chromosomes align during metaphase (Fig. 3A)
and is maintained at high levels even after most cells achieve fully-extended spindles and
completely separate their DNA masses (Fig. 3B). This implies that Revl is highly expressed
throughout mitosis and that maximal protein levels are maintained until cells re-enter G1. Levels
of REV1 mRNA exhibit a similar pattern of cell cycle regulation as the protein, peaking slightly
before the Revl protein levels in G2/M (Fig. IC).
Peak levels of Rev protein in G2/M cells are approximately 50-fold higher than the
barely-detectable Revl signal in Gi arrested cells (Fig. 3C), whereas we found only a ~3-fold
change between maximal and minimal levels of REV1 transcript (Fig. 3D). Thus, the cell cycle
control of Revl levels is primarily post-transcriptional. The observed cell cycle regulation is not
an a-factor specific effect, as cells synchronized by elutriation exhibit a similar pattern of Rev1
expression (Fig. 4). An identically tagged Rad30 shows no change during the cell cycle (Fig. 2A),
indicating that this type of cell cycle control is not a general property of all TLS polymerases.
UV Survival (10 J/m2)
WT revlA Revi-tag
UV-Induced Mutation Frequency (10 J/m2)
per 105 Survivors
vVT revl A Revl-tag
Fig. 1. The C-terminally tagged Revi construct retains full function. (A, B) Isogenic strains of
the wild-type background, a revlA, and the tagged Revl were compared for survival (A) and
mutagenesis (B) after 10 J/m 2 UV irradiation. The data plotted for the revlA reversion frequency
is the limit of detection, since no revertants were recovered. Therefore, the revlA reversion
frequency is likely lower than indicated.
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Fig. 2. Revl is cell-cycle regulated and expressed maximally at G2/M. (A) Immunoblot against
the protein A epitope shows Revi and Rad30 protein levels at indicated timepoints after release
from G1 oa-factor arrest. PGK is the standard loading control phosphoglycerate kinase. (B) FACS
analysis of the DNA content of cells. (C) RT-PCR showing REVI mRNA levels. ACT] was used
as a loading control.
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Fig. 3. Revl is high throughout mitosis and is post-transcriptionally regulated. (A, B) Cells from
the 60 (A) and 90 (B) min timepoints stained with DAPI and anti-tubulin to visualize DNA or
anaphase spindles, respectively. (C) Immunoblot quantitating the change in Revl protein levels
between minimal and maximal points, comparison of an undiluted G1 sample to various
dilutions (1 to 8, 10, 13, 15, 16, 18, 20, 23, 25, 32, 40, 45, and 50 fold) of a G2/M sample. (D)
R"T-PCR samples of minimal and maximal REV] mRNA levels were compared quantitatively
using two-fold serial dilutions of input cDNA.
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Fig. 4. Synchronization by elutriation shows Revl cell cycle expression. (A) Immunoblot against
the protein A epitope tag of Revl and the loading control PGK. Small, unbudded cells were
collected by centrifugal elutriation and samples taken at the indicated times after resuspension in
rich media. (B) FACS analysis of the DNA content. (C) Plot showing quantitation of the
immunoblot from (A) normalized in arbitrary units to a standard dilution curve.
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Revl Protein Is Stably Present Throughout Mitosis
To analyze the timing of Rev1 accumulation more precisely, cdc23-1 and cdc]5-2
temperature sensitive strains were used to arrest cells at the metaphase-to-anaphase transition and
at telophase, respectively (2, 22). Pdsl (securin) was used as a marker for cell-cycle progression
since it is synthesized during S-phase and is degraded at the metaphase-to-anaphase transition
(67). Cells were synchronized in G1 with a-factor and then, upon removal of a-factor, shifted to
the restrictive temperature to induce the second cell cycle arrest. We found that Revl levels do
not rise until after Pdsl has accumulated during S-phase, again demonstrating that Revl levels
are low during much of DNA replication. Furthermore, Rev 1 is present at high levels in cdc23-1
metaphase-arrested cells (Fig. 5A), indicating that Rev1 accumulation begins during G2 before
metaphase. Even more interestingly, Rev1 is also stable in cdc15-2 telophase-arrested cells (Fig.
:5B). The cdcl5-2 allele produces a very late arrest in the cell cycle during exit-from-mitosis, just
before re-entry into G1 (2). Following release from the cdcl5-2 telophase block, Rev1 levels
decrease as cells re-enter G 1 (Fig. 5C). Therefore, contrary to prevailing expectations for a TLS
polymerase, we demonstrate that Rev1 is maximally present after the majority of DNA
replication is finished, remains throughout all of mitosis, and is present even during exit-from-
mitosis while cells reset for G1.
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Fig. 5. Rev protein is stable in both metaphase and telophase arrested cells. (A, B) Immunoblot
showing Revl and Pdsl in cdc23-1 (A) or cdcl5-2 (B) arrested cells. Timepoints were taken
every 20 min after release from a-factor and shift to the restrictive temperature. (C) Immunoblot
showing Revl and Pds 1 levels at the indicated times after release from the cdc15-2 block. Cells
released from a cdcl5-2 arrest fail to separate due to a cytokinesis defect and generate a 4C peak
on FACS indicative of a second round of DNA replication.
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DNA Damage Does Not Significantly Alter Revl's Expression Pattern
Taken together, these observations suggest that, in undamaged cells, the major
physiological role of Rev in spontaneous mutagenesis occurs predominantly in G2/M. We
wondered, however, if exogenous DNA damage would significantly alter Rev1 expression so
that it would accumulate mainly during S-phase when the replication machinery would be
actively encountering lesions. Since Revl is required for bypass of the 6-4 photoproduct induced
by UV (42), we irradiated cells arrested in GI and followed Rev1 levels through the cell cycle
after DNA damage. Doses of UV irradiation of 10 J/m 2 and 50 J/m 2 resulted in ca. 100%, and
60% survival of the tagged Revl strain and ca. 75%, and 1% survival of an isogenic revAl
strain. We found that DNA damage did not result in a radical alteration of the overall pattern of
Revl expression (Fig. 6). Despite the fact that replication forks would have encountered UV-
induced lesions from the beginning of S-phase, Rev1 levels were not dramatically increased
early in S-phase relative to an unirradiated strain. As observed with undamaged cells, Revl
accumulated slowly through S-phase, only reaching its peak when most of the cells were in G2.
Some changes in the timing of Revlp accumulation, however, were discernable. After 10
J/m 2 of UV, low levels of Revl were still found in early S-phase but began increasing slightly
earlier to achieve higher levels during late S than in the absence of UV damage (Fig. 6A). After
50 J/m 2 of UV, this shift in Rev1 accumulation became more pronounced (Fig. 6B). The cells
proceeded more slowly though the cell cycle after significant amounts of DNA damage, so direct
comparisons of timecourses by minutes after release do not reflect cell cycle stage. Despite this
moderate shift in timing after substantial DNA damage, Revl protein is not present at high levels
throughout S-phase, as would be expected for a replication protein or an S-phase repair protein.
Instead, at high doses of UV, Revl accumulation appears to track slightly after the metaphase
protein Pdsl (Fig. 6B). Additionally, as with undamaged cells, after UV irradiation Rev1 still
appears to persist into G2/M as the cells complete replication and enter mitosis.
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Fig. 6. Cell-cycle expression pattern of Revl is modestly altered after DNA damage. (A, B) Plot
showing relative amount of Revl protein in arbitrary units as a function of cell cycle progression.
Gl-arrested cells were UV-irradiated with 10 J/m2 (A) or 50 J/m 2 (B), released from cc-factor
block, and timepoints taken as indicated. Immunoblots were quantitated and normalized to a
standard dilution curve of RevI to allow comparison between blots. FACS data monitors cell
cycle progression.
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REV1 Function Is Required Differentially During the Cell Cycle
To analyze the possible biological significance of the observed Revl cell-cycle
regulation, we monitored survival after UV irradiation at different cell cycle stages. Cells were
arrested in Gi with cc-factor or in G2 with nocodazole, washed to remove the drugs, plated, and
immediately UV irradiated. The WT strain was only slightly more sensitive to killing when UV
irradiated just after release from G1 than when UV irradiated just after release from G2 (Fig.
7A), in agreement with previous reports (59). The mild sensitivity of a rad30A strain to killing
by UV irradiation was likewise largely unaffected by the cell cycle stage during which the UV
irradiation occurred (Fig. 7A), consistent with the observation that the Rad30 protein is
constitutively expressed throughout the cell cycle (Fig. 1 A).
In striking contrast, the rev1Ad strain was markedly more UV sensitive when irradiated
after release from GI than when irradiated after release from G2 (Fig. 7B), showing clearly that
REV] function is required differentially throughout the cell cycle. Since Rev1 is largely absent in
G1 and present in G2, a plausible explanation is that irradiation after release from GI results in
replication forks encountering DNA lesions before they can be completely repaired by nucleotide
excision repair (NER), causing leading and lagging strand uncoupling and repriming events
downstream that lead to the generation of ssDNA gaps at lesions (37). Such ssDNA gaps would
require TLS. In contrast, irradiation in G2 would allow a more prolonged period for NER prior to
DNA replication, thereby reducing ssDNA gap formation and hence the need for TLS.
Consistent with this explanation, microscopic examination of the plates revealed that, when
irradiated with 20 J/m2 of UV after release from G , rev]A cells arrest predominantly as budded
cells (data not shown). This indicates that the lethal event after UV irradiation in revIA cells
occurs following replication, rather than in G or at a random point several generations later.
Interestingly, although the protein levels of Rev3 and Rev7 do not vary during the cell
cycle (S. D'Souza and G. C. Walker, data not shown), the rev3A and rev7A strains display the
same hypersensitivity to UV irradiation when irradiated after release from G as the rev] A strain
(Fig. 7B). The striking similarity of the pattern of cell-cycle dependent UV sensitivity indicates
that Revl's cell-cycle regulation is used to control the activity of DNA polymerase ý (Rev3/7)
during the cell cycle.
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Fig. 7. REV1, REV3, and REV7 are required differentially throughout the cell cycle for survival
after UV irradiation. (A) Percent survival of the WT (diamonds) and rad30A strains (circles)
after release from G2 (dotted line) or G1 (solid line) arrests. (B) Percent survival of the WT
(diamonds), revlA (squares), rev3A (triangles), and rev7A (circles) strains after release from G2
(dotted line) or GI (solid line) arrests. Note that revId, rev3A, and rev7A strains exhibit such
similar survival that the strains can hardly be distinguished from each other.
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Discussion
We report here that in S. cerevisiae, Revl protein levels are dramatically cell-cycle
regulated, being at least 50-fold higher in G2/M than in GI and much of S-phase. The
remarkable dependence of the UV sensitivity of a revlA mutant, but not a rad30A mutant, to the
cell cycle stage in which UV irradiation occurs indicates that the cell cycle regulation of Revi is
of major biological significance. As Revi and polymerase ý are required for -95% of the
mutagenic events in a cell (32), the cell cycle regulation of Revi has profound implications for
when mutagenesis takes place during the cell cycle.
We show that the amount of Revl protein is extremely low during G 1 and rises slowly
throughout early and mid S-phase. Revl levels only begin to increase rapidly in late S-phase,
reaching maximum levels in G2. The Revl protein is then maintained at a high intracellular
concentration throughout mitosis until after telophase. DNA damage causes Revl to accumulate
somewhat earlier in late S without significantly affecting the level reached in G2/M, but does not
convert Revl's expression pattern into that of a canonical replication protein, such as PCNA or a
replicative DNA polymerase (9, 62). The observed pattern of cell-cycle dependent expression
was initially surprising, given current models postulating that polymerase-switching allows
translesion synthesis to restart stalled replication forks during S-phase (10, 34, 51, 52). In
contrast, our unexpected finding that Revl is cell-cycle regulated with maximal expression
during G2/M suggests that RevI acts predominantly in G2/M rather than during the active phase
of DNA replication in S-phase. This is consistent with the report from Lopes et al. (37), which
challenges the assumption that the polymerase switch event occurs solely at blocked replication
forks in S-phase. We propose that Revi acts postreplicatively during G2, and even M, by
carrying out its well established roles in mutagenic TLS. During this process, Revl could
function both as a DNA polymerase and also recruit other TLS polymerases to fill the ssDNA
gaps that are left behind as a consequence of replication forks encountering lesions.
A rev1A strain is differentially sensitive to UV irradiation during the cell cycle,
demonstrating that REV] functions in a cell-cycle dependent manner. In yeast, DNA polymerase
. (Rev3/7) (1, 32) does not display cell-cycle regulated protein levels (S. D'Souza and G. C.
Walker, unpublished data), nor does the related Y family translesion DNA polymerase
il (Rad30) (Fig. 1A). A rad30A strain showed no cell-cycle dependence in its sensitivity to UV
damage beyond that of the WT strain. However, the rev3A and rev7A strains were
indistinguishable from the revl A strain in their responses to UV damage after release from G or
G2 arrests. Therefore, although the cell-cycle regulation exhibited by the Rev protein appears to
be unique among TLS polymerases, it is likely used to control the Revl/3/7-dependent error-
prone mode of translesion synthesis. Additionally, as polymerase ý dependent crosslink repair
also shows cell-cycle dependence (58), Revl's cell-cycle regulation may be used to coordinate
the responses of other damage tolerance pathways as well.
Although this is the first direct evidence for cell-cycle regulation of Revl, other recent
results are consistent with Revl and its partners Rev3/7 acting late in the cell cycle. For example,
Revl functions in preventing chromosomal breaks in mouse ES and transformed chicken DT40
cells in late S/G2 (23, 46, 60). Similiar to our observation with UV, rev3A cells progress through
S-phase normally but arrest permanently in G2 after cisplatin treatment (18). Analogous results
have been observed in mouse and chicken cells with Rev] BRC7T and Rev3 - deficient lines (23,
60, 68). Our discovery that Revl levels are highest in G2, after a sister chromatid has been
generated, is also consistent with the growing evidence for REV1/3/7 involvement in certain
aspects of homologous recombination (HR) (46). Evidence consistent with Revl and Rev3/7
contributing to the processing of double-strand breaks during HR in meiosis includes the
observations that, in yeast, each of the REV genes is upregulated during sporulation (4, 6, 61) and
in mammals, REV] and all of the other TLS polymerases are at high levels in the testes (29).
Further supporting an involvement in facets of HR repair, REV3 is required for the break-repair-
induced mutagenesis observed during DSB repair (21, 53). However our demonstration that
Revi persists until well after anaphase and sister-chromatid separation suggests that, beyond any
contribution to HR, Revl may play a role during mitosis after sister chromatids are physically
separated and unable to synapse. These data, together with the observation that hREV7
(hMAD2B) inhibits the metaphase-to-anaphase transition through the spindle checkpoint in
Xenopus extracts (5, 50), strongly indicate that Rev1/3/7 play a major role at the end of DNA
replication and throughout mitosis.
Is it reasonable that the majority of Revl -dependent mutagenic translesion synthesis
could occur after most DNA replication is completed and extend throughout mitosis? The
inhibition of many polymerases by DNA lesions in in vitro studies employing primed single-
strand templates has contributed to a widespread impression that real replication forks can be
similarly stalled by a single lesion. However, in vivo in both eukaryotes and prokaryotes,
replication forks uncouple leading and lagging strand synthesis when they encounter lesions and
leave gaps in their wake (7, 37, 49, 56), which may persist as cells enter G2. The recent results of
Lopes et al. (37) show that TLS defective S. cevervisiae cells do not further uncouple leading
and lagging strands, but rather have an increase in ssDNA gaps, consistent with the idea that TLS
may occur behind the replication fork and even after bulk replication has been completed.
Interestingly, after DNA damage E. coli seems to delay mutagenic translesion synthesis by using
the kinetics of the SOS-regulated UmuD -> UmuD' transition to impose a phase of largely
accurate DNA repair and tolerance followed by a phase of error-prone lesion bypass (47).
Restricting Revl to the latter part of the cell cycle may be a conceptually similar strategy to
reserve REV1/3/7-dependent mutagenic TLS until after high-fidelity repair or damage-tolerance
mechanisms have been attempted (Fig. 8A).
In our model, the major site of Revl action is at inappropriate primer termini remaining
in G2/M at gaps caused by lesions (Fig. 8B). A persistent gap in G2 may be recognized by Rev1
by its ability as a polymerase to bind primer termini or using its BRCT domain, since some
BRCT domains can bind DNA, particularly single- or double-stranded breaks (65, 66).
Therefore, the revl-1 mutation might also inactivate Revl's localization to aberrant DNA
structures rather than exclusively disrupting a protein-protein complex. Additionally, since it is
possible that modified forms of PCNA may persist at ssDNA gaps and serve as a marker for
repair activities, Revl may recognize a ssDNA gap remaining in G2 by binding to a
monoubiquitinylated PCNA through its UBM ubiquitin-interacting domains, in a manner
analogous to DNA polymerase t in mammalian cells (3). Interaction with monoubiquitinylated
PCNA also stimulates Revl's catalytic activity (11). Once at the lesion, Rev1 may facilitate
tolerance and gap-filling either by using its own dCMP transferase activity or by recruiting other
TLS polymerases through its C-terminal region (19, 40, 45, 63, 64). Revl may also interact with
other DNA repair or damage checkpoint signaling factors, for example using its BRCT domain
to form a complex with other BRCT-containing proteins or indirectly through PCNA (55) or the
alternative clamp 9-1-1 (57). Once a gap has been filled and the lesion bypassed, excision repair
machinery could then be recruited by Revl to remove the lesion prior to the start of the next cell
cycle.
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We cannot exclude some contribution of Revl during S-phase, since the low levels we
observe during DNA replication may be sufficient for at least some TLS. However, the levels of
Revl during S-phase are likely significantly lower than those of replicative DNA polymerases,
perhaps 10-fold or more. Asynchronous yeast cultures contain only -500 Revl molecules/cell,
the majority of which is presumably due to the G2/M cells in the population, compared to -2000
molecules/cell for Rad30 or the replicative polymerases (13). Furthermore, Rev and Rev3 are
also thought to be present at a very low cellular concentration in higher eukaryotes (14, 15, 36,
55). This low level of Revl, coupled with the cell-cycle regulation we have observed, suggests
that caution should be used in interpreting studies in which Revl is overexpressed (38, 64). The
finding that overexpressed Rev localizes to replication forks may provide a rationale for why
cells keep the amount of Revl low during S-phase; if Revl were present at high levels, it might
be recruited inappropriately to replication forks when not needed with mutagenic or lethal
consequences. During S-phase, relatively accurate TLS at stalled replication forks may be
accomplished by TLS polymerases such as polymerase rl (Rad30/XPV) recruited by mono-
ubiquitinylated PCNA (34). In contrast, we suggest that Revl acts mostly outside of outside of
S-phase coordinating a more mutagenic usage of TLS polymerases later in the cell cycle.
While this paper was under revision, a report appeared showing ectopically
overexpressed hRevl formed foci in S-phase as well as in GI (39). Although focus formation is
frequently interpreted as indicating the site of a protein's major function, in this case the most
biologically significant action of Revl might not manifest itself as a focus. Whereas recruitment
of many molecules of Rev 1 to a replication factory or repair center would likely generate a
focus, it is not clear that recruitment of Revl to multiple ssDNA gaps spaced out along replicated
DNA would result in a high local concentration of Rev 1.
Since most aspects of cell cycle control are shared between yeast and mammals, Revl's
cell cycle regulation may have general implications for TLS-dependent mutagenesis. Our results
suggest that cells delay potentially mutagenic TLS until later in the cell cycle as a strategy for
minimizing the mutagenic effects of DNA damage. In the environment, S. cerevisiae and other
microorganisms likely spend most of their life in a quiescent, nonproliferating state. Most cells in
higher eukaryotes are terminally differentiated and have withdrawn from the cell cycle. Thus,
restricting Rev 1 protein expression to G2/M may reflect a cellular mechanism for reducing
mutagenesis in resting cells.
Materials and Methods
Strains. Strains used were derivatives of W 1588-4C, a W303 strain corrected for RAD5 (69).
pYM10 was used to generate a C-terminal -TEV-ProA-7His tag (26). Strain information is
shown in Table 1 and primer sequences in Table 2.
Immunoblots. Whole cell extracts were prepared by TCA precipitation (26). Antibodies used
were rabbit PAP antibody (Sigma) against the protein A tag, anti-HA.11 (Covance), and anti-
phosphoglycerate kinase (Molecular Probes). Quantitation was performed using the Typhoon
'9400 (GE Healthcare) and ImageQuant software. Plots were generated by averaging two to four
replicate immunoblots.
Flow Cytometry. Cells were prepared essentially as described (31) and analyzed on a Becton
Dickson FACSCalibur flow cytometer.
Cell Synchronization. Logarithmically growing barlA yeast were arrested with 50 ng/mL a-
factor for 4 hours at 25 'C and washed to remove a-factor. In Fig. 1, cells were resuspended in
25 'C media and a-factor was added back after 75 min. In Fig. 2, cells were resuspended in
media pre-warmed to 37 'C. After 3 hours at 37 'C, cells were released from the cdc15-2 arrest
by harvesting and resuspending cells in 25 'C media. In Fig. 3, cells were resuspended in 20 mL
water, transferred to a 150 x 15 mm petri plate, and irradiated . Aliquots were assayed for
viability. Cells were diluted in 20 mL 2x media to start the timecourse. In Fig. 3A, a-factor was
added back after 90 min, in Fig. 3B after 80 min (0 J/m 2) or 100 min (50 J/m 2 UV).
Cell Cycle UV Survival Assay. At least 3 independent cultures of each strain were arrested with
5;0 ng/mL a-factor or 15 ptg/mL nocodazole for 3 hours at 30 oC and washed with water or 1%
DMSO in YEP media to remove a-factor or nocodazole respectively. Microscopic analysis of
cells confirmed arrest. Cells were diluted appropriately in water, plated on SC media,
immediately UV irradiated at 1 J/m2/sec using a G15T8 UV lamp (General Electric) at 254 nm,
and incubated for 3 days at 30 oC in the dark.
Immunofluorescence. Immunofluorescence was performed using anti-tubulin (Oxford
Biotechnology) and anti-rat-FITC (Jackson ImmunoResearch) (25).
RT-PCR. RNA was isolated using RNeasy Mini Kit (Qiagen) according to manufacturer's
protocol. To generate cDNA, 0.5 gig RNA was used in 20 gL reactions with 20 pmol oligo dT
primer, and 25 U Stratascript reverse transcriptase (Stratagene). All PCRs were performed for 26
cycles and different amounts of input cDNA were used to analyze relative levels of REV1 or
A.4CTI mRNA in each sample.
Survival and Mutagenesis Assays. Three independent cultures of each strain were grown to
saturation and appropriately diluted aliquots were plated on SC media to monitor survival.
Mutation frequencies were analyzed by plating undiluted aliquots on SC-Trp media to score for
reversion of the trpl-1 allele. Plates were irradiated at 1 J/m2/sec using a G15T8 UV lamp
(General Electric) at 254 nm and grown for 3 or 6 days at 30 oC for survival and mutagenesis
assays respectively.
Elutriation. Cells were collected by elutriation as described (2) in a JE-5.0 Elutriator (Beckman
Coulter) and resuspended in YPD media to initiate the timecourse.
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Table 1: Strains used in this study
Strain Genotype
W1588-4C
JAy 19
A2
W1588-4C barlA
rev1A barlA
rev3A
rev3A barlA
rev7A barlA
rad30A
MATa ade2-1, ura3-1, his3-11,15, trpl-1, leu2-
3,112, canl-100, RAD5
REV1-TEV-ProA- 7His.:HIS3MX6, RAD30-TEV-
ProA-7His:HIS3MX, barl.::LEU2
REV]1-TEV-ProA- 7His.HIS3MX6, RAD30-TEV-
ProA-7His:HIS3MX6, barl::.LEU2
REV1 -TEV-ProA- 7His.:HIS3MX6, barl].: URA3,
cdc23-1, PDS1-HA .LEU2
REV1-TEV-ProA- 7His.:HIS3MX6, barl . URA3,
cdc]5-2, PDS1-HA.:LEU2, SCC1-MYC.TRP1
barl ::LEU2
revl.'.:kanMX, barl.:.:LEU2
rev3. : kanMX
rev3..kanMX, barl.:.:LEU2
rev7..::kanMX, barl ::LEU2
rad30.: :kanMX
Rothstein lab (66)
R. Woodruff
this study
this study
this study
this study
this study
S. D'Souza
this study
this study
R. Woodruff
rad30::.kanMX, barl.::LEU2
Source
rad30A barlA this study
Table 2: Primers used in this study
Primer Name Primer Sequence
Revl-tag-fwd
Revi -tag-rev
RevlD
Rev1E
oligo-dT
ACTISEQA
ACTISEQB
pRS-Rev1-fwd
pRS-Revl-rev
REV7DELAFWD
REV7DELDBKWD
CATACTTACCAGACTGTGCGTAAACTTGACATGGACTTTGAA
GTTcgtacgctgcaggtcgac
CGCAAACTGCGTGTTTACTGTATGCTGAAATGTTTTTTTTTTT
TTAATatcgatgaattcgagctcg
GTGAAACAATGGGTTGCCGAAACTTTAGGTGATGG
GGCGAGGTCTTTCGGAATGGTGG
TTTTTTTTTTTTTTTTTTTTC
CAAGAAATGCAAACCGCTGC
GGTCAATACCGGCAGATTCC
GCTTTGAGTTGGGGTAGATTATCGC
GTGTTGGTACCAAAGGAGGAGTCGGCCATTCC
AGTATGTATTTCTTTTCCCCTTGCT
CGCCACTTACAAAATATTCAAGACT
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Chapter Three
Characterization of Novel Motifs Required for REVI Function
Abstract
Identified in 1971 in a screen for reversionless mutants, the REV] gene underlies the
majority of spontaneous and damage-induced mutagenesis in eukaryotes from yeast to humans
(11, 33). Although a member of the Y family of translesion DNA polymerases (44), Rev1 has
unique properties not shared by the other Y family members. Rev1 possesses limited
polymerase activity specialized to insert primarily dCMP nucleotides opposite to template G's
and certain DNA lesions (29, 42, 62). Additionally, Rev1 contains domains not present in other
Y family members, including an N-terminal BRCT domain (3) and a C-terminal interaction
region (14, 39, 43, 54, 55). Intriguingly, the catalytic activity of Rev1 is not essential for its
function in survival and mutagenesis in vivo (18, 51) whereas a role provided by the BRCT
domain and the C-terminal region is required for REV] activity (15, 28, 33, 51). Differences
have been observed in the contributions of the various domains of Rev1 to its function in the
s;everal systems used to study REV] activity (15, 19, 50, 51). In particular, the C-terminal
interaction region of Rev 1 has been reported to be lacking or very degenerate in yeast (6, 22, 39,
51, 55). To clarify the roles of each domain in Revl function, as well as to address the
conservation of the C-terminal interaction region in yeast, I have undertaken a structure-function
study to probe the molecular mechanisms behind Revl's enigmatic role in mutagenesis in vivo. I
have generated extensive protein sequence alignments which reveal conserved motifs among
Revl proteins from various organisms, in particular in the C-terminal interaction region. Site-
directed mutants in these motifs showed a functional relevance of these domains to REV]
function. Additionally, mutants affecting the catalytic domain revealed further details of REV]
activity. Future work to characterize the molecular nature of the defects uncovered will provide
a robust understanding of the mechanisms controlling Revl's unique role in DNA damage
tolerance in vivo.
Introduction
Cells are constantly exposed to DNA damage from endogenous, as well as exogenous,
sources. For example, it has been estimated that mammalian cells suffer -30,000 spontaneous
DNA lesions per day (34). To respond to and repair this extensive DNA damage, cells have
developed a battery of DNA repair and damage tolerance pathways (8). The majority of such
responses function in an error-free manner to restore the correct DNA sequence and maintain
genomic stability. However, one DNA damage tolerance pathway, known as translesion
synthesis (TLS), is responsible for the active generation of mutations into the genomes of all
organisms (8, 29). Translesion synthesis is the process by which a nucleotide is inserted
opposite to a DNA lesion and is mediated by a specialized class of DNA polymerases known as
translesion polymerases (7, 13, 48).
Translesion polymerases are thought to rescue stalled replication forks and enable
continuous DNA synthesis on damaged templates during replication (6, 31). In addition, TLS
polymerases may promote post-replicative gap filling at regions of ssDNA produced by
replication fork repriming downstream of a lesion (32, 35, 59). In either situation, TLS
polymerases mediate their function by providing lesion bypass capabilities to cells. The ability
to use an increased structural diversity of DNA bases as a template is paid for by a decreased
fidelity of replication (13, 26, 48). On undamaged DNA, TLS polymerases display an increased
error rate of up to five orders of magnitude relative to replicative DNA polymerases (7, 26).
However, it is now thought that each TLS polymerase may be specialized to bypass a particular
class of DNA lesions (7). For two TLS polymerases, the efficiency and fidelity of translesion
synthesis opposite a cognate lesion has been shown to exceed that of polymerization on
undamaged DNA templates (20, 27, 36, 37). Nevertheless, TLS polymerases are presumably
tightly regulated inside the cell to avoid inappropriate synthesis on non-cognate lesions or
undamaged DNA, uninhibited replication of which would lead to a high level of mutations. A
major mode of regulation of TLS polymerases is accomplished at the level of protein-protein
interactions which activate TLS both by recruitment to sites of DNA damage and by direct
biochemical stimulation of lesion bypass (6, 8, 47, 49, 56). Additionally, protein-protein
interactions leading to post-translational modifications of TLS polymerases control the activity
of prokaryotic TLS polymerases (8) and are likely to exist as well in eukaryotes [(2); L. Waters
and M.E. Wiltrout, unpublished data. See Appendix B).
In 1971, a screen for reversionless mutants of yeast defective in UV-induced mutagenesis
uncovered the REVi gene, which is required for -95% of cellular mutagenesis (30, 33). Revl
activity promotes mutagenesis from yeast to humans (11, 33). When cloned and sequenced, the
Revl protein was shown to have homology with E. coli UmuC (28), isolated in a similar screen
]for unmutable bacteria strains (23). However, the significance of this finding was not
appreciated for another decade until the recognition that Rev 1 and UmuC are members of a
novel family of DNA polymerases able to replicate over DNA lesions that would otherwise
block replication (8, 13, 44, 48).
In addition to its central TLS polymerase domain, Rev1 has three other characterized
regions: an N-terminal BRCT domain (3), two repeats of a ubiquitin binding motif (UBM) (2),
and a C-terminal polymerase interaction region (14, 39, 43, 54, 55). Interestingly, mutations in
all three of the latter regions have been reported to severely affect Revl's ability to promote
survival and mutagenesis after DNA damage (15, 16, 19, 28, 33, 51). In contrast, mutations
perturbing catalytic function do not seem to alter overall levels of survival and mutagenesis (18,
51), although they do affect the spectrum of mutations generated after DNA damage (45, 50).
Taken together, these findings have led to a model in which Rev1 functions primarily to
assemble a mutagenic translesion complex rather than to directly bypass lesions itself (6, 14, 18,
31, 55). In support of a principally non-catalytic role for Revl, it has been observed that REV1 is
required for bypass of 6-4 TT dimers in vivo, although in vitro the specialized dCMP transferase
activity of Rev1 is unable to insert a nucleotide opposite to UV photoproducts (41, 45, 62).
First characterized as the BRCA1 C-terminus, BRCT domains from a variety of proteins
mediate protein-protein interactions, often in a phospho-specific manner (3, 12). Additionally, a
limited subset of BRCT domains interact with DNA, often at regions of ssDNA or DSBs (25,
60). The original revl-1 mutation isolated in 1971 was determined to result from a G193R point
mutation in the BRCT domain of Revl (11, 28). In yeast, this mutant severely disrupts REV]
function, displaying at most -10% activity [(5, 28, 33); L. Waters, unpublished data, see Fig. 5B,
F]. The relative importance of the BRCT domain to REV] activity is less clear in higher
eukaryotic systems. It has been reported that chicken DT40 cells expressing BRCT-defective
versions of human REV] show no sensitization to DNA damaging agents (51). In contrast, other
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groups have shown that DT40 cells expressing mouse REV] require an intact BRCT domain for
REV] function in vivo (15) and mouse ES cells bearing a REV1 allele lacking the BRCT domain
exhibit a mild phenotype (19). The reason for the discrepancies between these results is not
clear, however the report which found no contribution of the BRCT domain to REV! function
only examined sensitivity to DNA damaging agents (51), while the latter two studies showed the
importance of the BRCT domain in several assays, including subcellular localization (15),
interactions with PCNA (15), cell cycle progression (19), UV-induced mutagenesis (19),
chromosomal rearrangements (15, 19), and to DNA damaging agents (15, 19). Therefore it
seems very likely the BRCT domain of Rev1 plays a major role in REV1 function from yeast to
humans. Importantly, the BRCT domain of both yeast and mouse Revl mediates an interaction
with PCNA and this interaction is abolished in revl-] mutants (15, 29). The Revl-1 protein,
when purified, retains its lesion bypass ability (41), consistent with the idea that the disruption of
REV1 function by mutation of the BRCT domain specifically affects a second, non-catalytic
function of Revl mediated by key protein-protein interactions.
All the eukaryotic Y family polymerases have motifs shown to confer the ability to
interact with ubiquitin: polymerase t and Revl share a similar ubiquitin binding motif known as
a UBM, while polymerase K and polymerase 1 have a distinct motif composed of a zinc-finger,
termed the UBZ (2). These ubiquitin binding motifs promote interaction with monoubiquitinated
PCNA to localize the translesion polymerases into DNA damage induced foci at sites of stalled
replication (2, 46). Very recently, it has been shown that the UBMs of mouse Revl mediate
these same functions (16). I identified these motifs independently and have characterized their
importance to Revl function in yeast.
Mammalian Rev 1 protein interacts with all of the other translesion polymerases-
polymerase fr, polymerase t, polymerase K, and the Rev7 subunit of polymerase ý, as well as the
X-family DNA polymerase X-through its C-terminal -100 amino acids (14, 39, 43, 55). This
interaction appears to be functionally important since cells expressing Revl lacking the C-
terminus displays a severe loss of viability after DNA damage, comparable to a deletion mutant
(28, 51). The presence of a conserved C-terminal interaction region in yeast has been debated
since the region was originally reported to be absent from yeast Revl and is now thought to be
quite degenerate (6, 39, 51). Moreover, its function in interacting with other TLS polymerases
appears less complex in S. cerevisiae, which only contains two other TLS polymerases. In
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contrast to its role in mammalian cells, DNA polymerase rl appears to function independently of
Revl genetically and biochemically in yeast [(6, 38); R. Woodruff, unpublished data].
Additionally, in yeast DNA polymerase ý interacts with Revl outside of the C-terminal -100
amino acids (1, 5), so the polymerase interaction motif may not be required or necessary. Thus,
Rev from higher eukaryotes has been proposed to have developed additional functions not
present in lower eukaryotes (6, 22, 39, 55). It should be noted, however, that full-length yeast
Rev 1, but not a version of Rev 1 lacking the C-terminus, is able to stimulate the lesion bypass
activity of polymerase ý, indicating that the C-terminal region of yeast Rev 1 interacts with
polymerase ý in vitro (17). Thus, the role of the C-terminus of Rev in yeast has remained
unclear.
In this chapter, I show that the C-terminus of Revl does exhibit reasonable homology
among most eukaryotes, with a major exception of worms and plants. Additionally, I show that
conserved motifs in the C-terminus mediate a critical function for REVI activity. The regulation
of Revl by ubiquitin binding was probed through mutations in the UBMs. I present data
confirming that the catalytic activity of Revi is dispensable for survival and mutagenesis in vivo.
In contrast, I demonstrate that mutations affecting non-catalytic function of the polymerase
domain of Rev 1 disrupt Rev l's function by showing that the DNA-binding ability of Rev 1 is
crucial for its function. Future experiments described in the Discussion will determine the
molecular nature of the defects in the mutants and allow characterization of the mechanisms by
which the various domains of RevI mediate its function in DNA damage resistance and
mutagenesis.
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Results
Alignments of Revl from multiple species reveal conserved motifs in the C-terminus which
are critical for function.
To address the question of the conservation of the C-terminal -100 amino acids of Rev1,
which mediate contacts with multiple other polymerases in mammalian cells, I obtained and
aligned Revl sequences from a variety of organisms, including multiple yeast species (Fig. lA).
Throughout this chapter, the term yeast will be used to refer specifically to S. cerevisiae unless
indicated otherwise. It has been reported that yeast Revl lacks the C-terminal interaction region
(39), however extensive inspection and hand alignment identified a reasonable level of
homology (Fig. IB). In the C-terminal -100 amino acids, several motifs could be observed.
Four amino acids were absolutely conserved throughout over 50 organisms: a tryptophan set
into a putative oc-helix, a proline flanked by small residues characteristic of a p-turn motif and
followed by a highly conserved charged motif including an invariant aspartate, and a tryptophan
in a less conserved region (Fig. 1B). To test whether these areas of limited homology mediated a
conserved function between yeast and mammalian Revl, I created site-directed alanine-patch
mutations (Fig. 1 B) and assayed for survival and mutagenesis after UV irradiation. Four of the
five mutations (rev]-108, revl-109, revl-110, rev-111) completely abolished REVJ-mediated
survival and the fifth mutation (revl-112) reduced survival efficiency by half (Fig. 2A, B).
Preliminary mutagenesis results were consistent with the survival data, however were not
statistically robust enough to include and will be repeated. Additionally, four of the five
predicted polymerase interaction mutants (revl-108, revl-109, rev]-110, rev-ill) displayed
pronounced sensitivity to MMS, comparable to the rev1A mutation (Fig. 2C). Thus, the Revl C-
terminus appears to be conserved between yeast and humans at the sequence and functional
levels, mediating a critical function of REV1 activity both in yeast and humans.
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Fig. 1 The C-terminal -100 amino acids of Revl is conserved across a wide range of organisms.
(A) An unrooted phylogenetic tree showing the diversity of species used to generate the
alignment in part B. (B) Multiple sequence alignment of Revl sequences from selected species.
Boxed residues and the text above indicate the alanine patch mutations. (See Table 3 for more
details.) Amino acids highlighted in light grey show conservation across all species, while
amino acids highlighted in dark grey indicate a conserved region not found in S. cerevisiae and
closely related yeasts. Arrows indicate absolutely conserved amino acids. Abbreviations are as
follows S. cerevisiae (S. cer), S. mikatae (S. mik), S. kudriavzevii (S. kud), and S. bayanus (S.
bay). The remainder are as indicated in part A. Revi sequences from over 50 organisms were
used to generate the alignment, but only 17 are shown due to space considerations.
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Fig. 2 Mutations in predicted polymerase interaction motifs disrupt REVJ-mediated survival.
(A) Survival of the indicated mutants after a dose of 30 J/m2 UV irradiation. Note that no
colonies were recovered for rev]-108. (B) Survival of revl-108 after a dose of 10 J/m2 UV
irradiation. (C) Sensitivity of the mutants to chronic exposure to 0.02 % MMS.
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Further bioinformatic analysis of the Revl C-terminus revealed that the region may fold
into an a-helical bundle (Fig. 3A, B). The first half of the C-terminal -100 amino acids is
predicted to have a highly conserved secondary structure consisting of two putative a-helices.
The pattern of hydrophobic residues indicated that the predicted a-helical stretches, in particular
the first helix, may form amphipathic helices (Fig. 3C). The charged/polar face may contain
species-specific binding interface since it does not exhibit a conserved pattern of positive,
negative, and polar residues. Interestingly, a particularly conserved motif starting just after the
second predicted helix (highlighted in dark gray in Fig. 3A) is present only in organisms more
distant from Saccharomyces and its relatives. This motif may represent a particular interaction
site not found in S. cerevisiae Rev1. Like the first part of the C-terminus, the final -50 amino
acids appear to be primarily a-helical, however the location of the predicted helices is not as
conserved throughout Revl sequences from various species. The reduced homology appears to
correlate with a decreased importance of this region for REV1 function in yeast (see Fig. 2A and
2C, rev]-112).
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Fig. 3 Predicted secondary structure of the C-terminus of Revl. (A) Multiple sequence
alignment of Revl sequences from selected species. The dark line shows the location of the
amino acids shown in part C. Amino acids highlighted in light grey show conservation across all
species, while amino acids highlighted in dark grey indicate a conserved region not found in S.
cerevisiae and closely related yeasts. (B) Alignment of yeast and human Revl excerpted from
part A for clarity with the predicted helices for each sequence indicated by wavy lines. The dots
connecting the last two helices of human Revl indicate that this helix is continuous. (C) Helical
wheel projections of the first predicted helix. Dark grey indicates hydrophobic residues, light
grey indicates charged residues, and white indicates polar residues and glycine. Size represents
the position along the helix, the larger circles indicate more N-terminal residues.
109
Identification of an additional conserved motif required for REV1 function.
In the intervening region between the end of the polymerase domain and the C-terminal
-100 amino acids of Revl, very little homology was observed among Rev1 sequences from all
organisms. This region was of variable lengths (-136 amino acids in yeast, -326 amino acids in
humans) and difficult to align. However, one motif was identified which was present in zero,
one, two, or three repeats (Fig. 4A). This motif was approximately 20 amino acids in length and
characterized by an absolutely conserved leucine-proline flanked by a fairly degenerate sequence
'(Fig. 4A). Interestingly, the motif was also found in the Toml protein, a ubiquitin ligase that
functions in multiple processes including rRNA maturation and export, transcription,
sporulation, stress responses, and cell cycle progression (4, 52, 53, 57). Recently, the "Toml"
motif in Rev 1 was shown to be an ubiquitin binding motif (UBM) present in multiple TLS
]polymerases (2). To address the contribution of these motifs to Rev1 function, site-directed
mutants consisting of alanine patches were generated and assayed for survival and mutagenesis
after UV irradiation. Although UBMI appears to be dispensable for RE !7 function, mutants in
UBM2 displayed a severe defect in survival after UV irradiation and exposure to MMS (Fig. 4B,
C). Preliminary mutagenesis experiments confirmed the findings. The lack of phenotype in the
UBM1 mutant may not be surprising since UBM1 is less well conserved in yeasts. Interestingly,
however, both UBM1 and UBM2 contribute equally to REV] function in mammalian cells (16).
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Fig. 4 Mutations in UBM2, but not UBM1, abolish REVJ-mediated survival and mutagenesis.
(A) Multiple sequence alignment of the Revi UBMs. Species and abbreviations are as in Fig. 1.
Amino acids highlighted in light grey indicate conserved residues, amino acids highlighted in
dark grey show positively charged Lys and Arg residues. Amino acids shown in yellow
correspond to the SQ/TQ ATM/ATR consensus phosphyorylation sequence. (B) Survival of the
indicated strains after a dose of 30 J/m 2 UV irradiation. (C) Sensitivity of the mutants to 0.02 %
MMS.
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The DNA binding activity of Rev1 appears critical for function while the catalytic activity
is dispensable.
Next, I examined the importance of the catalytic domain of Revl. Interestingly, mutations
inactivating the catalytic activity of Revl do not reduce survival or affect the levels of lesion
bypass and mutagenesis after exposure to most DNA damaging agents (18, 45, 50, 51). However,
although not required in vivo for survival or mutagenesis, the catalytic activity of Rev1 is indeed
employed during translesion synthesis. Catalytic dead variants of Revl exhibit an alteration in the
spectrum of mutations generated, with a reduced frequency of C's inserted opposite to abasic sites
(45, 50). Additionally, preliminary results from our lab suggest that the catalytic activity of Revi
provides some resistance to DNA damage opposite certain lesions. In particular, a strain bearing
a catalytic dead RevI shows increased frequency of cell death relative to wild-type after exposure
ito 4-nitroquinoline oxide (4-NQO) (M.E. Wiltrout, unpublished data). As the major products of
4-NQO include N2-dG adducts which Revl is capable of bypassing in vitro and in vivo (58, 62,
63), this observation may indicate that the cognate lesion for Revl's highly specialized catalytic
activity is a N2 -dG adducted lesion. Ongoing studies are directed at clarifying this point (M.E.
Wiltrout, unpublished data).
To investigate whether other activities of the catalytic domain besides the dCMP
transferase activity were required for its function, a site-directed mutant was constructed with the
goal of perturbing Rev l's ability to bind DNA. Based on the crystal structure of Rev 1 (40), an
arginine-lysine dyad that appeared to make specific contacts with the phosphodiester backbone
were mutated to two leucines. These residues were chosen since they are far from the active site
in an attempt to minimize effects on the catalytic activity of Revi per se (Fig 5A). Preliminary
data from a chromatin spin-down assay indicates that this mutant exhibits greatly reduced binding
to DNA relative to the wild-type Revl protein, however due to poor yield, the Western blot had to
be overexposed to observe the bands and could not be reproduced in this thesis. Interestingly, the
predicted DNA binding mutant showed a severe defect in survival and mutagenesis after UV
irradiation (Fig 5B-E). In contrast, the catalytic dead mutant displayed a near wild-type level of
survival and mutagenesis (Fig 5B-E), consistent with previous reports (18, 45, 51). These results
suggest that although the insertion of dCMP opposite to lesions is dispensable for REV] function
in survival and mutagenesis, the ability to bind DNA mediates a critical REV] activity.
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Fig. 5 The presumed DNA binding ability, but not the catalytic activity, of Revl is required for
its function in survival and mutagenesis after UV irradiation or exposure to MMS. (A) X-ray
crystal structure of Revl (40) showing the amino acids mutated in the predicted DNA binding
mutant. The active site is indicated by the location of the incoming nucleotide. (B, D) Survival
of the mutants after (B) 30 J/m 2 UV irradiation or (D) 10 J/m2 UV irradiation. The revl-1 BRCT
mutant was used as an additional negative control. (C) Reversion of the trpl-1 allele after a
dose of 30 J/m2 UV irradiation was monitored to determine the effect of the mutants on REV1-
mediated mutagenesis. Note that no colonies were recovered for the strains bearing the empty
vector or the revl-1 and revl-113 plasmids. (E) Reversion of the ade2-1 allele after 10 J/m2 UV
irradiation. (D) Sensitivity of the mutants to 0.02 % MMS.
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Identification of additional homology preceding the BRCT.
The extensive alignments necessary to observe conservation of the Rev C-terminus also
revealed a motif of approximately 40 amino acids just prior to the BRCT domain (Fig. 6). This
extended BRCT motif is characterized by three highly conserved hydrophobic residues and an
invariant lysine followed by a highly charged and polar glutamine-rich region, which could make
sequence-independent contacts to the DNA backbone. This region has been identified
independently in another lab by secondary structure predictions, although they could not identify
any primary consensus sequence (25). Interestingly, the extended BRCT motif is characteristic
of those BRCT domains that have the capability to bind to DNA, particularly DSBs (25). Thus,
the BRCT domain of Rev1 may mediate protein-DNA interactions as well as protein-protein
interactions. The BRCT may have a dual role in localizing Revl to sites of DNA damage either
directly by binding to aberrant DNA structures or indirectly by interacting with
monoubiquitinated PCNA marking sites of DNA damage (15).
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Fig. 6 Identification of an extended BRCT motif. (A) Multiple sequence alignment of Revl
sequences just prior to the BRCT domain reveals a region of homology. Arrows indicate
absolutely conserved amino acids and residues highlighted in light grey show similar amino
acids.
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Discussion
Summary of results
In this chapter, I present alignments that demonstrate homology between the polymerase
interaction regions of yeast and mammalian Revl. Importantly, I demonstrate that mutations in
conserved motifs in the C-terminus of Revl abolish the function of Revl in vivo, supporting the
idea that the C-terminus of Rev 1 and its interactions with other TLS polymerases are conserved
both in structure and in function. I also show that the second ubiquitin binding motif, UBM2, of
Rev is required for its function, while UBM1 appears to be dispensable. Finally, I provide
evidence that, although the catalytic activity of Rev1 is not necessary to provide resistance to UV
irradiation or to facilitate mutagenesis after UV irradiation, the DNA binding ability of Rev 1
may be required for these functions.
Bioinformatic analysis
C-terminal motifj. and their relevance to polymerase interactions
In eukaryotes, there are five distinct TLS polymerase families: Revl, polymerase r,
polymerase rl, polymerase t, and polymerase K. DNA polymerase r and polymerase ý are
conserved throughout all eukaryotes. It is thought that polymerase K is also found in all
eukaryotes and that polymerase i is restricted to higher eukaryotes. However, both polymerase K
and polymerase t appear to be scattered throughout Eukaryota in an ill-defined pattern (L.
Waters, unpublished observation). For example, both polymerase K and polymerase t are found
in some yeasts lineages like Aspergillus spp (L. Waters, unpublished observation). However, S.
cerevisiae lacks both of these enzymes. It is currently unknown why these polymerases are
fbund in some lineages and not in others.
Given that Rev from mammalian cells interacts with all of the other TLS polymerases
through its C-terminal -100 amino acids, it would be interesting to correlate the consensus
sequences of the putative helices in the C-terminus of Revl (Fig. 3A, B) with the species in
which polymerase K and polymerase t are found. For example, the first putative helix exhibits a
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well conserved amphipathic pattern found in all species (Fig. 3C)-perhaps this helix mediates a
conserved interaction with the Rev7 subunit of polymerase ý in diverse organisms. In contrast, a
region after the second predicted helix and continuing into the third helix displays a much higher
level of conservation in vertebrates, flies, and Pezizomycotinate yeasts. Interestingly, the
presence of this conserved motif correlates with those organisms which contain polymerase K
throughout all 50+ species investigated, suggesting that this motif may mediate a specific
interaction with polymerase K. Correlation of motifs with polymerase 1 has not yet been
addressed, but will be undertaken in the near future. Further such structure-function studies will
provide vital information as to how Revl coordinates lesion bypass.
Sequence analysis of the C-terminus of Rev1 has complicated an already confusing
relationship between Revl and polymerase rj. In yeast, REV] and RAD30-the gene encoding
polymerase r--exhibit additive sensitivities to DNA damaging agents, indicating that they act in
parallel pathways (38). Moreover, despite intensive effort a physical interaction between them
has not been identified to date [(6); R. Woodruff, unpublished data]. However, in mammalian
cells, Rev1 and polymerase rl interact robustly via the C-terminus of Revl (14, 43, 55). This has
lent support to the idea that Rev from higher eukaryotes mediates additional functions through
extra domains not found in lower eukaryotes (6, 22, 39, 55). However, I provide evidence that
the C-terminal interaction region of mammalian Rev1 is conserved in yeast, both at a primary
and secondary structure level, as well as functionally. These data may indicate that yeast Revl
and Rad30 do interact in a very transient manner or under specific conditions not yet identified.
Alternatively, yeast Rev and Rad30 may perform entirely separate roles in lesion bypass. In
this case, the sequence of yeast Rev may reflect the lack of an interaction between the two
translesion polymerases. Ideally, I would like to determine a Rad30 interaction motif by
comparing those organisms in which Revl and polymerase rI functionally interact or fail to
interact, however that information is currently not known.
The C-terminus of mammalian Revl also interacts with the X family polymerase k, but
not the related polymerase 3 or polymerase p (6). Interestingly, polymerase ,, like many
enzymes which participate in BER and NHEJ, contains a BRCT domain (9). Perhaps the
interaction with polymerase k indicates that Rev1 plays a role in these repair systems, possibly
by targeting BER factors to sites of unrepaired damage remaining after gap filling of ssDNA
119
regions opposite to DNA lesions. The interaction with polymerase X adds another layer of
complexity onto the distinct interactions the C-terminus must mediate.
Interestingly, consistent with another report (51), the C-terminal -100 amino acids appear
to be missing in Rev1 sequences from plants and extremely degenerate in worms, only being
alignable in the first -30 amino acids of the putative first a-helix. The functional significance of
this is unknown as only very limited studies have been done on Revl, or any translesion
polymerases, in these organisms. As Rev1 from plants also has only one UBM which is quite
degenerate and worms have no UBM repeats, this may point to either a different role for Revl in
these organisms or a separation of function of various Revl activities into two distinct proteins.
Variability in UBM repeat number and sequence
I have observed that Revl from the Pezizomycotinate yeasts contains three UBMs, while
Revl from plants has only one UBM. I have demonstrated that only one UBM is necessary in
yeast (Fig. 4B, C), but both UBMs have been shown to contribute to Revl function in mouse
cells (16). It would be interesting to determine the basis for this difference and to address why
various organisms contain different numbers of UBM repeats. Intriguingly, Revl sequences
from worms have no copies of the UBM repeat. Since I and others have shown that the UBMs
mediate a critical function of RE V in yeast and mouse cells, the lack of a UBM in worm Rev1
poses the question as to whether REV], and possibly other aspects of the DNA damage tolerance
response, function in a different manner in worms than in other eukaryotes.
The Rev UBMs from most organisms contain a conserved SQ/TQ preceding the motif
which represents the consensus site for ATM phosphorylation (Fig. 4A). Saccharomyces spp.
and related yeasts lack this site before the UBM but do contain a TQ motifjust after the
absolutely conserved leucine-proline in UBM2. Interestingly, I have shown that UBM2 is
essential for REV1 function whereas UBM1, which lacks any SQ/TQ sites, is dispensable (Fig.
4B, C). Additionally, the UBMs are followed by basic regions rich in lysine and arginine
residues (Fig. 4A'). Such basic regions often represent nuclear import signals. Alternatively,
they may mediate binding to negatively charged targets, such as DNA. The lysine residues may
also be covalently modified with ubiquitin or SUMO moieties. It is known that the TLS
polymerases become monoubiquitinated in a UBM-dependent manner, although it is currently
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unclear what the biological relevance of this modification may be (2, 16). Therefore, besides
mediating interactions with ubiquitin, phosphorylation or other modifications of the UBM may
alter nuclear import, substrate binding, and/or protein stability of Revl.
Additional and missing motifs an indicator of different REVl functions?
In addition to the degeneracy of the sequences, the variation in the length between
regions of homology led to difficulty in determining an alignment for Rev after the polymerase
domain. In yeast, the length between the end of the little finger domain and the C-terminal
region is -138 amino acids, whereas in humans it is -326 amino acids. In yeast, the entire -138
amino acids seem to comprise only the two UBMs and short linker regions between them.
Humans also have two UBMs, yet this region is more than twice as long. Although the
significance of these additional sequences is not known, they may provide more binding
s;urfaces, potentially for interactors specific to higher eukaryotes. Yeast Rev1 has -120 amino
acids preceding the N-terminal BRCT domain which are not found in human Rev 1. This region
may represent an alternative binding surface to the extra sequences flanking the human UBMs or
it may mediate a yeast-specific REVI function. Rev1 sequences from other organisms also
contain insertions or deletions relative to yeast and human Rev 1. In the future, it would be
interesting to delineate the differences, if any, between REV1 functions throughout eukaryotes by
determining whether these regions mediate novel functions or simply are alternate mechanisms
of achieving the same end.
Future Directions
The data shown in this chapter provides evidence for the importance of various motifs to
REV] function in survival and mutagenesis. However, the molecular nature of the defects in the
mutants and their physiological relevance to REV] activity are currently unknown. Further
investigations addressing these points are underway and are described below. First, new strains
have been constructed to facilitate the analysis. The experiments presented here were performed
with site-directed mutants created in a low-copy vector under the native REVI promoter and
containing the native 3' UTR. Epitope tagged versions of the plasmids were created, but
121
contained a mutation in the tag that inactivated it. Therefore, it is not known whether the UBM
and polymerase interaction mutants are expressed at the native level. The putative DNA binding
mutant was generated at a later time and was successfully epitope tagged and detected. It is
expressed at close to the native levels and preliminary chromatin spin-down experiments
indicated that it failed to bind chromatin. All of the mutants have been moved into an integrating
vector and been successfully crossed into the chromosome. The mutants are in the process of
being epitope tagged to allow visualization of protein levels. Once this is completed, the
following experiments will be performed to determine the molecular nature of the defects in the
mutant strains. Once I have investigated the effect of the mutations on the known protein-protein
interactions of Rev 1, I will further characterize their physiological role to determine the
mechanism and biological relevance of these interactions.
Analysis ofphysical interactions in the Rev] mutants
First, I will address whether the newly characterized Rev1 C-terminal region has an
analogous function in binding TLS polymerases in yeast as in mammalian systems. Yeast has
only two other TLS polymerases, one of which does not appear to interact physically or
genetically with Revl [(6, 38); R. Woodruff, unpublished data]. Therefore, to address whether
the C-terminal -100 amino acids of yeast Revl does indeed mediate an interaction with other
TLS polymerases, coimmunoprecipitation experiments with Rev and the Rev7 subunit of
polymerase C will be employed as described previously (5). I expect that the site-directed
mutants described above (rev]-108, rev]-109, revl-110, rev-ill, revl-112) will abolish or
reduce this interaction. More refined mutations than the alanine-patch substitutions can also be
generated to probe the interaction surface in greater detail.
Similar coimmunoprecipitation experiments will be used to confirm that the UBMs of S.
cerevisiae interact with ubiquitin. Very recently, an interaction between the UBMs of mouse
Rev and ubiquitin has been demonstrated (16). Once the interaction is established in yeast, the
UBM mutants (rev]-105, rev]-106, revl-107) will be assayed to determine if RevI binding to
ubiquitin is impaired. In mouse cells, the UBMs have been demonstrated to promote the
monoubiquitination of Revl (16). Therefore, I will also test the ability of the UBM mutants to
mediate monoubiquitination of yeast Rev 1. I expect that for these assays, the UBM 1 mutant
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(revl-105) will show little to no alteration relative to the wild-type while the UBM2 mutants
(revl-106, revl-107) will show a dramatic defect. It is possible that the two motifs will show a
specialization of function such that one UBM mediates an interaction with ubiquitin while the
other promotes or stabilizes monoubiquitination of Rev . Such an observation would have
interesting implications for the multiplicity of the UBM repeats observed in different organisms.
Additionally, the catalytic dead, DNA binding, and BRCT mutants (revl-AA, rev]-113,
and rev]-1 respectively) will also be analyzed in the experiments described above to investigate
their role(s) in interacting with DNA polymerase C, ubiquitin, and in mediating
monoubiquitination.
Investigation of the biological relevance of disrupting key protein-protein interactions
Concurrent with determining the molecular nature of the mutant phenotypes, I will also
characterize the physiological effects of the Revl mutations in more detail. The experiments
described below will establish the contribution of the catalytic activity of Revi and its several
protein-protein and protein-DNA interactions to the function(s) of Revl in vivo.
Cell-cycle expression of mutant alleles ofREV1
First, the effect of the UBM mutants on Revl cell-cycle dependent expression will be
analyzed. Rev protein levels are regulated throughout the cell-cycle and are unexpectedly
highest in G2/M rather than during replication (59). The molecular mechanisms controlling the
cell-cycle regulation of Revl are currently unknown, but it appears that Rev1 levels are
controlled in a post-transcriptional manner (59). Ubiquitin-mediated degradation is a common
mode of cell-cycle regulation and several lines of evidence tie Revi to regulation by ubiquitin.
Firstly, the UBM repeats of Revi not only bind to ubiquitin but also promote the
monoubiquitination of Rev (16). Secondly, multiple E2 ubiquitin conjugating and E3 ubiquitin
ligase enzymes show genetic interactions with REV1 (56). Finally, the pattern of Revl
expression fits the canonical profile for a Cdhl substrate of the anaphase-promoting
complex/cyclosome (APC/C) (61). Therefore, it will be very interesting to determine if the
UBM mutants alter the cell-cycle regulation of Rev 1.
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Although ubiquitination is clearly involved in regulating Rev1 activity (10, 15, 16, 56), I
might not expect that monoubiquitination mediated by the UBMs controls the cell-cycle
expression of the Revl protein. Mutants defective in DNA damage tolerance ubiquitination
showed no change in Revl expression throughout the cell cycle (Appendix B). As the Rad6-
Radl 8 heterodimer monoubiquitinates PCNA, it seems a likely candidate for the
monoubiquitination of Rev1 as well. Since Rev1 expression showed no change in rad6A and
radl8A strains (Appendix B), I expect that the UBM mutants may not show an alteration in the
cell-cycle dependent expression of Revl. Nonetheless, it is a critical experiment to carry out,
especially given that monoubiquitination may serve as a platform for additional
polyubiquitination, which is likely to be involved in the cell-cycle expression of Rev1. (For
further discussion of this point, see Appendix B.)
In addition to the UBM mutants, it will be interesting to determine if the polymerase
interaction mutants or the catalytic dead, DNA binding, and BRCT mutants affect the cell cycle
regulation of Rev 1 protein. These mutations may disrupt an interaction with a regulatory factor
not involved in ubiquitination.
Cell-cycle sensitivity to DNA damaging agents
Next, the mutants will be examined for a cell-cycle dependence in sensitivity to DNA
damaging agents. A revlA null mutant displays hypersensitivity to UV irradiation after release
from Gl arrest, but is only modestly sensitive after release from G2 arrest (59). We have argued
that this pattern of cell-cycle dependent sensitivity is consistent with a gap filling role for REV]
after replication of UV photoproducts (59). Repriming downstream of the lesion can produce
gaps opposite to lesions (35) which may persist throughout replication into G2/M. Considering
Revl levels are highest during G2/M (59), Revl-dependent gap filling might only occur after the
bulk of replication has been completed. In contrast, an alternate model states that Revl
facilitates polymerase switching during S-phase to resolve stalled replication forks (6, 31, 32).
This role of Revl in polymerase switching is thought to be mediated by its various protein-
protein interactions: with multiple TLS polymerase through the C-terminus, with PCNA through
the BRCT domain, and with ubiquitin through the UBMs (6, 14-16, 55).
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To examine whether Rev l's protein-protein interactions contribute to a recruitment role
for Rev 1 at sites of gaps opposite lesions in G2/M, I will examine the pattern of UV sensitivity in
the predicted polymerase interaction mutants, BRCT mutant, and UBM mutants. I expect that
these mutants will show a similar phenotype to the rev1A mutant. Additionally, the DNA
binding mutant is hypothesized to specifically affect the proposed gap filling ability of Rev 1 in
G2/M (see below) and will likely recapitulate the phenotype of the revlA mutant. It will be
especially interesting to determine the UV sensitivity of the catalytic dead mutant throughout the
cell cycle. In unsynchronized cells, the catalytic dead mutant exhibits survival frequencies
similar to the wild-type strain (Fig. 5B, F). However, in synchronized cells which display
hypersensitivity to UV irradiation after G arrest, more modest changes in survival may become
more pronounced. Any minor contribution that the catalytic activity of Rev 1 makes to lesion
bypass might be expected to occur during S-phase. It will be interesting to see whether the
catalytic dead mutant is slightly defective for UV survival at all stages of the cell cycle or
whether it displays specific defects at particular stages. Investigating Revi function during the
cell cycle may prove a more robust assay to distinguish subtle phenotypes that have hitherto been
unappreciated.
Significance and implications of the mutant phenotypes
Importance of the finding that the C-terminus of REV1 is critical for its function.
In higher eukaryotes, Rev is thought to mediate polymerase switching by virtue of its
ability to interact with multiple polymerases (6, 14, 31, 55). As its catalytic activity is
dispensable for DNA damage resistance or mutagenesis (18, 51), while its protein-protein
interaction modules are required (15, 16, 28, 33, 51), Revl is proposed to function mainly as an
assembly and coordinating factor for lesion bypass. In yeast there are only two TLS
polymerases, polymerase ý and polymerase q. Revi interacts with polymerase ý through
multiple contacts with the Rev7 subunit outside of the extreme C-terminal -100 amino acids (1,
5) and appears to not interact with polymerase ir either genetically or biochemically [(6, 38); R.
Woodruff, unpublished data]. Consequently, the C-terminal polymerase interaction motif might
not be expected to be conserved between yeast and vertebrates. However, the results presented
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here argue for sequence, structural, and functional conservation of the C-terminal interaction
region of Revl from yeast to humans. Besides confirming that S. cerevisiae is a useful model
organism in which to study DNA damage tolerance and mutagenesis, these findings suggest that
the function of Rev 1 requires its ability to recruit at least one translesion polymerase to sites of
DNA damage. Alternatively, the C-terminus of yeast Rev1 may perform a critical function
distinct from the recruitment of polymerase C to unreplicated regions remaining in G2/M, either
by recruiting unknown factors or by mediating an entirely novel activity. The experiments
described above will help to address this point.
Importance of the observation that the putative DNA binding mutant ofREV1 lacks activity in
vivo.
Two models postulate different roles of REV1 in DNA damage tolerance and
mutagenesis. The polymerase switching model envisions that the protein-protein interactions
critical to REV1 function coordinate the activity of TLS polymerases to resolve stalled
replication forks during S-phase. In contrast, the gap filling model proposes that Rev1 serves as
a sensor for sites of incomplete replication caused by replication repriming downstream of a
lesion. In this model, Revl functions during G2/M to recruit or stimulate TLS polymerases, and
likely other factors, after replication at sites of DNA damage. The putative DNA binding mutant
of Revl was designed to probe the contribution of Revl to each type of lesion bypass.
In the polymerase switching model, Rev1 is thought to serve as a scaffold for other TLS
polymerases. In general, scaffolding proteins function to orchestrate a substrate handoff between
two enzymes by positioning the proteins optimally for substrate transfer rather than by
interacting directly with the substrate. This would be especially true for a substrate which has
only one binding interface or for which the two enzymes have an overlapping recognition site.
Interaction of the scaffolding protein with the substrate would thus block interaction of the
recipient enzyme and prevent an effective handoff. Since DNA polymerases are optimized to
bind DNA at a primer terminus rather than at regions of dsDNA or ssDNA, there is arguably
only one way of effectively engaging a TLS polymerase at primer opposite a lesion. Therefore a
protein coordinating lesion bypass by promoting handoffs of the primer terminus between
polymerases would not be expected to bind the primer terminus itself.
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Since the catalytic activity of Revl is dispensable for its function in vivo while its
protein-protein interaction modules are required, Revl could function in assembly of a TLS
complex without ever engaging the primer terminus. Although a transient interaction cannot be
ruled out, it seems logical that in order to promote polymerase switching, Revl would not need
to gain access to the primer terminus. In fact, DNA binding by the catalytic domain of Revl
might prevent effective translesion synthesis by another polymerase, since Revl has only limited
polymerase activity. Therefore, it might be expected that the DNA binding ability of the
catalytic domain of Revl would be unnecessary if the primary function of Revl was to regulate
access of polymerases to sites of DNA damage during polymerase switching during S-phase.
A caveat to this hypothesis is that if Rev 1 were serving a recruitment role during S-phase
to bring the other TLS polymerases to sites of DNA damage, DNA binding by the polymerase
domain of Rev might be necessary to its function. However, as yet, no unique interactions for
Revl have been determined that indicate that Rev relocalizes to damage prior to other factors.
It is also important to note that a role for the non-catalytic domains of Revl, such as the BRCT
domain, in interacting with DNA during polymerase switching would not necessarily negatively
affect the polymerase handoff. However, it seems logical that DNA binding by the polymerase
domain of Revl would not be required, and might even be detrimental, to orchestrate effective
translesion synthesis by other TLS polymerases.
In contrast, DNA binding by the polymerase domain of Revl is crucial for REV] activity
in the gap filling model. Without the ability to bind to primer termini, Revl would be unable to
recruit other TLS polymerases to sites of incomplete replication opposite DNA lesions.
Engagement of the lesion by the active site of Revl would not prevent lesion bypass by other
TLS polymerases in this situation. In fact, it may serve as a mechanism for the cell to delay
potentially mutagenic translesion bypass until other high fidelity mechanisms, such as nucleotide
excision repair, had a chance to repair the lesion in a more accurate manner.
The fact that the predicted DNA binding mutant in the catalytic domain of Revl was
completely unable to promote survival or mutagenesis after DNA damage (Fig. 5B-F) supports a
role for Rev 1 in recruitment of other TLS polymerases rather than a role solely in regulation of
access of TLS polymerases. Although the ability of Revl to recruit TLS polymerases to stalled
replication forks in S-phase is not impossible, currently no evidence points towards this function
of Revl in polymerase switching. A direct test of the order of recruitment has only been
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performed with DNA polymerases r1 and t (21) and would be most interesting to extend to the
remainder of the TLS polymerases. Therefore, the phenotype of the putative DNA binding
mutant supports the recruitment role of Revi in gap filling in G2 and throughout mitosis.
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Materials and Methods
Strains and Plasmids. Strains used were derivatives of W1588-4C, a W303 strain corrected for
RAD5 (64), and are described in Table 1. The rev1A strain was generated by moving the
revl::kanMX4 cassette from the deletion library into a W15488-4C strain containing a
barl:.-LEU2 disruption. All plasmids were transformed into the rev1A barlA strain, either to be
stably maintained as low-copy plasmids or to be integrated into the REV1 promoter to restore the
REVI gene with appropriate site-directed mutations.
The pRS416-REV1 plasmid was generated using primers pRS-Revl-fwd and pRS-Revl-
rev to amplify the REV1 gene by PCR from the genome. The PCR fragment was digested with
BclI and KpnI and cloned into the pRS416 vector digested with BamHI and KpnI. This
produced a 3.4 kb region containing 210 bp of the REV1 promoter and 217 bp of the 3' UTR. It
has previously been shown using deletion analysis that REV] constructs containing 210 bp of the
REV1 promoter or 27 bp of the 3' UTR are able to complement a revl-] strain (28). Upon
sequencing, two point mutations were found. Quikchange mutagenesis was used to restore the
REV] construct to the wild-type sequence.
The pRS306-REV1 plasmid was created by digestion of pRS416-REV1 with Spel and
KpnI, gel purification of the 3.4 kb REV] fragment, and ligation into pRS306 backbone digested
with Spel and KpnI. Since the subsequent restriction digestion was inhibited by Dcm
methylation, the plasmid was miniprepped from XL 1 Blue and transformed into GM2163 (New
England Biolabs) which is a dam- dcm- E. coli host strain. The pRS306-REV1 plasmid, and site-
directed mutant derivatives, were miniprepped from GM2163, linearized at the SexAI site in the
210 bp REV1 promoter, and transformed into the rev1A bar1A strain. Integrated constructs were
selected on SC-Ura media and verified by PCR using the primers pRS-Revl-fwd and pRS-Revl-
rev.
Ongoing work is directed towards tagging the integrated REV] and mutated rev] alleles
using pYM10 as described previously (24, 59).
Site-Directed Mutagenesis. Site-directed mutations were generated according to the protocol of
Quikchange Mutagenesis kit (Stratagene) with the following changes. Since multiple amino acid
changes were made, it was found to be necessary to lower the annealing temperature to 50 oC.
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Additionally, the extension time was found to require 2 min/kb and for plasmids larger than 6 kb,
a 20 min. extension was necessary. However, 25 min. extension time was too long and resulted
in decreased efficiency of recoverable mutants. Primers are listed in Table 2 and a summary of
the mutations is listed in Table 3.
UV Survival and Mutagenesis Assays. Three independent cultures of each strain were grown
to saturation and appropriately diluted aliquots were plated on SC media to monitor survival.
Mutation frequencies were analyzed by plating undiluted aliquots on SC-Trp or SC-Ade media
to score for reversion of the trpl-1 allele or the ade2-1 allele respectively. Plates were irradiated
at 1 J/m 2/sec using a Gl 5T8 UV lamp (General Electric) at 254 nm and grown for 3 or 6 days at
.30 'C for survival and mutagenesis assays respectively. The cell-cycle sensitivity assays will be
performed as previously described (59).
MMS Sensitivity Assay. Strains were grown to saturation, serially diluted 10-fold, and 2.5 itL
of each dilution was spotted onto YPD media with or without 0.02% MMS (Sigma).
Immunoblots. Whole cell extracts were prepared by TCA precipitation (24) and were separated
by SDS-PAGE. Proteins were transferred to PVDF membrane (Millipore) using a Mini-
PROTEAN II transfer apparatus (Bio-Rad). Antibodies used were rabbit PAP antibody (Sigma)
against the protein A tag, anti-HA. 11 (Covance), and anti-phosphoglycerate kinase (Molecular
Probes).
Computational Analysis. Manual alignments were generated using the Lasergene suite of
sequence analysis programs. Helical wheels were adapted from
http://cti.itc.virginia.edu/-cmg/Demo/wheel/wheelApp.html. Secondary structure predictions
were made using the 3D-PSSM program at http://www.sbg.bio.ic.ac.uk/-3dpssm/.
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Table 1: Strains used in this study
Strain Genotype Source
W1588-4C MATa ade2-1, ura3-1, his3-11,15, trpl-1, leu2-3,112, Rothstein lab (62)
canl-100, RAD5
revlA barlA revl.':kanMX4, barl:.'.LEU2 L. Waters (57)
Table 2: Primers used in this study
Primer Name Primer Sequence Mutation
Generated
pRS-Revl-fwd
pRS-Revl-rev
revl-1 fwd2
revl-lrev2
Revl D467A
E468A
Revl D467A
E468A-r
SC1
SC1-r
SC2
SC2-r
SC3
SC3-r
GCTTTGAGTTGGGGTAGATTATCGC
GTGTTGGTACCAAAGGAGGAGTCGGCCATTCC'
TACACGAGATGATAGTTTTACATGGCaGAAAATTTT
TACACTATTTGTCTTC
GAAGACAAATAGTGTAAAAATTTTCtGCCATGTAAA
ACTATCATCTCGTGTA
GATTTTACCTATATCTATTGcTGcAGCTGTTTGTGTG
AGGATAATCCC
GGGATTATCCTCACACAAACAGCTgCAgCAATAGAT
ATAGGTAAAATC
GTGACGAACAGAGCTTTCGAAGCCGCCGCGGCAGC
TGTAAAAAATGACATTAACAACG
CGTTGTTAATGTCATTTTTTACAGCTGCCGCGGCGG
CTTCGAAAGCTCTGTTCGTCAC
CTATGGAAGAACAGTTTATGAATGCAGCCGCGGCC
GCAATTCGAGCAGAAGTAAGGCACG
CGTGCCTTACTTCTGCTCGAATTGCGGCCGCGGCTG
CATTCATAAACTGTTCTTCCATAG
TATGAATGAACTACCAACCCAAGCTGCCGCGGCAG
CAAGGCACGACTTGAGAATTCAG
CTGAATTCTCAAGTCGTGCCTTGCTGCCGCGGCAGC
TTGGGTTGGTAGTTCATTCATA
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none
none
revl-1
revl-1
revl-AA
revl-AA
revl-105
revl-105
revl-106
revl-106
revl-107
revl-107
SC4
GGAGAGAAGAGAGCCTACAGAACGAG
CTCGTTCTGTAGGCTCTCTTCTCTCC
SC4-r
SC5
132
CGGTTCAAAAAAATTTGTCAAGCCGCGGCACAAGC
GGCTGCCGAAACTTTAGGTGATGGA
TCCATCACCTAAAGTTTCGGCAGCCGCTTGTGCCGC
GGCTTGACAAATTTTTTTGAACCG
CGAAACTTTAGGTGATGGAGGGGCGCATGCAGCAG
CTGCTAAATTATTCGTGAAATATTT
AAATATTTCACGAATAATTTAGCAGCTGCTGCATGC
GCCCCTCCATCACCTAAAGTTTCG
GCCGCATGAAAAAGATGTTAAATTATTCGCGGCCG
CGGCGGCTAAACTTTGCGATTCTAATAGAGTCCAT
ATGGACTCTATTAGAATCGCAAAGTTTAGCCGCCGC
GGCCGCGAATAATTTAACATCTTTTTCATGCGGC
TATTTGATTAAACTTTGCGATTCTAATGCAGCGCAT
GCAGCTGCTCATTTATCAAACCTAATATCAAGGG
CCCTTGATATTAGGTTTGATAAATGAGCAGCTGCAT
GCGCTGCATTAGAATCGCAAAGTTTAATCAAATA
CCACTTTTAAACAGAAATAAACATGCTGCCCAGGC
CGCGGCTAAACTTGACATGGACTTTGAAG
CTTCAAAGTCCATGTCAAGTTTAGCCGCGGCCTGGG
CAGCATGTTTATTTCTGTTTAAAAGTGG
CTGTACGATCCCAAAGAAGTCTTACAACTCTTAAGC
TTATCAATTGATATCAATTGGGGAATC
GATTCCCCAATTGATATCAATTGATAAGCTTAAGAG
TTGTAAGACTTCTTTGGGATCGTACAG
CCAGATTAGAAGTAAATGATTTGCCCAGTACTATGG
CCATAGTACTGGGCAAATCATTTACTTCTAATCTGG
nt 2763 REVI
nt 2763 REV1
nt 2616 REV]
nt 2616 REV]
revl-108
revl-108
revl-109
revl-109
revl-l 10
revl-110
revl-111
revl-111
revl-112
revl-112
revl-113
revl-113
SC5-r
SC6
SC6-r
SC7
SC7-r
SC8
SC8-r
QC-R620L
K621L
QC-R620L
K621L-r
QCRev1A
QCRev1B
QCRevlC
QCRevlD
Table 3: Site-directed mutants used in this study
Amino acid changes
G193R
D466A E467A
L763A P764A E765A D766A
E820A L821A P822A T823A Q824A
I825A R826A E828A V829A
L889A V890A K891A W893A V894A
P903A E905A K906A D907A V908A
V912A K913A Y914A L915A I916A
R923A V924A L926A V927A L928A
T972A Y973A T975A V976A R977A
R620L K621L
Location
BRCT domain
pol domain
UBMI
UBM2
UBM2
C-terminus
C-terminus
C-terminus
C-terminus
C-terminus
pol domain
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Allele
rev 1-1
revl -AA
revl -105
revl -106
rev1l-107
revl-108
revl-109
rev 1-110
revl-111
revl-112
revl-113
Reference
(28, 33)
(18)
this study
this study
this study
this study
this study
this study
this study
this study
this study
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Summary of Results
DNA damage elicits a network of responses, most specialized to promote rapid and
.accurate repair of DNA lesions. However, certain genes actively promote the generation of
mutations, both spontaneously and after DNA damage. In eukaryotes, the vast majority of
mutagenesis requires Rev1 and DNA polymerase ý. My work has focused on the regulation and
molecular mechanisms of the S. cerevisiae translesion polymerase Revl.
In Chapter Two, I demonstrated the novel and unexpected cell-cycle regulation of Revl
in S. cerevisiae. Characterization of Revl expression levels revealed that Rev 1l was highly
expressed not during the bulk of replication, but rather afterwards in G2 and throughout all of
mitosis. This pattern of Rev1 accumulation was observed not only in normally growing cells,
but also after DNA damage, indicating that Revl operates in a similar manner even when
replication forks encounter DNA lesions during S-phase. Moreover, revlA cells displayed a cell-
cycle dependent sensitivity to UV irradiation, showing that the observed regulation of protein
levels was relevant to its function. These results challenged our understanding of translesion
s;ynthesis as a process operating predominantly during S-phase to enable replication to continue
in the face of DNA lesions. Rather, the finding that Revl was not present at high levels during
S-phase led to a model in which Rev1 promotes gap filling after replication at sites of DNA
damage where repriming events produced a region of ssDNA opposite to a lesion.
In Chapter Three, I described experiments designed to address the contribution of various
domains to REV] function in vivo. Novel motifs were identified by extensive sequence
alignments of Revl proteins from across diverse lineages throughout eukaryotes. Site-directed
mutations were generated to disrupt the motifs. Initial results suggest that protein-protein and
protein-DNA interactions are critical for REV] activity in vivo, while the catalytic activity of
Revl is dispensable for survival and mutagenesis. In particular, mutations in the C-terminus of
Rev 1 indicate that this region is conserved between yeast and vertebrates, contrary to some
indications in the literature. Additionally, the phenotype of a mutation of the catalytic domain
predicted to disrupt DNA binding lends support to the gap filling model of Revl activity
proposed in Chapter Two. Further experiments were discussed which will elucidate the
molecular mechanisms and physiological functions disrupted in the mutant strains.
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Molecular mechanism(s) controlling Rev1 cell-cycle regulation
As yet, we have only hints towards understanding what may be regulating the cell-cycle
dependent expression of Revl. Since Rev1 protein levels fluctuate -50-fold while the mRNA
levels display only a -3-fold change during the cell-cycle, we believe that the majority of the
Revl cell-cycle expression is regulated at the post-transcriptional level (65). Data presented in
Appendix B and recent work from our lab have revealed roles for CDC7 and UMP1 in the
accumulation of Revl protein (L.Waters, M.E. Wiltrout, unpublished data). Both have been
implicated through epistasis analysis to function in the REV1/REV3/REPV7 pathway of the RAD6
post-replicative repair group (46, 51, 53). CDC7 encodes a serine/threonine kinase required for
the initiation of S-phase (38). Both hypomutable and hypermutable alleles of CDC7 exist (22),
suggesting that Cdc7, together with its cell-cycle regulated accessory factor Dbf4 (38), regulate
mutagenic translesion synthesis. Since Dbf4 contains a BRCT domain (14), it may
heterodimerize with the BRCT domain of Rev1 to promote Cdc7-dependent phosphorylation of
Rev l. UMP1 encodes a nonessential subunit of the proteasome (54). An umplA strain displays
an increase in spontaneous and UV-induced mutagenesis which is REV3-dependent (46, 53). As
umplA mutants also exhibit defects in proteolysis (54), it seems likely that Umpl may degrade
Rev 1. In the absence of Ump 1, aberrantly high levels of Rev 1 may accumulate and promote
mutagenesis. Though we have evidence that CDC7 and UMP1 control Revl levels (see
Appendix B), we do not yet know whether these genes regulate Revl levels in a cell-cycle-
dependent or independent manner. The roles of CDC7 and UMP1 in the regulation of Revl are
currently being investigated in our lab.
Several lines of evidence link Rev1 to ubiquitin. The RAD6 epistasis group, of which
REV1 is a member, contains genes encoding three E2 ubiquitin-conjugating enzymes (Rad6,
Mms2, and Ubcl3) and two E3 ubiquitin ligases (Radl8 and Rad5) (61). Additionally, in
vertebrate systems Rev7 has been shown to interact with and inhibit the anaphase-promoting
complex/cyclosome (APC/C)-a multisubunit E3 ubiquitin ligase (7, 52). Thus, it seemed likely
that one or more of these proteins might regulate the accumulation of Revl levels by targeting it
for proteasomal degradation. Accordingly, the pattern of Rev 1 cell-cycle accumulation was
analyzed in the appropriate deletion mutant backgrounds (see Appendix B). However, no
change in Revl protein levels was observed in any of the mutant backgrounds, indicating that
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ubiquitination mediated by post-replication repair factors is not responsible for regulating Revl
accumulation.
Though ubiquitin-mediated degradation is a common mechanism controlling cell-cycle
dependent expression (70), preliminary data suggests that the accumulation of Revl during the
cell cycle may not be completely controlled by degradation. Initial experiments using REV]
under the control of a galactose-inducible promoter indicate that the half-life of Rev 1 protein
expressed in Gl-arrested cells is as long, if not longer, than in G2-arrested cells (Appendix B). It
should also be noted that REV1 transcription has been reported to initiate from two start sites,
differing by 24 nucleotides (30). Since the RT-PCR analysis used primers which amplified the 3'
end of the gene, the results reported in Chapter Two for the fold change of the REV1 transcript
represent the total levels of all REV1 mRNA's. It is possible that one REV] transcript displays
pronounced cell-cycle regulation while the other is produced at constant levels. If so, differential
regulation of translation by the two 5' UTR's may explain part of the observed cell-cycle
dependent accumulation of Rev1 protein levels. Therefore, regulation at the transcription and
translation levels may be partially responsible for the fluctuations in Revl protein levels, in
addition to degradation or post-translational modifications. RT-PCR experiments using primers
located in the 5' UTR of REV] are in progress to address the cell cycle levels of each transcript.
In summary, no definitive pathway has been identified to date that controls the cell-cycle
dependent regulation of Rev 1. So far, we have focused on investigating the role of post-
translational modifications and degradation to the differential accumulation of the Revl protein
through the cell cycle. However, we are now also considering alternate models of regulation
including translational control and multiple REV] transcripts. Thus far, we have employed a
candidate gene approach, but unbiased screens for regulators of Rev1 protein levels are also
planned. Identifying the genes involved in controlling the cell-cycle dependence of REV1
function will greatly expand our knowledge of how this enigmatic translesion polymerase
mediates its function in survival and mutagenesis in vivo.
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Why is Revl cell-cycle regulated?
As shown in Chapter Two, Revl protein levels are almost undetectable in G and slowly
accumulate throughout S-phase. As cells complete replication, Rev 1 levels rise rapidly and are
maintained at high levels throughout mitosis until telophase (shown in more detail in Appendix
D). As discussed in Chapter Two, the presence of high levels of Rev1 in G2/M indicates that its
true substrate may be a gap opposite to a lesion which would only be produced after replication.
However, this does not explain why Rev1 exhibits cell-cycle regulation. Instead of asking "Why
is Revl upregulated in G2/M?" one could as easily pose the question "Why is Revl not present
in G ?" It is fortuitous for us in elucidating Revl function that Rev does show a cell-cycle
dependent accumulation, but why might Rev 1 be detrimental to the cell if present significant
amounts in G 1 and/or throughout S-phase? Additionally, the cell-cycle regulation of Rev 1
appears to control polymerase ý activity as well, suggesting that polymerase ý activity may also
be deleterious during GI and/or S-phase. Several possible negative effects of Rev1 expression
during G and S-phase are discussed below.
Firstly, Rev1 may interfere with replication in S-phase. The physiological effects of
overexpression of TLS polymerases on DNA replication have not yet been addressed. However,
as the polymerization rate of TLS polymerases in vitro is very low relative to replicative DNA
polymerases (2, 13, 24, 34), it is probable that over- or misexpression of TLS polymerases in
vivo may act as a "molecular brake" for DNA replication, analogous to what has been recently
described for polymerase aO (31). Especially considering the limited polymerase activity of Revl
(48), inappropriate expression of Rev1 allowing it excess access to the primer terminus may
inhibit processive DNA synthesis. Additionally, the primary function of Rev is mediated by its
protein-protein interactions with PCNA and other TLS polymerases (18, 19, 30, 33, 57). These
interactions are thought to promote polymerase switching during S-phase (9, 17, 32, 60). We
have proposed that, instead, Rev1 serves primarily to recruit TLS polymerases in G2/M to
mediate gap filling (65). Inappropriate expression during S-phase might therefore promote
aberrant polymerase handoffs, allowing TLS polymerases unwarranted access to the DNA at
sites of normal replication pausing. Inappropriate TLS polymerase activity may not only perturb
normal DNA replication but also may increase the frequency of mutations, since TLS
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polymerases display substantially reduced replication fidelity on undamaged DNA relative to
replicative DNA polymerases (15, 27).
The presence of Rev1 may also be detrimental in G1. If expressed in G1, Rev1 may
inhibit a Gl-specific process. Given the high affinity of Revl for regions of ssDNA (Kd < 1 nM,
(40)) and primer template termini (Kd- 2.5 nM, (42)) , it is conceivable that Rev1 could interfere
in the initiation of replication by binding to unwound DNA at origins or nascent replication forks
and inhibiting further polymerization.
Finally, the cell-cycle regulation of Rev1 may be a mechanism to reduce the cellular
potential for mutagenesis. Outside of lab culture conditions designed to optimize cell growth,
many cells spend significant amounts of time in G 1, either due to nutrient limitation or to
specialized functions in multicellular organisms which require terminal differentiation. Low
Revl levels in these cells may reflect a strategy to minimize mutagenesis in cells which have a
low proliferation potential and are less likely to produce daughter cells for which adaptive
mutations may be beneficial. Additionally, as discussed in Chapter Two, delaying potentially
mutagenic Revl-dependent lesion bypass until late in the cell cycle may promote the action of
more highly accurate repair or damage tolerance systems, such as NER or DNA polymerase 1q.
Other roles of RE V, REV3, and REV7
Links between REV1 and cell proliferation
Rev1 may be regulated by various cell growth pathways. In global microarray
experiments, REV1 transcript levels have been shown to be modulated by glucose signalling
(63), the Ume6 transcription factor involved in induction of meiosis (67). rapamycin (23),
filamentous growth (37), and perturbations of various MAPK pathways (55). These networks all
monitor the carbon and nitrogen sources available and transmit downstream signals, using
overlapping kinase cascades. REV1 is upregulated by the addition of glucose (63) and is strongly
repressed after treatment with rapamycin (23), which mimics nutrient starvation. Uniquely
among the UME6-regulated genes, REV1 seems to require Ume6 for activation of transcription
during vegetative growth (67). Taken together, these data suggest that REV1 functions mainly
during times of active cell proliferation. Integrating the data from alterations in the filamentous
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growth and MAP kinase pathways into an interpretable model is more challenging. However, it
is clear that multiple metabolic and cell proliferation pathways impinge upon the REV] gene in a
way that, so far, has not been observed for REV3 or REV7. As Revl is the only TLS polymerase
known to be cell-cycle regulated thus far, these microarray studies may highlight a unique role
for REV] in response to the regulation of cell growth.
The Ume6-dependent transcription of REV1 is particularly intriguing in light of the fact
that REV1, as well as REV3 and REV7, has been shown to be upregulated during sporulation in
yeast (4, 8, 58). All of the TLS polymerases also show increased levels in meiotic tissues in
mice (29). However, only REV1 was found to require Ume6 for its transcription during
vegetative growth (67). Interestingly, the REV] gene contains an URS 1 consensus binding site
for the Ume6 transcription factor (4). Consistent with its unusual pattern of Ume6-dependent
regulation, the URS 1 site is located in the Rev open reading frame rather than in the promoter
region. A site-directed mutant which silently removes the URS 1 consensus without altering the
protein sequence has been generated and will be tested for its effect on survival and mutagenesis
after DNA damage, as well as cell-cycle regulation.
Translesion polymerases and RNA metabolism
Multiple seemingly tangential links between the TLS polymerases and RNA metabolism
exist. In a directed yeast two-hybrid with splicing components, yeast Rev1 and Rev7 were each
reported to interact with a component of the spliceosome: Snpl and Smd3 respectively (12).
Human Rev7 also interacts with trichosanthin, a protein related to ricin which binds to the 23S
and 28S rRNA subunits of the ribosome (6). Additionally, in a recent proteomics study
polymerase rl was identified to interact with Lsml2, which likely binds RNA, and Snul3, which
participates in splicing and rRNA processing (26). Thus, TLS polymerases may bind to RNA
interacting proteins. The biological significance of any of these interactions is currently
unknown. However, a functional correlation between REVI and RNA metabolism was shown in
the two microarray analyses which analyzed glucose signalling and rapamycin effects, where
REV1 clustered tightly with genes involved in ribosome biogenesis and RNA metabolism (23,
63). Given that translesion polymerases mediate their function by interacting with a structurally
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similar nucleotide polymer, it is worth keeping in mind that several studies have found
connections between TLS polymerases and RNA.
In contrast to the poorly characterized interactions described above, the interaction of
vertebrate Rev7 with the human papillary renal cell carcinoma-associated protein PRCC has
been well documented to be functionally important (62, 66). Interaction with PRCC is required
for the nuclear import of Rev7; in the absence of PRCC, human and Xenopus Rev7 exhibit
exclusively cytoplasmic localization (62, 66). Interestingly, the normal function of the PRCC
protein appears to be in pre-mRNA splicing, since it colocalizes and interacts with several
components of the spliceosome (59). Chromosomal translocations fusing the PRCC and TFE3
genes are strongly correlated with renal cancers (59, 62, 66). The PRCC-TFE3 or TFE3-PRCC
fusions fail to interact with Rev7 which prevents Rev7 from translocating into the nucleus (62,
66). Intriguingly, cells transfected with either the PRCCTFE3 or TFE3PRCC fusion exhibit
mitotic checkpoint defects (62, 66). These results suggest that Rev7 may play a role in RNA
splicing and/or that Rev7 function is important for proper mitotic progression in vertebrate cells.
Interactions with membrane proteins
Although the physiological relevance is uncertain, it is worth noting that Rev and Rev7
have been shown to associate with multiple membrane proteins. Human Revl was identified by
a two-hybrid screen to interact with the cytoplasmic domain of several integrin proteins (68).
Integrins are a class of transmembrane receptors which mediate signalling from the extracellular
matrix to the cytoskeleton (68). In similar two-hybrid screens, human Rev7 was found to
interact with the cytoplasmic domains of two metalloprotease-disintegrin proteins (49) and with
the adenovirus death protein ADP (69), all of which are membrane proteins. Human Mad2,
which is homologous to human Rev7 (1), also showed a two-hybrid interaction with a disintegrin
(49). The biological relevance of the Revl-integrin and Rev7-disintegrin interactions is
unknown. Indeed, these interactions may well represent nonphysiological artifacts, since in vivo
Revl and Rev7 are unlikely to be found in the cytoplasm. However, given that in yeast REV]
appears to be regulated by cellular proliferation signals (see above) and that in vertebrates, REV7
has been shown to inhibit cell-cycle progression (7, 52), it is possible that interaction with these
cell surface proteins, which relay environmental signals, may provide a mechanism to integrate
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cell growth cues with their molecular effectors. In a more complete study, human Rev7 was
shown to coimmunoprecipitate with the adenovirus death protein ADP and overexpression of
Rev7 was demonstrated to antagonize cell lysis caused by ADP expression (69). As ADP
localizes to nuclear membranes and the ER, this interaction may represent a valid physiological
function of the Rev7 protein upon viral infection, possibly to coordinate cell cycle arrest with
resistance to viral infections (69).
Why is the novel catalytic activity of Revl dispensable yet conserved?
Rev from both yeast and mammals displays limited polymerase activity, restricted
primarily to the insertion of dCMP (20, 35, 48, 71). Additionally, both yeast and mammalian
Revi prefers to bind DNA containing a template G (20, 39, 41, 71). Crystallization of yeast
Revl with DNA has revealed an elegant explanation for the predominant insertion of C's, as well
as for the preferential binding to a template G (47). A template G is selected for by specific
contacts with the backbone and sidechains of amino acids in the "G loop" of the little fingers
domain (also called the polymerase associated domain or PAD) (47). The preferential insertion
of C relies on hydrogen bonds formed between the incoming nucleotide and an arginine residue
in Rev 1, rather than between the incoming nucleotide and the template base (47). This
mechanism of substrate choice using the protein itself for a template is utterly unprecedented in
DNA polymerases and argues for a high level of specialization of the Rev active site. Yet,
bizarrely, this novel mechanism of polymerization using the enzyme itself as a template does not
seem to be required for the function of Revl in vivo.
Intriguingly, strains bearing a catalytically inactive version of Rev1 (42) display no
significant decrease in survival or mutagenesis after exposure to the alkylating agent MMS (21).
I confirmed this finding in Chapter Three and extended the observation to another DNA
damaging agent, UV irradiation. In a more direct assay for translesion synthesis past various
lesions, the catalytic dead allele of Rev 1 showed only a slight decrease in the frequency of lesion
bypass in vivo, however the spectrum of nucleotides inserted opposite the lesion was
significantly altered (50). Additionally, the catalytic activity of Revl was shown to be employed
in somatic hypermutation initiated by AID-mediated deaminations, however the in vivo
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phenotype of the catalytic dead Revi was not investigated in this system (56). Therefore,
although it contributes to lesion bypass, the highly specialized and conserved dCMP transferase
activity of Revl is dispensable for its function in survival and mutagenesis after DNA damage.
These findings indicate that another activity of Revi mediates its function in vivo, which is
believed to be protein-protein interactions as discussed in Chapters Two and Three.
The observation that the catalytic activity of Revl does not contribute to its function in
vivo suggests that we do not understand a fundamental property of Rev 's mechanism of action
inside cells. Why would such a unique and highly optimized enzymatic activity that is conserved
from yeast to humans exist if it did not perform an important role in the cell? Perhaps we have
not examined REV1 function using as assay that can detect the contribution of its catalytic
activity. A related question is why would a cell evolve and maintain a DNA polymerase whose
only activity is to insert one of the four nucleotides? The answers are still a mystery, but I
discuss some possibilities below.
The cognate lesion for Rev1 may be an adducted G
Since the discovery of low fidelity TLS polymerases, a recent paradigm shift has moved
from considering TLS polymerases as "sloppier copiers" (15) to enzymes optimized for accurate
bypass of particular types of DNA damage termed a "cognate lesion" (10). Evidence for the
specialization of TLS polymerases for a particular cognate lesion has now been provided for two
TLS polymerases (25, 28, 43, 45). The characteristic features of cognate lesion bypass by TLS
polymerases are a high level of accuracy and an increased efficiency of polymerization opposite
the lesion relative to other substrates (44). These parameters are thought to ensure that a
particular translesion polymerase preferentially synthesizes DNA opposite its cognate lesion,
rather than undamaged DNA or non-cognate modified bases (25, 28, 43, 45).
Studies of the kinetic parameters of Revi have shown that Revi is optimized not only to
insert a C but also to do so opposite a template G, an abasic site, or certain adducted G's (20, 39,
41, 71). These findings may give us a clue as to the function of Revl's catalytic activity in vivo.
Preliminary work from our lab reveals that the catalytic dead mutant of Revi displays a
reduction in survival after exposure to 4-nitroquinoline oxide (M.E. Wiltrout, unpublished data)
which, among other products, generates N2- and C8-adducted G's (11). This finding, together
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with the finding that Revl can bypass N2-adducted G's in vitro and in vivo (64, 71, 72), suggests
that a cognate lesion for the dCMP transferase activity of Rev is adducted G's. Future work
using purified Rev in primer extension assays with templates containing various adducted G
lesions will determine the particular lesion structures that Rev1 can bypass most efficiently. As
Revl preferentially inserts C's, bypass of adducted G's would be accurate. The fidelity of Rev1
opposite its proposed cognate lesion would partially explain why its catalytic activity does not
seem to contribute towards mutagenesis in vivo. However, the hypothesis that adducted G's
constitute a cognate lesion for Revl does not address the contribution of the catalytic activity of
Rev towards survival. If adducted G's were a major source of spontaneous damage, such that
cells needed a specialized enzyme for their bypass, reviA strains might be expected to show a
growth defect, which they do not (L. Waters, unpublished observation). Additionally, Revl has
been shown to efficiently bypass other lesions as well, including adducted A's and abasic sites.
Insertion of C opposite these lesions would not result in accurate bypass.
Other lesions bypassed by Rev1 in vivo?
Kinetic and structural parameters indicate that other lesions besides adducted G's may
also preferentially bound by Revl. The crystal structure of Revl suggests that the steric
discrimination used to select for binding to a template G over an A, T, or C would provide no
selection against an abasic site (47). The KM for Rev1 template binding opposite to abasic sites
indicates that they may be a relevant substrate in vivo. In both yeast and mammalian systems,
purified Rev1 displays only a 2.5 - 25-fold discrimination for template G's relative to template
abasic sites (20, 39, 41, 71). Thus, abasic sites may also serve as a significant source of Revl
lesion bypass events in vivo for all organisms. Indeed, insertion of C's opposite to abasic sites is
specifically lost in cells bearing a catalytically inactive Rev1 (50, 56).
Additionally, in vitro mammalian Revl shows only a -10-fold discrimination for
template G's over template A's or template U's (39, 41, 71). In contrast, yeast Revl exhibits a
--600-fold discrimination against A's in vitro (20) which is borne out by the crystal structure
showing loss of stabilizing bonds and potential steric clashes with a template A (47). Activity
opposite a template U has not been measured for yeast Revl. Therefore, adducted A's or C's
which have deaminated to U's may also be lesions which employ the catalytic activity of Revl in
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mammals. Since bypass by Rev of abasic sites, adducted A's, and inappropriate U's would be
predominantly mutagenic, it is not clear whether these substrates would be considered as cognate
lesions. It is also not clear why cells might use Rev1 to bypass these lesions.
Since abasic sites are non-informational lesions, they cannot be bypassed in an accurate
manner. However, if the base lost most often endogenously to produce an abasic site were a G,
then insertion of a C by Revl would only rarely result in a mutation. While it has been shown
that purines are hydrolyzed from DNA -20-fold more frequently than pyrimidines, it does not
seem that G's are lost more frequently than A's in vivo (3, 11). One possible scenario for
predominant loss of G's would be that upon deamination of C's, the loss of a hydrogen bond
would destabilize the G-C base pair and allow hydrolysis of a G more frequently than an A.
Still, it seems reasonable that cells would not have selected for a polymerase optimized only to
insert C's opposite to abasic sites unless the vast majority of abasic sites were produced by
hydrolysis of G. Moreover, repair of abasic sites by base excision repair would be occur with
much higher fidelity since the undamaged strand is used as a template to restore the damaged
sequence. Thus, it seems more likely that cells co-opted an already existing dCMP transferase to
perform translesion synthesis over an abasic site when no other option was available. This may
be especially relevant in mammals, which generate immunoglobulin diversity by targeted
deamination events which are processed to generate abasic sites (5). Abasic sites are likely to be
a particularly severe problem for cells, as base hydrolysis leading to abasic sites is the most
common form of spontaneous DNA damage, occurring in each mammalian cell -10,000 times a
(lay (36). Possibly the misincorporation of C's across from spontaneously generated abasic sites
contributes to an advantageous basal level of mutagenesis which allows the generation of
variation necessary for evolution.
Whether Revl is employed in mammals to bypass adducted A's and U's found
inappropriately in DNA is unknown. Ethenoadenine adducts are commonly produced after
exposure to oxidative stress, which is commonly encountered during inflammation in
mammalian tissues and is associated with cancer (16). In vivo, ethenoadenine adducts are highly
mutagenic (16) and human Rev has been shown to bypass a 1, N6-ethenoadenine adduct by
insertion of a C (71). Why mammalian cells would preferentially use Rev1, which would bypass
adducted A's and C's in a highly inaccurate manner, over another TLS polymerase, which might
do so more accurately, is an open question.
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Importance of Revl's unique activity
Given that all eukaryotic cells possess a highly optimized DNA polymerase specialized
for DNA synthesis of only one base pair-insertion of a C opposite a template G, it seems
reasonable that this activity is used for an important cellular function which is relevant to a wide
variety of organisms living under many diverse conditions. This function may include such
processes as replication of G quartets or maintenance of G-rich telomeres. Alternatively, Rev 1
activity may be needed to bypass a particular DNA lesion. Since the sequence of the catalytic
domain of Revl is very highly conserved across all eukaryotes (L. Waters, unpublished
observation), it is likely that the dCMP transferase activity of Revl is likewise very similar
throughout many organisms. Therefore, the lesions which Revl bypasses are likely to be similar
across all eukaryotes and fundamental to the process of living itself. These lesions may occur
either frequently and pose a constant problem for cells or rarely but have serious consequences.
Future studies elucidating the as-yet mysterious function of Revl's specificity for C insertion
opposite a template G will provide critical insight into one of the most enigmatic and
fundamental players in mutagenesis.
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Appendix A
Preliminary Characterization of the Lethal Event
in reviA cells after DNA damage
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Introduction and Results
As shown in Chapter Two, reviA strains are hypersensitive to UV irradiation after release
from G1 arrest while showing only mild survival defects after release from a G2 arrest. At first,
this seemed counterintuitive since Rev1 levels are low in GI and high in G2. I might have
predicted that the requirement for Revl-mediated lesion bypass would occur during the period in
which its levels are highest and therefore that cells lacking Rev1 would show an increased
sensitivity to DNA damaging agents during G2/M. However, we have proposed that the true
substrate for Rev1 is a gap opposite to a lesion generated by repriming of the replicative
polymerase downstream of the damaged base (1). This substrate would only be generated after
replication on a damaged DNA template. Thus, cells which were UV irradiated prior to DNA
replication would immediately encounter DNA lesions and produce gaps opposite to the TT
dimers. In contrast, cells irradiated after replication would require a substantial period of time
corresponding to G2, M, and G 1 until replication generated the proposed substrate for Rev 1-
mediated lesion bypass. During this time, nucleotide excision repair or other high fidelity
processes will repair the TT dimers and reduce the number of lesions encountered by replication
forks. This hypothesis predicts that revIA cells exposed to UV irradiation after release from G
would arrest during late replication or G2/M when the proposed gaps opposite to lesions are
being processed in a Rev 1-dependent manner.
To test this prediction, I observed the cell cycle stage of rev1A cells after release from Gi
arrest following a dose of UV irradiation which killed -99 % of revlA cells. To monitor cell
cycle progression, I quantified the percentage of budded cells at various times after UV
irradiation by microscopic inspection. While wild-type cells showed significant accumulation of
budded cells 2 hrs after release, rev1A cells lagged behind, perhaps indicating a defect in
initiating or progressing through S-phase (Fig. lA). After 24 hrs, the wild-type cells had all
formed microcolonies and by 48 hrs had grown into a lawn covering the entire plate. In contrast,
even after 48 hrs, -90 % of revlA cells were arrested as budded cells (Fig lA). The observation
that rev1A cells arrest as budded cells supports the hypothesis that Revl activity is required
specifically after replication on damaged DNA templates produces gaps opposite to DNA
lesions. Interestingly, rad30A cells, which lack DNA polymerase r', do not display a bias in
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arrest stage (Fig 1 A), consistent with the fact that Rad30 is not subject to cell-cycle regulation at
the protein level and does not show differential sensitivity to UV irradiation throughout the cell
cycle (1). These results might be confounded by alterations of the DNA damage checkpoints in
the rad30A and rev1A cells, however it is unclear at this time how loss of TLS polymerases
affect checkpoint function.
Further examination of the rev1A cells after 48 hrs revealed that approximately half of the
budded cells were arrested with a small bud indicative of S-phase and half with a large bud
indicative of G2/M (Fig. 1B). Additional experiments using DAPI staining and anti-tubulin
immunofluorescence will be performed to address more precisely where reviA cells arrest after
DNA damage. In the future, methods which more robustly reveal replication status, such as
DNA combing or incorporation of radiolabelled nucleotides, could be employed to determine at
what point during replication Revl is required for viability.
Materials and Methods
Strains. Strains used were derivatives of the wild-type strain W1588-4A: MATa ade2-1 ura3-1
his3-11,15 trpl-1 leu2-3,112 canl-100 RAD5 (2). All strains were barl::LEU2 and additionally
contained revl::kanMX4 or rad30::kanMX4 deletions.
Cell cycle arrest assay. Logarithmically growing barlA yeast were arrested with 50 ng/mL a-
factor for 4 hours at 25 'C or until cultures displayed at least 95 % unbudded cells. Cells were
washed twice to remove a-factor and plated on SC media. Plates were irradiated at 1 J/m2/sec
using a G15T8 UV lamp (General Electric) at 254 nm. A dose of 20 J/m 2 was used since this has
been previously shown to result in -99 % lethality (1). Plates were examined by light
microscopy at the indicated timepoints.
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Fig. 1 revlA cells accumulate as budded cells after UV irradiation following release from G1
arrest. (A) Quantitation of unbudded vs. budded cells reveals that revAl cells predominantly
arrest as budded cells following UV irradiation, while rad30A cells show equal numbers of
arrested unbudded and budded cells. (B) revlA cells accumulate both as small budded and as
large budded cells.
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Appendix B
Initial Characterization of the Molecular Mechanism
of the Regulation of Rev1
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Introduction
As discussed in Chapter Two, Revl is subject to pronounced cell-cycle regulation,
fluctuating -50-fold between GI and G2/M (26). The molecular mechanisms of this regulation
are currently unknown, however the majority of the cell-cycle dependent oscillation in the
concentration of the Revl protein appears to occur at the post-transcriptional level (26). REV1 is
a member of the poorly characterized RAD6 epistasis group of post-replication repair genes,
which includes many genes involved in various types of post-translational regulation: multiple
E2 ubiquitin conjugating enzymes and E3 ubiquitin ligases; a modifier of a major E3 ubiquitin
ligase controlling cell cycle progression; a cell-cycle regulated kinase required for the initiation
.of replication; and a proteasomal subunit.
When I undertook this work, it was known that five members of the RAD6 pathway were
E2 ubiquitin conjugating enzymes (RAD6, MMS2, and UBC13) or E3 ubiquitin ligases (RAD18
and RAD5), however their targets were unknown (11, 25). Since that time, it has been shown
that the Rad6/Radl 8 heterodimer is responsible for monoubiquitinating IPCNA after DNA
damage and that Rad5/Mms2/Ubc 13 polyubiquitinate PCNA through non-canonical K63
linkages (9, 11). Since ubiquitination often leads to degradation, either directly or indirectly, I
hypothesized that RAD6, RAD18, RAD5, MMS2, or UBC13 may affect the cell-cycle dependent
regulation of Rev 1.
The pattern of Revl expression I observed in wild-type cells was consistent with
degradation by the anaphase-promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase
which is responsible for regulation of the cell cycle through timed ubiquitination of cyclins and
other cell cycle factors (27). Revl interacts with the Rev7 subunit of DNA polymerase C in
yeast, flies, and mammals (1, 4, 6, 8, 17, 19, 23, 24). In higher eukaryotes, Rev7 also interacts
with the spindle checkpoint protein Mad2 (18). Moreover, similar to Mad2, Xenopus Rev7
interacts with components of the APC/C and inhibits cell-cycle progression (3, 21). Although
yeast Rev7 has not been shown to have such a function, I wanted to investigate whether REV7 is
responsible for any part of the cell-cycle-dependent expression of Rev1.
One of the most intriguing members of the RAD6 epistasis group is CDC7, a kinase
required for the initiation of S-phase. Different mutant alleles of CDC7 can display either a
hypermutator or a hypomutator phenotype after DNA damage (12). The fact that CDC7 mutants
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show both an increase and a decrease in mutagenesis implies that CDC7 may be involved in
regulating mutagenic TLS. Indeed, cdc7A mcm5-bobl mutants were recently found to be
epistatic to rev3A mutants for survival after UV irradiation, although they show an additive
relationship for survival after exposure to MMS (20). Although Cdc7 levels do not change
during the cell-cycle, its interacting partner Dbf4, which is required for Cdc7 kinase activity,
displays cell-cycle regulation, peaking during late Gi/early S-phase (14). Interestingly, Dbf4
contains a BRCT domain (5) and it is attractive to speculate that the Cdc7-Dbf4 complex binds
to the BRCT domain of Rev1 in order to phosphorylate Rev1 and alter its levels and/or activity.
In order to analyze the effect of CDC7 on Revl expression, two temperature-sensitive alleles can
be employed: cdc7-1 which displays a reduced frequency of mutagenesis and cdc7-4 which
displays an increased mutation frequency (12).
I also initiated an investigation into the role of a proteasomal subunit in Rev 1 cell-cycle
regulation. UMP1 has been implicated in REV3-dependent mutagenesis (16, 22). Since an
umplA strain and other proteasomal mutants show a slight hypermutator phenotype (16, 22), I
'wondered if the proteasome was responsible for degrading Revl in a cell-cycle dependent
fashion and further, if aberrantly high levels of Revl caused by proteasome dysfunction might
result in an increase in mutation frequency.
The above genes were mostly implicated in ubiquitin-mediated degradation as a
mechanism controlling cell-cycle expression. To directly address whether Rev1 cell-cycle
expression was mediated by degradation, I employed a modified pulse-chase analysis to compare
the half-life of Rev1 protein in GI relative to G2.
The preliminary results from these experiments have begun to provide us with an
explanation for the cell-cycle regulation of Revl. Understanding of the regulation of Rev will
provide us with valuable insight into its function in vivo, which is still unclear despite decades of
research.
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Results
RAD6, RAD18, MMS2, UBC13, and REV7 have little effect on Revl expression levels
To investigate the effect of several genes known to mediate ubiquitination or cell cycle
arrest, I moved kanMX4 disruption cassettes from the deletion library into the Rev 1-TEV-ProA-
His 7 strain and assayed for the expression of Rev throughout the cell cycle. An abbreviated set
of timepoints were taken to gain a quick look into whether Revl levels were aberrantly high in
G1 or whether they failed to accumulate in G2/M. The results showed no striking difference in
the pattern of Rev expression (Fig. 1A), indicating that the majority of the cell-cycle regulation
of Rev1 is independent of these factors or depends on a redundant function not disrupted in the
single mutant strains. However, some subtle alterations were observed. The maximal levels of
Rev1 were somewhat lower in the mms2A and ubcl3A strains. Moreover, the last 120 min.
timepoint representing M phase may show a reduction in Rev1 levels. As this experiment was
only performed once, replicates are needed to determine whether these observations are
reproducible. Both the rad6A and radl8A strains exhibited slow growth; in particular the
rad6A strain grew so slowly that it did not achieve > 95 % unbudded cells until after 8 hrs in a-
factor arrest at 30 'C, relative to only 4.5 hrs at 25 'C for the other strains. Due to the extremely
slow growth of the rad6A strain, only the first timepoint immediately after release from a-factor
was taken for cell cycle analysis. The rad6A mutant showed no detectable Revl in G1. The
slow growth and pleiotropic phenotypes of rad6A mutants have led many groups to use radl8A
strains instead to analyze rad6A effects specific to DNA damage tolerance, as Rad6 requires
Radl 8 to monoubiquitinate PCNA (9). In this experiment, the radl8A strain showed an
essentially wild-type Rev 1 pattern, however the overall levels of Revl may be reduced.
Subsequently, the effect of a rev7A mutant on Rev1 expression was investigated.
Overall, Rev1 levels were low after release from GI and accumulated as cells entered G2,
indicating that REV7 does not play a major role in the cell-cycle regulation of Revl (Fig. 1B).
However, relative to the previously observed pattern, the rev7A strain showed higher levels of
Revl in G1 and a more gradual accumulation through the cell cycle. These results require
repeating, especially since the rev7A strain grew uncharacteristically slowly in this experiment.
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Fig. 1 Revi expression is not significantly altered in rad6A, radl8A, mms2A, ubcl3A, or rev7A
strains. (A) Immunoblot shows that Revi levels are low during GI and rise as cells enter G2 in
the indicated mutant backgrounds. FACS analysis monitors cell cycle progression. Due to its
extremely slow growth, only the 0 min. timepoint was taken for the rad6A strain. (B)
Immunoblot showing Revl cell cycle expression in a rev7A strain. A bubble prevented transfer
of protein in the region of the 0 and 20 min. timepoints, as indicated by the grey type. FACS
analysis shows DNA content of cells as they progress through the cell cycle.
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CDC7 and UMP1 alter Revl levels, perhaps in a cell-cycle dependent manner
The role of CDC7 in the cell-cycle regulation of Revl was analyzed by moving the Revl -
TEV-ProA-His 7 epitope tagged construct into a strain bearing the temperature-sensitive cdc7-4
allele. Revl expression throughout the cell cycle was monitored at the permissive temperature to
allow cell cycle progression. It should be noted that the original cdc7-4 mutant in the Hartwell
strain background was only back-crossed 3 times with W303 to generate the strain used here.
'Therefore, the cdc7-4 strain used in the experiment may be slightly different from our W303-
based lab strain used as a control, so the effects observed may result from a mutation present in
one genetic background relative to the other. As an additional complicating factor, the strains
released poorly from ao-factor, as seen in the FACS analysis. However, with these caveats in
mind, the cdc7-4 strain did show -5-fold or more increase in Rev1 levels in GI relative to the
wild-type (Fig. 2). Interestingly, the cdc7-4 allele is reported to have an increased mutation
frequency (12). As higher levels of Rev were observed, the cdc7-4 background may promote
Revl accumulation and hence mutagenesis. It is difficult to compare Revl levels at any other
timepoint since the cdc7-4 did not display the same kinetics of cell cycle progression as the wild-
type, therefore correlating cell-cycle stages between the two strains is too subjective. In order to
perform this experiment in a more robust manner, the cdc7-4 allele will be moved to our lab
strain background. The cdc7-1 allele will also be moved and tested for its effect on Rev
expression. As the cdc 7-1 strain displays a reduction in mutagenesis (12), it will be fascinating
to determine if Rev 1 levels are lower in this mutant background.
Finally, the role of UMP1 on Rev1 expression was investigated in collaboration with
Mary Ellen Wiltrout. Preliminary evidence clearly indicates that Rev1 levels are significantly
higher in an umplA strain, as well as after treatment with the proteasome inhibitor MG132 (M.E.
Wiltrout, unpublished data). However, at this time it is unclear whether this represents a
constant degradation throughout the cell cycle or whether the proteasome is employed at specific
times to promote cell-cycle dependent turnover of Rev1.
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Fig. 2 Revl levels are -5-fold higher in GI in a cdc7-4 mutant strain. (A) Immunoblot shows
that Revl displays cell-cycle dependent expression in the cdc7-4 mutant strain. (B) FACS
analysis monitoring cell cycle progression in the cdc7-4 and WT strains. (C) Quantitative
dilutions of the 0 min. timepoint from part A shows that Rev is expressed at a higher level in
the cdc7-4 mutant background. Ponceau-S staining of the membrane revealed that the total
protein concentration in the cdc7-4 whole cell lysates was twice that of the protein concentration
in the WT samples. Thus, Revl is present at -5-fold higher levels in the cdc7-4 strain just after
release from GI arrest.
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Revl degradation may not contribute to its cell-cycle expression
To monitor the half-life of the Revl protein in Gi arrested cells relative to G2 arrested
cells, I employed a modified pulse-chase protocol using a C-terminally HA-tagged Rev1
construct under the control of the galactose-inducible promoter. Revl expression was induced
with galactose and cells were arrested in G1, S, or G2. At time zero, glucose was added to the
cultures to prevent further Rev expression and timepoints were taken as indicated. The
galactose induction corresponds to a pulse of Rev1 expression followed by a chase phase when
Revl is repressed by the addition of glucose. However, unlike a classical pulse-chase
experiment where radiolabelled amino acids specifically monitor protein stability, in this assay,
mRNA stability influences the outcome of the protein levels as well. To remove the
complicating factor of the mRNA stability, in the second experiment cycloheximide was added
to prevent further translation from any remaining REVI transcripts. Despite the difference in
experimental design, both replicates of the assay consistently showed that, under these
conditions, the Rev1 protein is reasonably stable throughout the cell cycle (Fig. 3). In fact, the
half-life of Revl in Gl -arrested cells appeared to be slightly longer than in G2-arrested cells
(Fig. 3). The Rev -1 protein, which contains a mutation in the BRCT domain which inactivates
its function in vivo, shows equivalent stability to the wild-type protein (Fig. 3B). Interestingly,
under these conditions, Rev 1 is able to be overexpressed stably in Gl and is only present at -3-
fold lower levels than in G2, despite being present at -50-fold lower levels in G1 than in G2
under normal chromosomal regulation (26). Thus, misregulation of Revl by overexpression in
G I is possible. This finding can inform future experiments probing the effect of ectopic
expression of Rev in G 1. Though these preliminary experiments do not have a control to
confirm that the assay worked properly, the results indicate that Revl may not be subject to
differential degradation throughout the cell cycle. Future work will confirm and extend these
findings.
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Fig. 3 Rev1 cell-cycle expression does not seem to be controlled significantly by degradation.
(A) Immunoblot shows Revi stability is roughly the same cells arrested in G1, S, or G2. (B)
Immunoblot showing Revl and Revi-1 protein stability after addition of cycloheximide in G1 or
G2 arrested cells.
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Discussion
Summary of results
A candidate gene approach was taken in order to determine the molecular mechanisms
controlling the cell-cycle regulation of Revl. For several of the genes investigated, no
significant alteration in Revl levels was observed. In retrospect, the lack of an effect may not be
surprising in the case of the mms2A and ubcl3A mutants or the rad6A or rad18A mutants since
these genes mediate K63-linked polyubiquitination and monoubiquitination respectively, neither
of which are not thought to be involved in protein degradation (10, 11). An indirect role of these
modifications in promoting protein degradation is not excluded, however since no major change
in Revl expression was observed, it is not likely that such an indirect effect occurs. More subtle
alterations of Rev1 protein levels may be important and need to be investigated further.
In contrast, two less characterized members of the RAD6 epistasis group appear to be
involved in regulating Revl: CDC7 and UMP]. Since Revl appears to increase slightly after
cells initiate replication and slowly accumulates throughout S-phase (26), I speculated that Cdc7-
Dbf4 may phosphorylate Revl upon entry into S-phase to allow accumulation of very low levels
during replication. A second Rev1 modification as replication is completed may promote
significant stabilization of Rev1 as its levels rapidly increase during late S-phase as cells enter
G2. Indeed, preliminary data supports a role for CDC7 in controlling Revl levels. Although the
Cdc7 kinase is only activated after GI when its regulatory subunit Dbf4 is expressed, I observed
increased Revl levels in the cdc7-4 background immediately after release from G1. This may
indicate a non-catalytic role for Cdc7 in Revl accumulation during Gi or that Cdc7 can be
activated by another subunit in G 1. This result is very preliminary, but the difference observed is
worthy of further experiments to verify the importance of CDC7 to Rev 1 expression.
Additionally, degradation by the proteasome, mediated by the Ump 1 subunit, reduces
Revl levels by -10-fold (M.E. Wiltrout, unpublished data). This may be a continuous process
throughout the cell cycle to keep Revl levels low even during G2/M, or Revl may be subject to
proteasomal degradation only during G1 and S-phase. The preliminary results from the modified
pulse-chase assay indicate that Revl protein is as stable in G1 and S-phase as in G2, supporting
the former possibility. However, this experiment may suffer from artifacts imposed by the long
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galactose induction necessary to observe Revi or by the overexpression of Revi from a high
copy plasmid. Thus, further experiments are underway to investigate this question (M.E.
Wiltrout, unpublished data).
Model for regulation of REV1 activity by ubiquitin
Revl binds to monoubiquitin through recently identified ubiquitin-binding motifs
(UBMs) (7). Additionally, the UBMs mediate self-monoubiquitination of Revl (7). The
biological relevance of this modification is currently unknown. I speculate that, similar to the
auto-inactivation exhibited by Src kinase (2), the UBMs of Revi may mediate its
monoubiquitination and then, via in an intramolecular interaction, bind to its own monoubiquitin
moiety. This would prevent the recruitment of Revl to monoubiquitinated PCNA and inactivate
its localization to sites of DNA damage. Upon DNA damage, a deubiquitinating enzyme (DUB)
may relieve the inhibition of Revl localization by removing the monoubiquitin moiety from
Rev 1. Thus freed from self-interaction, the UBMs of Revl would facilitate recruitment of Revl
to monoubiquitinated PCNA at sites of DNA damage. Once present at a blocked primer
terminus, Revl would promote translesion synthesis and subsequently might serve as its own E3
ubiquitin ligase to inactivate itself once more, preventing further unnecessary and potentially
mutagenic TLS. A convenient source of monoubiquitin would be provided by PCNA itself.
Transfer of the monoubiquitin moiety from PCNA to Rev would thus accomplish two levels of
inhibition of TLS-inactivation of Rev 1 activity and removal of the recruitment signal on PCNA
for translesion polymerases. Although highly speculative, this model is consistent with the
current evidence that, while Rad6 and Radl 8 are required to activate mutagenic TLS after DNA
damage, they do not control the cell-cycle expression of Rev1.
Materials and Methods
Strains and Primers. Strains used are shown in Table 1. All strains are derivatives of W1588,
a W303 strain corrected to be RAD5 (28). Briefly, kanMX4 disruption cassettes from the yeast
deletion collection were amplified by PCR and transformed into the REVl-TEV-ProA-
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7His.:HIS3MX6, barl::LEU2 strain. For the cdc7-4 strain, the REV]-TEV-ProA-
7His::HIS3MX6 cassette was amplified by PCR and transformed into strain OAy711. As the
cdc 7-1 strain is already His+ (15), the epitope tagged Revl construct could not be moved into the
cdc7-1 strain background by this method. Primers are shown in Table 2.
Cell Synchronization. Logarithmically growing barlA yeast were arrested with 50 ng/mL a-
factor for 4 hours at 25 'C or until cultures displayed at least 95 % unbudded cells. Cells were
washed twice to remove a-factor and released into YPD media. Timepoints were removed as
indicated for TCA precipitation and FACS analysis.
FACS Analysis. Following fixation in 67% ethanol at 4 OC for up to one week, cells were
washed in 50 mM sodium citrate and incubated overnight at 50 oC with 250 ptg/mL RNaseA
(Qiagen). Proteinase K was added to 500 ptg/mL and incubated at 50 'C for 1 hour. Cells were
sonicated, stained with 16 jtg/mL propidium iodide (Sigma), and analyzed on a Becton Dickson
FACSCalibur flow cytometer.
Immunoblots. Whole cell extracts were prepared by TCA precipitation (13) and were separated
by SDS-PAGE. Proteins were transferred to PVDF membrane (Millipore) using a Mini-
PROTEAN II transfer apparatus (Bio-Rad). Ponceau-S staining confirmed that the total protein
loaded in each lane was equivalent. Antibodies used were rabbit PAP antibody (Sigma) against
the protein A tag, anti-HA. 11 (Covance), and anti-phosphoglycerate kinase (Molecular Probes).
PGAL Pulse-Chase Assay. A rev1A strain bearing pAC311-REV 1-HAC or pAC-revl-1-HAC
(4) was grown in SC-Trp media containing 2 % sucrose as a carbon source. Approximately
eighteen hours prior to arrest, cells were resuspended in SC-Trp media containing 2 % galactose
to induce Rev1 expression. Logarithmically growing barldA yeast were arrested with 50 ng/mL
a-factor (SynPep), 200 mM hydroxyurea (Sigma), or 15 ptg/mL nocodazole (Sigma) for 4 hours
at 25 OC or until cultures displayed at least 95 % unbudded cells for GI arrest or at least 95 %
budded cells for S-phase and G2 arrest. At time zero, glucose was added to a final concentration
of 2 % and timepoints were removed as indicated for TCA precipitation. In Fig. 3B,
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cycloheximide (Calbiochem) was added to a final concentration of 50 ýtg/mL at the same time as
glucose addition.
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Table 1: Strains used in Appendix B
Strain Genotype
W1588-4C
JAy 19
rad6A Rev -tag
rad] 8A Rev 1-tag
mms2A Rev -tag
ubc]3A Rev1-tag
rev7A Rev -tag
unmplA Rev -tag
revlA barl A
RM 14-3 a
OAy711
cdc 7-4 Rev 1 -tag
MATa ade2-1, ura3-1, his3-11,15, trpl-1, leu2-3,112,
canl-100, RAD5
barl .:LEU2, REV1 -TE V-ProA- 7His.HIS3 MX6,
RAD30-TEV-ProA- 7His.:HIS3MX6
rad6.-::kanMX4, barl].:.LEU2, REV1. TEV-ProA-
7His.:HIS3MX6
radl8.::kanMX4, barl].:.LEU2, REV1.TEV-ProA-
7His:.HIS3MX6
mms2..kanMX4, barl .:LEU2, REVI:TEV-ProA-
7His. HIS3MX6
ubcl3..kanMX4, bar].:LEU2, REV:.TEV-ProA-
7His.:HIS3MX6
rev 7.. kanMX4, barl .LEU2, REV1:TEV-ProA-
7His. HIS3MX6
ump-l:.kanMX4, bar1.:LEU2, REV1:TEV-ProA-
7His. HIS3MX6
revl ..kanMX4, barl.::.LEU2
MATa cdc7-1, barl, ura3-52, trpl-289, leu2-3,112,
his6
MAT a ade2, ural, ura3, his3, his7, leu2, cdc7-4
OAy711 REV]-TEV-ProA-7His.:HIS3MX6
Rothstein lab (27)
R. Woodruff
this study
this study
this study
this study
this study
M.E. Wiltrout
L. Waters (25)
Bell lab, (14)
Bell lab
this study
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Primer Name
Rad6-f
Rad6-r
Radi8-f
Rad 18-r
Mms2-f
Mms2-r
Ubcl3-f
Ubc 13-r
REV7DELAFWD
REV7DELDBKWD
RevID
Rev 1E
Umpl-fwd
Ump I-rev
Sequence
GGTGACTACATTTCCCGGATTAG
CGGGTATCGGCAGTTATAACC
CTTGCCCCGTTGCCTTGC
CAGCACTTAACGTGGAGATCAC
CATTGCAATGCCGCTCTCACATC
CTTGGGTGCAACAGTCTTTCTG
CCGCATCCGTATTGTTACCCG
CTTACATTAGTGTAGGACGGTCG
AGTATGTATTTCTTTTCCCCTTGCT
CGCCACTTACAAAATATTCAAGACT
GTGAAACAATGGGTTGCCGAAACTTTAGGTGATGG
GGCGAGGTCTTTCGGAATGGTGG
CAGGATTTAAGAAGTCCATACCGCAGG
CCTCCAACTGGATTCAACTGAAACTGG
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Appendix C
Purification of Revl
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Introduction and Results
A major focus of my thesis research was to identify the interacting partners of Rev1 in S.
cerevisiae. Additionally, I wanted to produce antibodies to Revl that could detect its
endogenous levels. To that end, I generated epitope tagged constructs for Rev expression both
in E. coli and yeast and attempted several purification schemes outlined below.
Overexpression of Revl from plasmids in S. cerevisiae and E. coli
I was able to purify a small amount of Revl from overexpressing plasmids in yeast and
E. coli, but the protocols were never optimized and were not pursued in order to focus on
purifying native levels of Revl and its interacting partners. First, I set out to purify Revl from
yeast using pJN60, a high-copy plasmid containing an N-terminal GST fusion to Rev1 under a
galactose-inducible promoter (4). The yield of Revl was poor, so I turned to bacterial
expression systems. To purify Revl from E. coli, three plasmids were created: pGEX-Revl,
pET16b-Revl, and pET11T-Rev1. pGEX-Revl encoded an N-terminal GST fusion to Revl
under the PTac promoter and included a thrombin protease site in the linker between GST and
Rev 1. The thrombin digestion was very ineffective and overnight incubation resulted in the
disappearance of Revl. Additionally, much of Revl expressed in E. coli seemed to be insoluble
and precipitated in the pellet after centrifugation of the crude lysate. Thus, I turned to using an
N-terminal His6 tag to allow purification of Revl under denaturing conditions in order to obtain
large amounts for antibody production. To this end, I constructed pET16b-Revl and pET11T-
Revl which both expressed His 6-Revl from the T7 promoter. The pET 11T vector contains a
terminator upstream of the T7 promoter which substantially reduces background expression
levels (5) and has been used successfully to express moderately toxic proteins at high levels (2).
Both of these plasmids seemed to express equivalent amounts of Rev 1. I transformed the His6 -
Revl plasmids into multiple E. coli strains optimized for expression of eukaryotic proteins and
fbund that optimal induction of Rev 1 from pET16b required short inductions at low temperatures
to prevent rampant degradation (Fig. 1). Initial purification attempts were thwarted by low yield.
It was decided to pursue antibodies directed against Rev1 synthetic peptides and to purify Rev1
and its interacting partners from natively expression levels in yeast.
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Optimal induction conditions: 1-3 hours at 18 - 23 oC.
Fig. 1 Optimum expression of full-length Rev in E. coli requires short induction times at low
temperatures. (A) Immunoblot directed against the N-terminal His 6 tag of Rev1. Cells were
grown to OD 600 -0.5 and IPTG was added to a final concentration of 1 mM. Lane 1 contains
whole cell lysate from a strain bearing the empty vector pETi 6b, lane 2 shows lysate from an
uninduced culture. Both lanes 1 and 2 exhibit a cross-reacting band just below full-length His6-
Rev l. Lanes 3 - 15 show different induction conditions as indicated. Cells were harvested and
boiled in loading buffer to prepare samples for SDS-PAGE.
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Purification of natively expressed Rev1 in S. cerevisiae
For purification of Rev1 expressed from its native promoter in the chromosome, I used a
C-terminal protein A epitope tag which has a high affinity for IgG. I grew large volumes of cells
to mid-late log phase to obtain a dense culture in which cells were still actively growing, since
Revl is predominantly expressed during G2/M. Cells were collected, lysed, and the lysate
applied to IgG beads. The beads were washed and a pre-elution sample was taken to analyze the
amount of Rev1 bound to the beads before elution with TEV protease. The beads were also
boiled to assess the efficiency of TEV cleavage by observing the amount of Revl remaining on
the beads. Samples were analyzed by SDS-PAGE followed by either Sypro Ruby staining or by
Western blot detection against the protein A epitope tag. Sypro Ruby can detect -1 ng or less of
protein per band. Even with this level of sensitivity, it was very difficult to detect Rev 1 on
stained gels, although Revl could be easily seen by Western blotting, indicating that the yield of
the purification was very poor (<1 ng/L).
I repeated this purification, with some variations, nine times in an attempt to optimize the
protocol, however I was only able to observe Rev by Sypro Ruby staining in three experiments
(Fig. 2). In two experiment could I detect potentially copurifying bands specifically found in the
eluates from the Rev1-tag strain and not found in the WT eluates (Fig 3). The identity of these
bands is unfortunately unknown. In order to visualize the bands, I loaded the entire sample onto
the gels and thus had no eluate fraction remaining to send for mass spectrometry analysis. Sypro
Ruby staining is only detectable by fluorescence imaging so I could not cut out the bands, and
silver staining was not sufficiently sensitive to detect these proteins. It is possible that the -68
kD bands correspond to Rad30, which encodes DNA polymerase r1 in yeast, although genetic
and biochemical evidence indicates that Revl and Rad30 do not interact [(1, 3); R. Woodruff,
unpublished data]. Alternatively, the -68 kD band may represent the Ddc 1 subunit of the
alternative 9-1-1 sliding clamp. The -175 kD band may correspond to the Rev3 catalytic subunit
of DNA polymerase ý. Unfortunately, leaching of IgG molecules from the beads prevented
identification of any bands smaller than 50 kD. To test the identity of these bands or to detect
proteins present at less than 1 ng, a candidate Western blot approach could be used to assay for
enrichment of particular proteins, such as PCNA or Rev7, bound to the Rev -tag beads relative
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to the WT control beads. Due to progress in other areas of my research, I did not employ this
method, although we did obtain antibodies to several candidate proteins.
By Western blot, I could determine that at least 50 % of Rev 1 present in the crude extract
was precipitating in the pellet after centrifugation (Fig. 4A). However, Revi was substantially
enriched on the beads prior to elution, indicating that the purification was effective but needed to
be optimized (Fig. 4A). During the optimization of the purification (Fig. 4B), I discovered that
Revi was expressed differentially throughout the cell cycle and began to pursue the
characterization of Revl regulation. Due to advances in other areas of my project, the
]purification was never performed after DNA damage or under G2 arrest when Rev levels are
high. It would be very interesting to repeat the purification of Rev using the new knowledge we
have gained regarding its cell-cycle regulation and proteasomal degradation. Indeed, a
combination of approaches using G2-arrested yeast as well as proteasomal inhibitors like MG132
may increase the starting concentration of Revi in cell lysates to the point where copurification
of Revl and its interactors may be feasible.
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Fig. 2 Visualization of Revl and Revl-TEV-ProA-His 7 in purified fractions. (A) Sypro Ruby
stained gel of the pre-elution, elution, and post-elution fractions from the first trial of the protein
A purification. (B, C) Sypro Ruby stained gel from the third (B) and sixth (C) protein A
purifications showing bands specifically present in the tagged strain corresponding to the
uncleaved Rev 1-TEV-ProA-His 7 in the pre-elution fractions and the shorter Revl in the elution
fractions. No bands are visible in the post-elution fraction, indicating that TEV protease
effectively digested all the Revl bound to the beads. In (C), cell lysates from 2 L of cells (2x)
compared to lysates from 1 L of cells (lx) did not reveal a corresponding increase in the amount
of Revl purified in this experiment.
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Fig. 3 Visualization of proteins copurifying with Revl. (A, B) Sypro Ruby stained gels from
the third (A) and sixth (B) protein A purifications reveal bands specifically present in lysates
from Revl -TEV-ProA-His 7 cells relative to WT cells.
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Fig. 4 Optimization of lysis conditions to reduce insoluble Revl. (A) Immunoblot directed
against the protein A epitope of Revl shows the efficiency of purification in the fourth protein A
purification. Dilutions (1, 1:10, and 1:50) of the crude lysate, insoluble pellet, and clarified
supernatant fractions reveal that approximately half of the Revl protein in the crude lysate
precipitates after centrifugation. (B) Immunoblot against protein A reveals the amount of
soluble Revl after centrifugation in various lysis buffers. Cells were lysed in a French pressure
cell in a buffer consisting of 50 mM NaH2PO 4, 100 mM NaCl at pH 7.0. Aliquots were taken
and adjusted to the indicated concentration of salt, glycerol, detergents, reducing agents, or pH.
Samples were spun at 15,000 x g, or for the sample in the last lane, at 5000 x g, for 20 minutes.
The supernatant was collected and subjected to immunoblot analysis.
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Materials and Methods
Strains and Primers. Strains used were derivatives of W1588-4C, a W303 strain corrected for
RAD5 (6), and are described in Table 1. Primers used to create the strains are shown in Table 2.
Protein A Purification. Yeast cells bearing the Rev1-TEV-ProA-His 7 epitope tagged construct
under the native promoter in the chromosome were grown to mid-late log phase (OD 600 ~0.7 -
0.9) to obtain a dense culture in which cells were still actively growing to enrich for higher levels
of Revl in cycling cells. At least 1 L of cells were harvested and resuspended in lysis buffer
containing 50 mM NaH2PO 4, 300 mM NaCl at pH 7.0 and protease inhibitors consisting of 5
alg/mL pepstatin, 5 mM benzamidine, 10 mM EDTA, 1 mM EGTA, 1 tablet Mini-Complete
Protease Inhibitors - EDTA (Roche) per 30 mL lysis buffer, and 10 Vpg/mL E-64. Usually, 100
jltg/mL bacitracin and 0.1 % NP40 were also added. Cells were lysed either in French pressure
cell by three passes at 15,000 psi or by grinding with dry ice. In the latter case, cells were frozen
dropwise in LN 2 and stored at -80 oC until the LN 2 had evaporated. Cells were then added to a
coffee grinder (Krups) filled with dry ice and ground for 5 min. at 4 OC. The lysate was thawed
for 1-2 hrs at 4 'C to remove dry ice. No difference was observed in the amount of Rev 1 in the
crude lysate was observed between these two lysis procedures. The lysate was clarified by
centrifugation either at 15,000-20,000 x g or at 1500-2000 x g and the supernatant applied to
magnetic beads (Dynal) coated with rabbit IgG (Sigma). The beads were washed and a pre-
elution sample was taken to analyze the amount of Rev 1 bound to the beads before elution.
Between 25 and 100 units of TEV protease (-1 U/tiL) (Invitrogen) was added to cleave Rev1
from the protein A tag and incubated between 1 hr and overnight at 4 oC. The beads were also
boiled to assess the efficiency of TEV cleavage by observing the amount of Rev1 remaining on
the beads. Variations on the procedure included different volumes of cells harvested, an
ultracentrifugation step, a DNaseI digestion to clarify the lysate, varying numbers and types of
washes, and in later purifications, different purification resins. For two experiments, rabbit IgG
coupled to Affi-gel (Bio-Rad) was used and in two other trials, Ni-NTA beads (Qiagen) were
used.
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Immunoblots. Fractions from the purification were separated by SDS-PAGE. Proteins were
transferred to PVDF membrane (Millipore) using a Mini-PROTEAN II transfer apparatus (Bio-
Rad). Antibodies used were rabbit PAP antibody (Sigma) against the protein A tag and anti-His
(Santa Cruz) to detect the His 6 tag.
Protein Visualization. Fractions from the purification were separated by SDS-PAGE and
stained with Sypro Ruby (Molecular Probes). Gels were analyzed on a Fluorlmager 595
(Molecular Probes).
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Table 1: Strains used in Appendix C
Strain Genotype
M4T o ade2-,] ura3-1, his3-11,15, trpl-1, leu2-3,112,
canl-100
M4Ta, ade2-1, ura3-1, his3-11,15, trpl-1, leu2-3,112,
canl-100, RAD5
W 1588-4A REV1-TEV-ProA-7His.:HIS3MX6
W303 lys2.:hisG, barl.:.hisG, pep4..kanMX4
taglO pep4..kanMX4
lab stock
Rothstein lab (6)
this study
Bell lab (S. Chen)
this study
E. coli B F ompT hsdS(rB- mB-) dcm
[argU ile& leuW CamR]
Table 2: Primers used in Appendix C
Sequence
PEP4-5' GCGGTTATTGAATCTATGGAGAGGCTG
PEP4-3'ap GGGCAGCAGCATAGAACAATGG
KanMX4-5'ap GTATTCTGGGCCTCCATGTCGC
KanMX-D CGATACTAACGCCGCCATCCAG
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W303
W1588-4A
tag 10
ySC7
Source
BL21-RIL TetR gal endA Hte Stratagene
Primer Name
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Appendix D
Fine Timecourse of Revi Cell-Cycle Dependent Expression
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Results
To investigate the precise timing of Revi accumulation during the cell-cycle, I monitored
Revi expression as described previously (1) at five or ten minute intervals during the cell cycle
(Fig. 1). Cell cycle progression was assessed by FACS analysis as described previously (1), as
well as by microscopic analysis to determine the percent of budded cells. Quantitative dilutions
were used to estimate Revl protein levels relative to the peak value at 120 min. The results
show that Revl levels are nearly undetectable during G1, but rise slightly just prior to or
simultaneously with the initiation of replication at 40 min. after release from a-factor. During S-
phase, Rev 1 levels rise slowly but are still quite low even when the bulk of replication has been
completed at 80 min. Following the completion of replication, Revi protein begins to
accumulate more rapidly in G2. Revl levels appear to peak during mitosis and begin to decrease
as cells exit from mitosis and re-enter G1.
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Fig. 1 Fine Timecourse of Revl Cell-Cycle Dependent Expression (A) Immunoblot showing
Revi protein levels throughout the cell cycle. Note that a long exposure was chosen to
emphasize the difference between G1 and S-phase Rev1 expression. In order to detect Rev1 in
G ( and S, the bands in G2/M are highly overexposed. Pdsl was used as a marker for cell-cycle
progression and PGK (phosphoglycerate kinase) as a loading control. (B) FACS analysis
monitoring DNA content throughout the timecourse. (C) Plot showing the percent budded cells
(solid line) and the percent of Revl protein relative to peak value (dashed line) as a function of
time.
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